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Preface
Scope and ideas of the workshop
The training course “Non-targeted effects of ionising radiation” took place at 
the STUK – Radiation and Nuclear Safety Authority, Helsinki, Finland 14 – 16 
February 2005. Proceeding of this course is collected in this volume. The idea 
of the course was to convene a number of scientists leading in the area of 
non-targeted effects of ionising radiation with the aim to outline their visions for 
the role of these effects and outline the future directions of radiation research 
on the basis of their expertise.
The course was generously supported by the RISC-RAD IP FI6R-CT-
2003-508842, Euratom specific programme for research and training on nuclear 
energy, 6th FP of the EC.
It was clear for almost a decade that the universality of the target theory 
of radiation-induced effects is challenged by observations on non-targeted 
effects such as bystander effects, genomic instability and adaptive response. 
Essential features of non-targeted effects are that they do not require direct 
nuclear exposure by radiation and they are particularly significant at low doses. 
This new evidence suggests a need for a new paradigm in radiation biology. A 
better understanding of non-targeted effects may have important consequences 
for health risk assessment and, consequently, on radiation protection. It is 
important to explore the mechanisms involved in the non-targeted effects of 
ionising radiation, to determine the dose-effect relationships of non-targeted 
effects in space and time, to address the role of individual susceptibility in 
response and to determine whether the non-targeted effects relate to protective 
or harmful responses to radiation. The linkage between the bystander 
response, adaptive response and genomic instability needs to be studied. A 
longer term objective is to establish a conceptual framework for the generation 
of a new radiobiological paradigm that covers both targeted (direct) and 
non-targeted (indirect) effects of ionising radiation. This, in turn would help in 
4STUK-A234
setting the scientific basis for development of a new, more realistic, radiation 
protection system.
Some questions can be addressed by employing a range of low-dose broad 
field and microbeam irradiation approaches to investigate both high- and low-LET 
responses, and by employing well-defined biological systems, such as human cell 
cultures, 3D artificial tissue systems and ex vivo tissue explants. At the cell 
and molecular levels, new research should focus particularly on identifying the 
signals and signal receptors for the non-targeted effects. It will be important to 
understand whether such signals are produced by all cell types and whether 
reception and response is general or limited by cell type or organ. Identifying 
and understanding the action of the signalling process could lead to a means of 
predicting the outcome of an exposure in an individual.
While research at the cellular, molecular and ex vivo tissue levels will be 
critical for understanding the mechanisms of these processes, their influence on 
risk must also be determined more directly. To properly assess the net impact 
of targeted and non-targeted radiation effects, new research should specifically 
employ whole animal models, using both strains that are genetically normal 
and strains that are suspected to be radiation sensitive or cancer prone. Overall 
measures of risk need to be used together with tissue specific measures, and these 
tissues need to be assessed for cellular and molecular changes. These results 
will also be important in understanding the relationship between dose and 
tissue weighting factors as dose decreases. The animal models could additionally 
provide clarification on interactions of non-targeted effects with exogenous 
(e.g. dietary) and endogenous (heritable) variables as a possible part of an 
inflammatory-type response to radiation-induced stress under in vivo conditions. 
Long-term clonal variability of non-targeted responses and cell type differences 
needs to be studied. More information is required on the influence of LET, and 
on simultaneous exposures to radiations of different LET. More information 
is also required on the relationship of dose rate and total dose for induction of 
these responses. Mathematical and statistical modelling is likely to improve the 
understanding of the potential role of non-targeted effects in the development 
of different pathologies.
To summarise, the main objectives of the training course were: (1) to 
clarify the mechanisms of non-targeted effects, in particular, bystander effects, 
genomic instability and adaptive response; (2) to look if and how non-targeted 
effects modulate the cancer risk in the low dose region, and whether they 
relate to protective or harmful functions; (3) to clarify if ionising radiation can 
cause non-cancer diseases or beneficial effects at low and intermediate doses; 
(4) address the issue of individual susceptibility and other factors modifying 
non-targeted responses; (5) attempt to assess the relevance of non-targeted effects 
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for radiation protection and to set the scientific basis for a modern, more realistic, 
radiation safety system; (6) and finally to contribute to the conceptualisation of 
a new paradigm in radiation biology that would cover both the classical direct 
(DNA-targeted) and non-targeted (indirect) effects.
Oleg Belyakov
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BELYAKOV Oleg V. RISC-RAD – epäsuorat isonisoivan säteilyn soluvaikutuk-
set.Kurssijulkaisu. Säteilyturvakeskus, Helsinki, 14. – 16.2.2005. STUK-A234. 
Helsinki 2008, 175 s.
Avainsanat: ionisoivan säteilyn epäsuorat vaikutukset, terveysvaikutukset, 
matemaattinen mallintaminen
Esipuhe
Kurssin aihe ja tavoitteet
Kurssi ”Ionisoivan säteilyn epäsuorat soluvaikutukset” järjestettiin Säteily-
turvakeskuksessa (STUK), Helsingissä 14 – 16.2.2005. Kurssin ohjelma on koottu 
tähän kirjaan. Kurssin ajatuksena oli kutsua koolle alan johtavia asiantunti-
joita tavoitteena luonnostella heidän asiantuntemuksensa pohjalta näkemyk-
siä säteilyn epäsuorien vaikutusten roolista ja suunnitella säteilytutkimuksen 
tulevaisuuden suuntalinjoja.
Kurssin järjestämistä tuki Euroopan komission (6th FP) Euratomin ydin-
energian tutkimus ja koulutusohjelma RISC-RAD IP FI6R-CT-2003-508842.
Jo vuosikymmenen ajan on ollut ilmeistä, että havainnot säteilyn epä-
suorista vaikutuksista, kuten naapurisoluvaikutuksesta, perimän epävakai-
suudesta ja adaptiivisesta vasteesta haastavat yleispätevän teorian säteilyn 
suorista vaikutuksista. Epäsuorien säteilyvaikutusten oleellinen piirre on, että 
niiden syntyminen ei vaadi suoraa säteilyaltistumista ja ne ovat erityisen mer-
kittäviä alhaisilla säteilyannoksilla. Epäsuorien säteilyvaikutusten ymmärtä-
minen voi johtaa terveysriskien uudelleen arvioimiseen ja tämän myötä vai-
kuttaa myös säteilysuojeluun. Ionisoivan säteilyn aikaansaamien epäsuorien 
vaikutusten mekanismien tutkiminen on tärkeää määritettäessä annosvaste-
suhdetta ajallisesti ja paikallisesti, tutkittaessa yksilöllistä alttiutta ja määri-
tettäessä liittyvätkö epäsuorat vaikutukset säteilyn suojaavaan vai haitalliseen 
vasteeseen. Pitkän aikavälin tavoite on muodostaa käsitteellinen kehys uudelle 
säteily biologian paradigmalle, joka pitää sisällään sekä ionisoivan säteilyn suo-
rat että epäsuorat vaikutukset. Tämä vuorostaan auttaa asettamaan tieteelliset 
perusteet uudelle realistisemmalle säteilysuojelujärjestelmälle.
Altistamalla soluja matalille säteilyannoksille leveä- (broad field)- ja 
kapeakenttä (microbeam) olosuhteissa voidaan selvittää sekä tiheään että har-
vaan ionisoivan säteilyn vaikutusta tarkoin määritetyissä biologisissa malleissa, 
kuten ihmisen soluviljelmissä, kolmiulotteisissa keinokudosviljelmissä ja ex vivo 
kudossiirrännäisissä. Solu- ja molekyylitasolla tutkimuksen tulee keskittyä eri-
7STUK-A234
tyisesti tunnistamaan epäsuorien vaikutusten aikaansaamia signaaleja ja niitä 
vastaanottavia reseptorimolekyylejä. On tärkeää tietää, tuottavatko kaikki solut 
näitä signaaleja ja onko signaalien vastaanottaminen ja niihin vastaaminen 
yleistä, vai rajoittuvatko ne tiettyihin solutyyppeihin tai elimiin. Signaalinvä-
litystapahtumien tunnistaminen ja ymmärtäminen mahdollistaa säteilyaltis-
tumisen vaikutusten ennustamisen yksilötasolla.
Säteilyn epäsuorien vaikutusten mekanismien ymmärtämisen kannalta 
on oleellista tutkimus solu-, molekyyli- ja ex vivo kudostasolla. On kuitenkin 
tärkeää myös määrittää tarkemmin epäsuorien säteilyvaikutusten mahdollinen 
vaikutus riskiin. Suorien ja epäsuorien säteilyn nettovaikutusten huolellinen 
arvioiminen vaatii, että tutkimuksen tulee keskittyä eläinmalleihin ja kantoihin, 
jotka ovat geneettisesti normaaleja ja kantoihin, jotka ovat säteilylle ja syövälle 
alttiita. Riskin kokonaismääritys tulee arvioida yhdessä kudosspesifisten mää-
ritysten kanssa ja edelleen solu- ja molekulaaristen muutosten suhteen. Tämä 
on myös tärkeää määritettäessä suhdetta annoksen ja kudoskorjauskertoimen 
välillä kun annos laskee. Eläinmallit saattavat lisäksi tarjota selvennystä epä-
suorien vaikutusten interaktiosta ulkoisten (esim. ravitsemuksellisten) tai sisä-
syntyisten (perinnöllisten) tekijöiden välillä, kun arvioidaan säteilyn aikaan-
saamaa tulehduksellista vastetta in vivo olosuhteissa. Epäsuorien vaikutusten 
aikaansaama pitkän ajan klonaalinen vaihtelevuus ja erot solutyyppien välillä 
tulee myös tutkia. Tietoa tarvitaan myös LET:n (LET Linear Energy Transfer, 
säteilyn luonteenomainen energiansiirtokyky) vaikutuksesta ja samanaikaisesta 
altistumisesta erilaiselle säteilylle. On myös tärkeää selvittää annosnopeuden ja 
kokonaisannoksen suhteesta muutosten syntymisessä. Matemaattiset ja tilas-
tolliset mallit tulevat lisäksi valaisemaan epäsuorien säteilyvaikutusten mah-
dollista roolia erilaisten sairauksien synnyssä.
Yhteenvetona, kurssin päätavoitteet olivat 1) selventää epäsuorien sätei-
lyvaikutusten mekanismeja, erityisesti naapurisoluvaikutusten, perimän epä-
vakaisuuden ja adaptiivisen vasteen mekanismeja; 2) tarkastella muuttavatko 
epäsuorat vaikutukset syöpäriskiä alhaisilla annoksilla ja liittyvätkö ne suojaa-
viin vai haitallisiin vaikutuksiin; 3) selventää voiko ionisoiva säteily aiheuttaa 
muita kuin syöpätauteja ja osoittaa säteilyn mahdolliset hyödylliset vaikutuk-
set alhaisilla ja keskisuurilla annoksilla; 4) painottaa yksilöllistä herkkyyttä ja 
muita tekijöitä, jotka vaikuttavat epäsuoriin vaikutuksiin; 5) yrittää arvioida 
epäsuorien vaikutusten merkityksellisyyttä säteilysuojelulle ja asettaa tieteel-
linen pohja uudenaikaiselle säteilysuojelujärjestelmälle; 6) ja lopulta osallistua 
uuden paradigman luomiseen säteilybiologiassa, joka kattaa sekä klassiset suo-
rat (DNA:han kohdistuvan) että epäsuorat vaikutukset.
Oleg Belyakov
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Non-targeted effects of ionising radiation
Oleg V. Belyakov
Non-Targeted Ionising Radiation Effects Research Group,  
Radiation Biology Laboratory, Research and Environmental Surveillance,  
STUK – Radiation and Nuclear Safety Authority, Helsinki, Finland,  
P.O. Box 14, FI-00881 Helsinki, Finland
Abstract
The universality of the target theory of radiation-induced effects is challenged 
by observations on non-targeted effects such as bystander effects and genomic 
instability. Essential features of non-targeted effects are that they do not require 
direct nuclear exposure by radiation and they are particularly significant at 
low doses. This new evidence suggests a need for a new paradigm in radiation 
biology. The new paradigm would cover both the classical (targeted) and the 
non-targeted effects. New aspects include the role of cellular communication 
and tissue-level responses. A better understanding of non-targeted effects may 
have important consequences for health risk assessment and, consequently, 
on radiation protection. Non-targeted effects may contribute to the estimation 
of cancer risk from occupational, medical and environmental exposures. In 
particular, they may have implications for the applicability of the Linear-No-
Threshold (LNT) model in extrapolating radiation risk data into the low-dose 
region. This also means that the adequacy of the concept of dose to estimate risk is 
challenged by these findings. Moreover, these effects may provide new mechanistic 
explanations for the development of non-cancer diseases. Further research is 
required to determine if these effects, typically measured in cell cultures, are 
applicable in tissue level, whole animals, and ultimately in humans.
Non-targeted effects of ionising radiation
Cellular targets for radiation damage
The target theory of radiation induced effects [1, 2] postulates that cells contain 
at least one critical site or target that must be hit by radiation in order to kill a 
cell. Radiation damage outside of the target does not cause cell death. It is widely 
accepted that nuclear DNA is the critical target for radiation induced cell death. 
Early experiments demonstrated that damage to the DNA is more than 3.000 
times more effective than membrane damage in the killing of cells in vitro [3]. 
14
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However, there is evidence suggesting that the cell membrane might also be a 
target of death in some instances [4, 5].
When a tissue absorbs ionising radiation, its energy results in the production 
of a fast recoil electron. This electron may then cause damage, either by direct 
interaction with the DNA, or indirectly through production of free radicals, 
particularly the hydroxyl radical (OH•), which can cause a break to the DNA 
helix. Charged particles with high linear energy transfer (LET) radiation such 
as 3He2+ or α-particle would induce predominantly “direct” damage, whereas low 
LET radiation (γ and x-rays) predominantly cause “indirect” damage through 
the action of free radicals [6].
There are a few major types of DNA damage that can be produced by 
ionising radiation. Single-strand breaks (SSBs) occur due to the deposition of 
radiation energy on one strand of DNA. Double-strand breaks (DSBs) can be 
formed by a single ionising event or by the coincidence of random single-strand 
breaks on the complementary strands, DNA base damage occurs when radiation 
damages the purine and pyrimidine bases of DNA and finally DNA-DNA and 
DNA-protein crosslinks [7].
Radiation induced DNA damage can be repaired. There are three types 
of repair: error-free repair includes excision repair and generally does not result 
in mutations or lethality, error-prone repair may result in non-lethal or lethal 
mutations and incomplete repair does not result in the re-establishment of 
continuity in the DNA sequence and thus may be considered lethal [6].
Non-repaired DNA breaks may lead to chromosomal aberrations. Many 
types of chromosomal aberrations are produced, some of them lethal (unstable 
aberrations like dicentrics, rings, fragments), and some non-lethal (stable 
aberrations i.e. reciprocal translocations). Non-lethal aberrations may lead to 
oncogenesis. Unstable aberrations may result in the formation of micronuclei, 
which are the consequences of separation of acentric fragments (or whole 
chromosome) from the mitotic spindle, and are clearly visible in cellular cytoplasm 
at the first post-irradiation mitosis [8]. These ultimately lead to loss of clonogenic 
survival.
In addition to repair, cells may respond rapidly to irradiation, through a 
number of biological pathways by the initiation of signal transduction pathways, 
the activation of gene transcription, and cell cycle-specific growth arrest. These 
early events precondition and predetermine the later consequences of irradiation. 
Depending on the efficacy of the repair processes, damaged cells may undergo 
necrosis, apoptosis, proliferative death, senescence (premature differentiation) or 
ultimately survive and proliferate [6].
There is a range of delayed effects, which may occur in remote descendants 
of irradiated cells several generations after irradiation. If a cell survives and 
15
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Figure 1. New paradigms for Low-Dose Radiation Response.
Targeted effects Non-targeted effects
• Bystander effect
• Radiation-induced genomic instability
• Low dose hypersensitivity
• Adaptive response 
• Abscopal (out-of field) effects
• Clastogenic factors  
• Delayed reproductive death
• Induction of genes by radiation
New evidence
Classical paradigm of 
radiation biology
• DNA damage occurs
during or very shortly after irradiation
of the nuclei in targeted cells.
• The potential for biological 
consequences can be expressed
within one or two cell generations 
?
produces progeny then the initial biological response to the irradiation may 
influence cell differentiation, shorten life-span, induce genomic instability [9], 
or carcinogenesis [10].
Non-targeted effects, a new paradigm of radiation biology
According to the target theory of radiation induced effects, which forms a 
central core of radiation biology, DNA damage occurs during or very shortly 
after irradiation of the nuclei in targeted cells and the potential for biological 
consequences can be expressed within one or two cell generations [11, 12].
A range of evidence has now emerged that challenges the classical effects 
resulting from targeted damage to DNA (Fig. 1). These effects have also been 
termed “non-(DNA)-targeted” [11] and include radiation-induced bystander 
effects [13], genomic instability [14, 15], adaptive response [16], low dose hyper-
radiosensitivity (HRS) [17], delayed reproductive death [18] and induction of 
genes by radiation [19]. An essential feature of “non-targeted” effects is that they 
do not require a direct nuclear exposure by irradiation to be expressed and they 
are particularly significant at low doses.
This new evidence suggests a new paradigm [20] for radiation biology that 
challenges the universality of target theory. 
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Figure 2. Scheme of the bystander effect. Directly damaged cell is marked black;
bystander damaged cells are marked white.
?
Figure 3. Radiation induced genomic instability, damaged cells are marked white.
Bystander effect and genomic instability, definitions
This paper will discuss mainly the bystander effect and to a lesser extent, 
genomic instability.
The radiation-induced bystander effect is a phenomenon whereby cellular 
damage such as sister chromatid exchanges [21, 22], chromosome aberrations 
[23 – 25], apoptosis [23], micronucleation [26], transformation [27, 28], mutations 
[29 – 31] and changes of gene expression [32 – 35] is expressed in unirradiated 
neighbouring cells near to an irradiated cell or cells (Fig. 2).
Radiation-induced genomic instability is defined as a persistent elevation 
in the rate of de novo appearance of genetic changes (mutations, chromosome 
aberrations or micronuclei) within a clonal population [9, 14, 15], see Fig. 3.
17
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Genomic instability and the bystander effect are both non-targeted effects 
of irradiation. They have a cross-section much larger than the nucleus. The 
bystander effect and genomic instability might be related phenomena. There is 
as yet no evidence that the bystander effect persists for many generations. On 
the other hand, it was reported that persistent genomic instability can be induced 
via a bystander mechanism under in vitro [24] and in vivo [25] conditions. This 
evidence suggests that the initial cross-section for radiation damage is increased 
by the bystander effect, and cells that are affected by the bystander mechanism 
may remain at an increased risk of genetic change for many generations.
Evidence for bystander effects
Interactions between hit and non-hit cells after exposure to ionising radiation 
have been known for many years in radiation biology. Much of the early data 
was obtained from studies of chromosome damage induced by plasma from 
radiotherapy patients [36, 37] and accidental exposures [38] in test cell cultures. 
These indirect effects were explained by the production of “clastogenic factors” 
[39]. These clastogenic factors were extensively studied in victims of the Chernobyl 
Accident [40 – 42]. It was hypothesised that they may be related to lipid peroxide 
products [43] ionisine nucleotides [44], cytokines [45] and reactive oxygen species 
(ROS) such as superoxide radicals [39].
Other evidence has come from abscopal or “out-of-field” effects, which are 
well known in radiotherapy [46 – 49]. These phenomena are defined as the effects 
of radiation on tissues of the same person or organism at some distance from the 
actual radiation site or target. A recent paper by [50] related radiation-induced 
out-of-field effects in lung of rodents with DNA damage. A strong correlation 
between lethality and DNA damage was found.
In the last few years, a large number of papers were published 
demonstrating evidence for the radiation induced bystander effect [13, 51]. 
Nagasawa and Little first published a paper, describing the bystander effect [22], 
measured as an increase of sister chromatid exchanges (SCE). They irradiated 
Chinese hamster ovary cells with low doses of α-particles from a conventional 
broad field source in a way that only a few cells within a population were 
actually traversed by a particle. A much higher level of SCEs were produced 
in cells than would be predicted on the basis of the number of cell nuclei 
targeted. The authors proposed a hypothesis that cell irradiation induces some 
indirect effects within neighboring cells via free radical cascades or signal 
transduction pathways.
Significant numbers of the recent publications with evidence for bystander 
effects have come from the studies with α-particle irradiation delivered with 
18
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specially constructed conventional low doses broad-field sources [52]. In this case 
irradiation have been delivered to a population of cells in such a way that only 
a few cells within a population were actually traversed by α-particles. Hickman 
measured changes in the TP53 expression after rat lung epithelial cells were 
exposed to low doses of α-particles [35]. They found that a higher fraction of cells 
demonstrated an increased TP53 expression than were hit by α-particles.
A series of papers from the Los Alamos National Laboratory demonstrated 
that extracellular factors are involved in SCE formation following low dose 
α-particle exposure. Deshpande and co-workers [21] irradiated cell cultures of 
primary human fibroblasts with α-particles and observed a high level of sister 
chromatid exchanges. The percentage of cells showing SCEs was 9-fold higher 
than expected on the basis of the number of nuclei traversed. The authors provided 
convincing evidence for the production of extracellular factors, released into the 
cell culture medium [53]. Later, the same group [54] attributed the observed 
bystander effects to the action of TGF-β1 and reactive oxygen species (ROS).
In a series of studies, Mothersill and Seymour demonstrated that medium 
from γ-ray irradiated cell cultures reduces the survival of unirradiated cells [23, 
55 – 58]. Under this protocol supernatant from irradiated cells was transferred 
to test “reporter” cell cultures, which were analysed using the Puck and Marcus 
clonogenic assay [59] and for presence of micronucleated, apoptotic and cells 
with chromosome aberrations.
Another approach was utilized by Bishayee and co-workers [60, 61]. They 
detected a pronounced bystander effect in a V79 three-dimensional tissue culture 
model labelled with 3H-thymidine when the isotope is localised in the cell nucleus 
and distributed non-uniformly among the cells. A related class of effects was 
demonstrated in thymocytes [62]. They demonstrated that interactions between 
different types of γ-irradiated cells lead to different degrees of radiation-induced 
apoptosis via the production of soluble autotoxic mediators. When irradiated cells 
were mixed with non-irradiated ones, less interphase-induced cell killing was 
observed than would be predicted on the basis of ratios of the cells mixed together. 
This protection effect is not observed when the medium from non-irradiated cells 
is added to the irradiated thymocytes.
Previous studies at the Gray Cancer Institute demonstrated that the target 
for chromosomal damage is larger than the nucleus on basis of calculations of the 
fraction of micronucleated Chinese hamster V79 cells after α-particle irradiation 
[63]. It has been demonstrated a direct evidence of bystander effects in normal 
human AG01522B fibroblasts using the Gray Cancer Institute charged particle 
microbeam [64, 65]. Irradiation of a single fibroblast with a single 3He2+ particle 
delivered by the microbeam through the nucleus would give a significant rise 
of bystander damaged cells measured as micronucleated and apoptotic cells. 
19
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In general a 2 – 3 fold increase in the level of damaged cells was measured in 
comparison to controls.
Other groups have also utilised microbeam approaches to study bystander 
effects. Evidence for the existence of extra-nuclear target(s) for radiation-induced 
effects [66] was observed when the cytoplasm of human-hamster hybrid A(L) cells 
was irradiated avoiding traversal of the nucleus. Cytoplasmic irradiation led to 
considerable mutagenesis at the CD59 (S1) locus with minimal cytotoxicity. The 
mutations found were similar to those of spontaneous origin and are entirely 
different from those of nuclear irradiation. On other hand, it was demonstrated 
that cytoplasmic irradiation initiates the generation of reactive oxygen species. 
The final conclusion from the paper was that cytoplasmic irradiation might be 
more dangerous than nuclear irradiation, as mutagenicity is accomplished by 
little killing of the target cells.
Zhou and co-authors [30] demonstrated a bystander mutagenic effect 
after α-particle microbeam irradiation. They showed that cells, irradiated with a 
microbeam, could induce a bystander mutagenic response in neighbouring cells, 
which were not directly traversed by an α-particle. Intercellular communication 
plays a critical role in mediating the bystander phenomenon under these 
conditions. It was shown that irradiation of 20% of randomly selected human-
hamster hybrid A(L) cells with 20 α-particles each, resulted in a mutant fraction 
that is 3-fold higher than expected, assuming no bystander effect. Analysis by 
multiplex PCR demonstrated that the types of mutations induced are significantly 
different from those of spontaneous origin.
Another study from the same group [31] showed that irradiation of even 
10% of confluent human-hamster hybrid A(L) cells with a single α-particle per 
cell through the nucleus results in a mutant yield similar to that observed when 
all cells in the population are irradiated. This effect was significantly eliminated 
by an inhibitor of gap junction-mediated intercellular communication, or in cells 
carrying a dominant negative connexin 43 vector. 
An important question is whether the bystander effect contributes to 
carcinogenesis. Lewis and co-authors [27] tested the response of non-irradiated 
cell cultures when these were exposed to medium from X-irradiated 
human CGL1 hybrid cells. They reported an increased radiation-induced 
bystander neoplastic transformation after treatment with medium from 
irradiated cells. Medium, exposed with 5 or 7 Gy of X-ray increased the 
frequency of neoplastic transformation significantly from 6.3 × 10-6 in control 
to 2.3 × 10-5 (~ 4-fold).
Sawant and co-authors [28] used the Columbia University microbeam 
system to delivered 0, 1, 2, 4 or 8 α-particles through the nuclei of all or 10% of 
C3H 10T1/2 cells. They demonstrated that when 10% of the cells are exposed to 
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α-particles, the frequency of induced transformation is the same as that observed 
when every cell was exposed to the same number of α-particles.
Sigg [67] used β-particle emitting 90Y wires (average energy 934 keV) to 
create an inhomogeneous radiation field in C3H 10T1/2 cell cultures. Total 24h 
doses ranging from 0 to 750 Gy across the exposure field were tested and at equal 
levels of toxicity a 10 fold enhancement of neoplastic transformation frequency 
was observed in the presence of heavily damaged cells. Homogeneous fields of 
low-dose-rate β-particle radiation produced neoplastic transformation frequencies 
typical for comparable photon exposures reported in the literature.
Radiation induced bystander effects may produce not only damage but 
other effect which can be interpreted as neutral or beneficial. For example, 
[54] reported that exposure of normal human lung fibroblasts to a low dose of 
α-particle stimulates their proliferation in vitro. On the other hand, this response 
also occurs when unirradiated cells were treated with media from α-particle 
irradiated cell cultures. The promitogenic response is attributed to superoxide 
dismutase and catalase-inhibitable increases in the concentrations of (TGF-β1) 
in cell supernatants and with intracellular increases in ROS, expression of TP53 
and CDKN1A.
Matsumoto [68] found that the radiosensitivity of A-172 human glioblastoma 
cell lines to X-irradiation in the range of 0 to 10 Gy was increased in the case of 
treatment with pre-conditioned medium from irradiated cells in comparison to 
those irradiated in fresh medium. The key role in modification of the response 
is attributed to nitric oxide, which was emitted by irradiated cells and induced 
radioresistance in cells treated with supernatant.
Bystander effect can be induced by low and high LET irradiation
There is evidence that various types of radiation can induce the radiation 
bystander effect. The bystander effect induced by α-particles has already been 
discussed. β-particle irradiation is able to initiate a bystander response [60, 
61]. Media transfer experiments showed that low LET γ-rays [23, 55] can also 
produce a significant effect. Unpublished data, which will be described in more 
detail later (part 5.3), demonstrated a bystander effect after targeted ultra-soft 
X-rays produced by the Gray Cancer Institute microprobe facility.
Characteristic features of radiation-induced bystander response
In comparison to direct, classical effect of irradiation the bystander effect has 
three characteristic features:
Bystander responses predominate in the low-dose region (< 0.5 Gy);1. 
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The bystander effect has a non-linear dose dependence, suggesting a 2. 
switch-on (“all or nothing”) mechanism for its activation;
The bystander effect is maximally induced by very low doses.3. 
Nagasawa and Little first demonstrated evidence of the bystander effect induced 
by a very low dose of 0.16 mGy and saturating at 0.31 mGy without further 
statistically significant increases up to 4.9 mGy [22]. Hickman in his experiments 
with irradiation of rat lung epithelial cells, showed that the dose-effect for TP53 
expression was different for α-particles in comparison to X-rays [35]. α-particles 
gave a no-threshold response whereas there was a low dose threshold observed 
with X-rays at around 0.1 Gy. Overall, the shape of the dose-effect curve for both 
types of irradiation had a tendency to flatten after exposure with 0.2 – 0.5 Gy 
and did not demonstrate a statistically significant increase with increasing 
dose. Deshpande and co-workers [21] did not observe a dose-dependence of the 
bystander effect above 0.02 Gy with saturation up to highest does tested, 13 Gy 
of α-particles. Zhou [30, 31] noted that a level of bystander mutagenesis effect 
after α-particle microbeam irradiation did not depend on the number of particles 
delivered. Lewis [27] also showed that the amount of cell death induced by 
bystander effects is not dependent on dose.
The bystander effect contributes to a significant proportion of the overall 
damage yield in the low-dose region by an apparently distinct mechanism from 
the “classical” radiation response. Recently obtained data [26, 64] demonstrated 
that the fraction of damaged (micronucleated and apoptotic) human fibroblasts 
was independent of the number of charged particles delivered to the targeted 
cell. One 3He2+ ion, delivered to the nucleus of one cell among a few hundred 
non-irradiated neighbours induced the bystander effect to the maximum extent. 
Further increase of dose to the targeted cell does not change the dose response. 
Similarly, the effect was independent of the number of cells irradiated. The same 
level of damage was observed whether 1 or 4 cells were targeted within the dish. 
These data are considered in detail in [26, 64].
The general shape of the bystander effect dose response in comparison 
to direct radiation consequences is illustrated at Fig. 4. Most observations of 
bystander effects have shown a saturation of the response above the threshold 
dose (0.2 Gy is an estimation) and do not demonstrate a linear relationship to 
the dose, see review [69].
The model proposed here (Fig. 4) is supported by data, obtained with normal 
human fibroblast cell cultures published in [26, 64]. Experiments with primary 
urothelial explants similarly demonstrated the absence of a dose response.
The model proposed here is in marked contrast to that proposed by 
Brenner [70] as a quantitative model for the application of the bystander effect 
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Figure 4. Comparison of ”classical” and ”bystander” types of response to ionising 
irradiation.
Classical
effects
Bystander effects
Dose~0.2 Gy ?
to carcinogenic risk. The BaD (Bystander and Direct) model of radiation response 
is supported by the data from the same group on in vitro oncogenic transformation 
after broad-field or microbeam α-particle irradiation [28]. BaD postulates that 
the bystander effect is a binary “all or nothing” phenomenon and might be 
expressed in a small sensitive sub-population of “interested neighbors” [71], 
which do not cover the entire cell population. The authors believe that there may 
be purely geometrical reasons for the existence of a subpopulation, susceptible 
to bystander effects. They assume that a hypothetical bystander factor has a 
limited penetration distance. However, in this case some clustering of damage 
should be observed around the irradiated cell. To date, no evidence of clustering 
has been reported and in contrast, data published in [64] suggest that cellular 
damage is uniformly distributed throughout the cell culture dish.
The BaD model also suggests that the bystander effect can only be observed 
at low doses (Fig. 5). At low doses, the bystander effect dominates the direct 
response. The authors point out that this may lead to an underestimation of 
low-dose risks extrapolated from high doses, where direct effects dominate. 
Similar to the model proposed here, BaD assume that the total response of a 
cellular system to ionising radiation has two components: direct and bystander 
damage. Direct damage has a linear dose-relationship, whereas bystander 
damage is induced to the maximum extent by very low doses (less than 1 cGy). 
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Figure 5. Contribution of bystander and direct component to the radiation induced rate 
of oncogenesis, a BaD model, reproduced from [70].
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Figure 6. Contribution of bystander and direct component to the radiation induced 
damage, proposed model.
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In contrast to the proposed model, the authors believe that the bystander effect 
would decline with increasing dose because bystander signal-sensitive cells, 
whose nuclei are hit directly, cannot produce a bystander response Therefore, the 
total effect would be (as presented at Fig. 5) a result of summing bystander and 
direct effects at low dose region (up to 30 cGy). At the higher dose (from about 
30 cGy) it would be predominantly influenced by direct effects. To date, however, 
there is not enough experimental data to assume that a direct hit would prevent 
a cell from releasing a bystander factor.
Therefore, a different model can be suggested (see Fig. 6), which has a 
more pronounced plateau in the low dose region and fits better to both the 
results, obtained during this project and other published experimental data. We 
assume that bystander signal-sensitive cells, whose nuclei are hit directly, can 
produce a bystander response. Finally, the model proposed here can be utilised 
to describe any dose-effect relationship for cellular damage whereas the BaD 
model is designed for the estimation of carcinogenic risk.
Recently another novel stochastic model was proposed [72] A model of the 
radiation-induced bystander effect is developed that takes account of spatial 
location, cell killing and repopulation. The ionizing radiation dose- and time-
responses of this model are explored, and it is shown to exhibit pronounced 
downward curvature in the high dose-rate region, similar to that observed 
discussed above. One significant advantage of this model is that this model is 
suitable for 3D modelling of bystander effect can be applied to the tissue data.
Bystander versus direct effects
For studies of cell killing, it is important to determine numerically the relative 
contribution of “classical” and “bystander” effects. Recently, Seymour and 
Mothersill [58] have presented a method of correcting the overall survival 
curve to enable analysis of the relative contributions of the bystander effect 
and the effects attributable to direct interaction of the radiation with the target 
cell. They used a standard Puck and Marcus assay [59] to obtain a clonogenic 
survival curve for HPV-G human keratinocytes. Two separate sets of cell culture 
flask were used. One set was irradiated with broad field of γ-rays with various 
doses, medium was harvested, filtered and added to a second set of flasks, which 
had not seen a direct radiation exposure. The survival results were converted 
to clonogenic death for both bystander and total effect and by subtraction, the 
percentage of cell death due to non-bystander induced death was determined. 
The data show that for this human epithelial cell line, doses within the range 
0.01 – 0.5 Gy of γ-rays would induce clonogenic death only by the bystander effect 
(see Fig. 7).
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Figure 7. Clonogenic cell death measured in human keratinocytes. The total bar 
represents the total death detected after exposure of cells to the radiation dose. The 
death measured after exposure to medium from irradiated cell cultures (Bystander) 
is represented by the blue portion of the bar, and the remaining death determined by 
subtraction is represented by the red portion of the bar, giving a value (Direct) for death 
not attributable to bystander effects of radiation. Adapted from [58].
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It can be seen that there is a large bystander component at low doses 
but at doses of 0.5 Gy and above the direct effects of radiation begin to appear. 
The magnitude of the bystander effect is relatively constant and it appears to 
saturate at doses in the range of 0.03 – 0.5 Gy. After doses greater than 0.5 Gy, 
the clonogenic death curves are the result of a dose dependent non-bystander 
effect and a dose independent bystander effect.
Mechanisms of the bystander effects
It is known that the bystander effect is cell type dependent [23], depends on cell 
proliferative state (discussed in [73]) and that energy / REDOX metabolism may 
be involved in the expression of a radiation induced bystander response [74]. The 
exact mechanisms of the bystander effect are not yet known. However, it is clear 
that bystander signal production and cellular response may involve different 
pathways [51]. Bystander signalling is a complex and well-tuned system, which 
most likely involves more than one messenger and is connected with tissue 
microenvironment signalling [75, 76].
There is experimental evidence that the bystander effect may have at 
least two separate pathways for the transfer of damage from irradiated cells to 
unirradiated neighbours: by gap junction intercellular communication (GJIC) or 
cell culture mediated factors. A junction between cells, which consists of many 
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pores, mediates GJIC. Each pore is formed by a hexagonal array (connexon) 
of six transmembrane proteins (connexins) in each plasma membrane: when 
joined together the pores open, allowing communication and the interchange of 
metabolites between cells [77]. 
Azzam and co-workers [32] have demonstrated that the bystander effect 
is dependent on gap junction intercellular communication in confluent cultures 
of 5 different primary human diploid fibroblast lines exposed to low fluences 
of α-particles. They showed that TP53 and CDKN1A expression are activated 
in bystander cells after low dose α-particle irradiation. Importantly, they also 
observed clustering of expression in neighbouring cells. Treatment of the culture 
with lindane, which inhibits GJIC, led to a marked reduction in the increase 
in the levels of TP53 and CDKN1A. A recent paper from the same authors 
suggested direct evidence for the participation of GJIC in the transmission of 
damage signals from irradiated to non-irradiated cells [33]. Other workers have 
also shown that lindane treatment leads to inhibition of bystander-induced cell 
killing in hamster V79 cells [61]. The bystander effect was also significantly 
reduced in cells pretreated with 1 mM of octanol, which inhibits gap junction-
mediated intercellular communication [31]. The same paper also reports that the 
bystander effect was suppressed in cells carrying a dominant negative connexin 
43 vector, which is a part of the connexon complex.
Little is known concerning the signals, which may be transferred via 
GJIC. The connexin proteins, which form the gap junctions, allow ions, secondary 
messengers and small molecules to pass between cells and modification of these 
proteins, by phosphorylation, can open or close the pores. Whether specific signal 
molecules are transmitted between cells or the junctions are specifically opened, 
as part of a bystander response needs to be addressed.
The second proposed mechanism of the bystander effect is mediation by 
secretion of factors into the culture medium. Medium transfer experiments [23, 
58] suggest the existence of a relatively long-lived bystander effect mediator, 
which cannot be eliminated by media filtering. A series of studies suggested 
another possible mechanism in which the irradiated cells secrete cytokines 
or other factors that act to increase intracellular levels of reactive oxygen 
species in unirradiated cells. Lehnert and co-workers [53] demonstrated that the 
culture medium harvested from cells irradiated with low fluences of α-particles 
could induce an increase in sister chromatid exchanges when incubated with 
unirradiated test cells. According to results [53, 78], α-particle irradiated cells 
secrete into the serum containing medium some short-lived factor(s). It was found 
that the activity of this factor(s) could be inhibited by superoxide dismutase, 
can survive freeze and thawing but not heating. A recent paper by Lewis and 
co-authors [27] used a medium transfer protocol and observed delayed death and 
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neoplastic transformation. And finally, Mothersill and Seymour [55] reported 
data which suggest that the bystander effect does not depend on communication 
through gap junctions formed between cells in contact but is due solely to media 
release factors, in contrast to that predicted from other studies.
Hypothetical messenger(s)
The exact nature of bystander signalling is not known. Two mechanisms of 
transmission from an irradiated cell to an unirradiated neighbour have been 
proposed as described above. A bystander messenger can be either a soluble factor 
excreted into the cell culture medium from the irradiated cells or be directly 
transmitted by GJIC – gap junction intercellular communication between hit 
and non-hit cells [51].
Based on this distinction it can be speculated that at least two types of 
the bystander messenger might exist. Primary messenger is emitted by targeted 
cell. It is short lived, not very stable, travels through gap junctions, should be 
water soluble and most likely not a protein. One suitable candidate here could be 
long-lived organic radicals capable of transferring through gap junctions. Such 
radicals could have lifetimes of up to 20 hours [79, 80]. Among other candidates 
for GJIC mediated primary bystander messenger are antioxidants (thiols) [81], 
Ca2+ [82] Ip3 (storage form of intercellular Ca2+) and cAMP [83], which is an 
important secondary messenger involved in Ca2+ metabolism.
Secondary bystander messenger should be long-lived, more stable, most 
likely emitted by activated, not directly traversed, cells. It might be a media 
borne factor and most likely a protein. Suitable candidates here would be lipid 
hydroperoxidases [84], ceramide [5], death ligand (TNFSF6) produced from 
exfoliation [85]. Other evidence supports a role for cytokines as key signalling 
molecules in the transfer of bystander damage cytokines such as TNF-α [43, 86], 
TGF-β [54, 76] or IL-1 [43].
There is a range of possible candidates for bystander effect mediation, 
which are medium borne and could be either primary or secondary messengers. 
Reactive oxygen species (H
2
O
2
/O-2) have been proposed as possible signals involved 
in bystander responses [54, 87]. Another group proposed that nitric oxide (NO) 
might play a central role in mediation of bystander effect [68, 88] potentially 
having a protective value.
In conclusion, it is most likely that there is no single mechanism underlying 
the bystander effect and both media borne and GJIC factors are involved in its 
induction and perpetuation. The mechanisms involved are probably cell type 
specific which may reflect a lot of the current uncertainty in the literature as to 
the processes involved. 
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The relationship between radiation induced 
bystander effect and genomic instability
The relationship between the bystander effect and genomic instability is not 
clear. It was reported that persistent genomic instability could be induced in 
vitro via a bystander mechanism. Chromosomal instability was demonstrated in 
the clonal descendants of haemopoietic stem cells after irradiating murine bone 
marrow with α-particles [24]. The authors studied the effects of interposing a 
grid between the cells and the α-particle source so that the surviving population 
consisted predominantly of non-traversed stem cells. It was shown that the 
number of clonogenic cells transmitting chromosomal instability was greater 
than the number expected to be hit and survive. Later, the same group utilised 
a bone marrow transplantation protocol in which a mixture of irradiated and 
non-irradiated murine bone marrow cells was transplanted into mice. It was 
demonstrated that genomic instability could be observed in the progeny of 
non-irradiated haemopoietic stem cells under in vivo conditions [25].
The data published in [89] suggest that the same AG01522B normal human 
fibroblast cell line is susceptible to radiation induced genomic instability (after 
both α-particle and X-ray irradiations), and bystander response after microbeam 
3He2+ irradiation according to the results, published in [26, 64]. Also, the urothelial 
model, which demonstrates a pronounced bystander response [73, 90, 91] may 
express genomic instability as a part of the response. 
Other studies have suggested a common relationship between genomic 
instability and the bystander response. Some evidence of protective function 
of bystander effect is available [76]. This issue is discussed in greater detail in 
part 6.1 of this thesis. There is some indication that genomic instability may play 
a protective role as well. It was recently demonstrated [92] that chromosome 
instability in GM10115 cells can lead to the development of cell variants that 
are more resistant to radiation. Bystander effect and genomic instability might 
be parts of a comprehensive system of oxidative damage control, which aims to 
reduce the risk of carcinogenesis [93, 94] and both have been observed in vivo 
[25, 95]. Finally there are suggestions that both the bystander effect [96] and 
genomic instability [97] are controlled through epigenetic mechanisms [98] such 
as DNA methylation [99].
Bystander effect in multicellular systems
The bystander effect cannot be comprehensively explained on the basis of a 
single cell reaction. It is well known that an organism is composed of different 
cell types that interact as functional units in a way to maintain normal tissue 
[100] function. Radiation effects at the tissue level under normal conditions prove 
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that individual cells cannot be considered as an isolated functional unit within 
most tissues of a multicellular organism. Therefore the radiation response is 
not simply the sum of cellular responses as assumed in classical radiobiology, 
predominantly from studies using cell cultures. Experimental models, which 
maintain tissue-like intercellular cell signalling and 3-D structure, are essential 
for proper understanding of the bystander effect. The tissue microenvironment 
is also important for proper manifestation of the bystander effect [75]. Barcellos-
Hoff and Brooks hypothesise that the radiation bystander effect and genomic 
instability are positive and negative manifestations of a tissue homeostatic 
process [76]. Extracellular signalling in normal tissues plays a crucial role in 
initiation and perpetuation of bystander effect.
Only a few papers have been published on bystander effects in multicellular 
systems. The radiosensitivity of HPV-G and HaCaT epithelial cells lines irradiated 
within microcolonies (> 50 cells) was found to be lower than those irradiated as 
single cells [23, 101]. A series of papers by Bishayee and co-workers [60, 61] 
detected a pronounced bystander effect in a V79 three-dimensional tissue culture 
model labelled with 3H-thymidine when the isotope is localised in the cell nucleus 
and distributed non-uniformly among the cells. Jen and co-workers [102] found 
that the radiosensitivity of mouse kidney cells that are irradiated under in vivo 
conditions in situ or in vitro as fragments was higher than those irradiated in 
vitro as single cells.
Our recent work [103] clarifies mechanisms of bystander responses in a 
3D normal human-tissue system. Endpoints were induction of micronucleated 
and apoptotic cells. A charged-particle microbeam was used, allowing irradiation 
of cells in defined locations in the tissue yet guaranteeing that no cells located 
more than a few micrometers away receive any radiation exposure. Unirradiated 
cells up to 1 mm distant from irradiated cells showed a significant enhancement 
in effect over background, with an average increase in effect of 1.7-fold for 
micronuclei and 2.8-fold for apoptosis. The surprisingly long range of bystander 
signals in human tissue suggests that bystander responses may be important in 
extrapolating radiation risk estimates from epidemiologically accessible doses 
down to very low doses where non-hit bystander cells will predominate.
With the exception of abscopal effects and clastogenic factors in blood 
plasma of patient undergo radiation therapy, which were discussed above, 
little evidence of bystander effect under in vivo conditions is available. The one 
experimental paper, which deals with bystander effect under in vivo conditions is 
work by Watson and co-authors [25]. They utilised a bone marrow transplantation 
protocol to demonstrate that genomic instability could be induced in bystander 
cells. Mixture of irradiated and non-irradiated cells distinguished by a cytogenetic 
marker, was transplanted into CBA/H mice. Genomic instability was demonstrated 
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in the progeny of non-irradiated cells. Another recent paper [104] demonstrated 
oncogenic bystander radiation effects in mouse cerebellum. Authors reported 
bystander (in fact “abscopal”) tumour induction in cerebellum of radiosensitive 
Patched-1 (Ptch1) heterozygous mice after x-ray exposure of the other parts 
of the body. They also provided evidence supporting the role of gap-junction 
intercellular communication (GJIC) in transmission of bystander signals in the 
central nervous system.
Rationale for the current interest in non-targeted responses
The current interest in non-targeted effects such as bystander responses is 
particularly timely. Firstly there is currently a tremendous shift of emphasis from 
high-dose effects towards low and ultra-low doses, of relevance to environmental 
and occupational exposures both in terms of research needs and public interest. 
This has coincided with tremendous advances in the technical possibilities for 
precise low dose irradiation such as development of microbeams [105, 106], 
imaging and computerised automation. Apart from technical developments, low 
dose studies would not be possible without development of more specific and 
sensitive methods of cellular and molecular biology. Apoptosis assays, techniques 
to measure changes in cell cycle regulation, protein expression, advanced methods 
of cytogentic analysis has enabled radiation biology to start to probe low frequency 
changes in individual cells. This allows the systematic studies of processes (i.e. 
apoptosis, genomic instability or bystander effect) now considered to be important 
and are ultimately challenging the existing fundamentals of the understanding 
of the action of radiation on biological systems.
Hypothesis: bystander effect is a protective 
mechanism of tissue damage control
The discovery of a bystander effect is important for understanding the dose-
response mechanisms relevant to low-dose irradiation in vivo. One important 
question is whether the bystander effect is a protective mechanism or whether, 
conversely, it amplifies the number of cells damaged by the isolated radiation 
tracks of low-dose exposures leading to an increased risk of carcinogenesis.
One theory, supported by the experimental data obtained during this 
project is that the main function of the bystander effect is to decrease the risk 
of transformation in a multicellular organism exposed to radiation. It can be 
speculated that individual cells within a tissue may not have the ability to detect 
irradiation such that an individual cell response is not expressed. An integrated 
multicellular system may be able to detect damage from irradiation and respond 
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to it by removing a functional group of cells, which could be potentially damaged. 
The existence of a potentially sensitive group of cells, susceptible to the bystander 
response has also been proposed by [70]. However, not every cell will respond 
to the hypothetical bystander factor, which is released by targeted cells. Only 
1 – 3% of the total number of cells in the system would express damage [26, 73] 
and approximately 10 – 15% would go on to bystander induced differentiation 
[91, 107]. Lehnert and co-workers believe that differences in the gene expression 
profiles and temporal and spatial patterns of key proteins expressed in directly 
irradiated and bystander cells may determine how the cells ultimately respond to 
low doses of radiation [108]. The data obtained during this project are consistent 
with every cell being able to initiate the bystander effect. Such a mechanism 
of co-operative response would make the tissue system much more robust. It 
would work only for low doses of charged particle irradiation (below ~ 0.1 – 0.2 
Gy, depending on system and type of radiation) because only in this case is the 
damage localised within a small fraction of the cell population.
In some systems, the most convenient way to remove potentially damaged 
cells is via apoptosis. In particular, apoptosis allows the removal of affected cells 
without a negative impact on other cells via inflammatory responses. However 
many apoptotic pathways are controlled by cellular signals, which would also 
enable the selective removal of certain functional groups of cells. Apoptosis is not 
playing a significant role in the urothelial explant system [26, 73]. Another way to 
isolate damage is to prompt affected cells into irreversible differentiation. Results 
[91, 107], which support this mechanism, have been obtained. Underlying this 
theory is that a normal 3-dimensional tissue microarchitecture is essential for the 
manifestation of the bystander effect [103, 109].Therefore, the bystander effect 
might be a tissue-specific epigenetic phenomenon, which can be observed in full 
scale when there is presence of natural cellular stratification with differentiated 
and dividing cells present and an intact tissue microenvironment. However, the 
data suggest that initial nuclear damage seems to be essential for initiation of 
this system. Perpetuation of the bystander effect might involve cascade-like 
epigenetic mechanisms.
Tissues remove all potentially damaged cells from the system to avoid 
the risk of carcinogensis following sparse low dose irradiation or any other local 
oxidative damage [75]. Bystander induced differentiation seems to play a central 
role in this process. It is known that cellular senescence is a powerful tumour 
suppressor mechanism [110].
A general scheme explaining the proposed theory is illustrated in Fig. 8. 
Tissue, exposed to sparse natural irradiation, would respond as a single unit 
(1). The damaged cells would produce some bystander signal or signals. Some 
sensitive sub-population of potentially damaged cells would respond to the 
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Figure 8. A general scheme of radiation induced bystander effect in tissue systems.
1. Sparse irradiation 2. Bystander signal 3.Tissue response
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bystander messenger (2). The tissue response to sparse irradiation would affect 
just a fraction of cells within the tissue (estimated at 10 – 15%). A minor fraction 
of the cells will be eliminated (probably by apoptosis – estimated as < 1%). The 
majority of the cells would be removed from proliferating pool by being prompted 
into differentiation (3). Such a significant response of tissue might be explained by 
the great danger of even one transformation event induced by natural background 
radiation. Removing from the proliferating pool all the potentially damaged cells 
would significantly reduce the risk of transformation for any one cell.
Recently, two theories were proposed concerning the possible meaning of the 
bystander effect. One of them hypothesises that the radiation-induced bystander 
effect is a manifestation of a tissue homeostatic process [76]. Cell growth, 
differentiation and death are directed significantly by extracellular signaling 
through the interactions of cells with other cells and with the extracellular 
matrix and the tissue microenvironment. According to the authors’ theory the 
bystander effect eliminates abnormal cells in order to inhibit neoplastic behavior 
and preserve tissue integrity. Genomic instability is interpreted by the authors as 
results of absence the bystander effect. They write: “radiation-induced bystander 
effects and genomic instability, are, respectively, positive and negative cellular 
manifestation of multicellular programs of damage response” [76]. Therefore, 
the bystander effect is hypothesised to be an important mechanism of tissue 
integrity maintenance.
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Another theory concerning a possible role of the bystander effect 
for the genome as a whole was recently proposed by Baverstock [111]. The 
author proposed that the radiation induced bystander effect (as well as 
genomic instability) can be understood in the terms of the dynamic genome 
concept proposed in this paper. These phenomena are interpreted not just 
as the result of loss of stability from specific modifications of the genome 
sequence, but, as a response of the genome in order to preserve the integrity of 
the genomic sequence. 
The relationship between the bystander effect and genomic instability
Radiation induced bystander effect and genomic instability are both non-targeted 
effects of irradiation. However, the relationship between the bystander effect 
and genomic instability is not clear. Genomic instability and bystander 
effect can both be induced in vitro and in vivo [25, 95]. The data published 
in [64, 65, 89] suggest that the same cell line (primary human fibroblasts) 
can express radiation induced genomic instability and bystander response, 
although a direct relationship between the two endpoints has not been 
tested implicitly. 
On the other hand, the experiments with irradiation of ureter tissue 
fragments [107, 112] demonstrate that genomic instability (i.e. de novo appearance 
of cellular damage) and the bystander effect could be closely linked. With the 
damaged or differentiated cells that are expressed 7 days later in the explant 
outgrowth, many must be several generations removed from the initially targeted 
cells and those which initially express the bystander phenotype. It is likely 
that a cascade mechanism of bystander cell damage probably dominates the 
initial phase of the targeted exposures. However a significant contribution 
of genomic instability (probably, bystander-induced) on the later stages 
cannot be ruled out.
Where the bystander effects might be important?
Bystander effect could be important in a few areas related to radiation. The 
bystander effect might contribute to the estimation of cancer risk from domestic 
radon exposure [113]; the effects of HZE particles during space mission to the 
Mars, see discussion on cosmic radiation at [114]; health effects of air crew 
personnel, exposed to radiation during i.e. inter-continental flight [115]; high 
energy radiotherapy outcome.
I would like to concentrate on two issues, where the bystander effects might 
contribute significantly: cancer radiotherapy and radiation protection.
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Significance of the bystander effects for radiotherapy
The bystander effect is a low dose (up to 200 mGy) phenomenon. Therefore, at the 
first look, it cannot play any considerable role in radiotherapy, which operates 
with doses of tenth of Grays and more. However, the spectrum of secondary 
malignancies in radiotherapy patients may suggest some contribution of the 
bystander effect [116]. On the other hand, Trott [117] points out that the future 
experiments are needed to prove the potential therapeutic value of the bystander 
effect in radiotherapy and nuclear medicine.
The theory concerning a protective role of the bystander effect may be 
supported by the recent data of microbeam radiation therapy [118]. It was 
demonstrated that arrays of parallel X-ray microbeams could be efficiently used 
for treatment of central nervous system tumours because of minimal damage to 
normal tissues. Another group of publications [119 – 121] deals with microbeam 
radiation therapy of brain tumours. They have demonstrated an unusually 
high resistance of normal tissues irradiated with array microbeams of energetic 
synchrotron-generated X-rays and that this method can be successfully used 
for either curative or palliative treatment of brain tumours. It may point to 
that fact that the bystander effect, induced by microbeams would remove all 
potential targets in normal tissues, making them more radioresistant. On the 
other hand, the bystander effect as a phenomenon, which requires normal tissue 
microarchitecture and microenvironment would not act in the same way in 
tumours being either switched-off or damaging.
Finally, the finding of a significant bystander induced differentiation after 
microbeam irradiation would suggest a potential value of the bystander effect 
for differentiation therapy of cancer treatment; see review of [122].
Applicability to radiation protection and 
contribution to LNT discussion
According to the Linear-Non-Threshold (LNT) model, which currently dominates 
in radiation protection, cancer risk for low dose low LET exposures is derived 
from high-dose epidemiological data, mainly obtained from A-bomb survivors 
cohort [123]. The average dose of the A-bomb survivors was about 0.3 Gy, which 
corresponds to about 300 electron tracks at the cellular level (ignoring the very 
small neutron component) and which were delivered in a short time. Low-dose 
environmental exposures correspond to around 1 mGy per year of low LET 
radiation, which is roughly equivalent to 1 electron track per cell per year. The 
risk at low doses might be different than predicted by a linear extrapolation of 
the high dose epidemiological data. There is not any reliable epidemiological 
information in this dose region (Fig. 9).
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Figure 9. LNT and uncertainties in extrapolation of radiation risk.
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The bystander effect does not demonstrate a linear relationship to dose. 
It is maximally induced by very low doses, suggesting a switch on mechanism 
for its activation. The general form of the bystander dose response curve may 
have implications for the applicability of the linear no-threshold (LNT) model 
in extrapolating radiation risk data into the low-dose region. How bystander 
effect might contribute to the risk estimation? The key question here: is whether 
the bystander effect is a protective mechanism or non-specific damage from 
irradiation.
There are findings, which point out that the bystander effect might be 
harmful. Several independent groups demonstrated evidence for bystander-induced 
mutagenesis [29 – 31]. Bystander-induced transformation has also been demonstrated 
[27, 28]. It was proven that chromosomal damage is produced in bystander cells 
after low doses of radiation [24]. Considering this evidence, the bystander 
effect would increase the risk of carcinogenesis in the low dose region (Fig. 10). 
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Figure 10. The risk at low doses might be greater than predicted by LNT.
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However, most of the data concerning the harmful character of the bystander 
effect was obtained from in vitro experiments with normally, immortalised, 
transformed or artificially constructed cell lines. This makes it difficult to apply 
these data to estimation of the carcinogenesis risk in the human population. 
There is however evidence for a protective nature of the bystander effect. A gross 
bystander induced differentiation has been demonstrated in the urothelial explant 
outgrowth versus a low level of cellular damage after microbeam irradiation. 
Matsumoto [68, 88] found that survival is increased after treatment with medium 
from irradiated cells. Similar data of a proliferation increase was reported by 
Iyer [54], although authors interpreted it as a step towards carcinogenesis. And 
finally, Barcellos-Hoff [76] published data and proposed a theory suggesting 
that the bystander effect is a mechanism of tissue integrity maintenance. This 
evidence suggests that bystander effects might decrease risk of carcinogenesis 
in low dose region (Fig. 11).
Regrettably, the current state of understanding of the underlying 
mechanistic basis of radiation induced bystander effect in vivo does not allow 
a firm conclusion to be expressed one way or the other on the validity of a 
association with a reduction or increase of cancer risk in human populations. 
The observation of the bystander phenomenon is preliminary in nature, and the 
applicability of any conclusion derived from in vitro studies to in vivo situation 
is still uncertain. The risk at low doses might be greater or less than predicted by 
a linear extrapolation of the high dose depending on consideration of data for in 
vitro or in vivo like systems. However, bystander effect will clearly result in an 
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Figure 11. The risk at low doses might be less than predicted by LNT.
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overall risk, which is a non-linear function of dose. It would be highly premature 
to consider revising current risk calculations on the basis of current in vitro and 
in vivo like studies of bystander phenomena. On other hand, the LNT model is 
important for radiation protection as a simple method to optimise procedures 
and regulations. However, it should not be mistaken as a scientific model directly 
derived from the present state of knowledge of the processes involved in radiation 
carcino genesis [124].
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Abstract
This article summarizes the technical details of European Nuclear Microprobe 
facilities with radiobiological programs which are either operational or under 
construction. A short introduction to the principal components of these systems 
is given with an outlook of ongoing or planned applications.
*) The author list comprises the heads of the involved institutions / laboratories only. The essential 
contribution of numerous group members to develop and to build the facilities is particularly 
acknowledged.
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1 Introduction
The investigation of biological effects due to ionising radiation is usually carried 
out with broadbeam X-ray or γ-ray or alpha-sources or ion accelerators. In these 
experiments the interaction point between the photon or ion and tissue or a cell, 
respectively, is not known (except for in-situ ion track detection behind the cells) 
nor controllable. Since cells communicate with each other, a superposition of 
various interaction points renders the interpretation of data difficult. Most of the 
targeted irradiations were performed thus far on isolated cells, sometimes also on 
tissue. In the following, only isolated cells will be considered. Furthermore, the 
discussion is restricted to ions. In order to distinguish between an interaction of 
the incident particle with the cell nucleus, the cytoplasm, or the media, collimated 
or focused beams are required with beam diameters in the  m-range or below. 
Such systems are usually called “Nuclear Microprobes”. For work with living cells 
the beam has to be extracted from vacuum to the ambient (“external beams”). 
In addition, very efficient cell-recognition procedures are required in order to 
position the target exactly in front of the beam or to direct the beam exactly to 
the target. If such irradiation facilities are equipped with a fast beam-switch, 
an exactly counted number of particles – from one to an arbitrary number – can 
be placed at the desired target.
This new approach in radiobiological research allows to address questions 
such as the investigation of the spatially resolved radiation sensitivity of cells, 
cell-to-cell communication  and bystander-effects, DNA-damage without hitting 
the cell nucleus and many more. The  pioneering institutions in this field of 
research are the Texas A&M University, USA, the Columbia University, USA and 
the Gray Cancer Institute, UK. In recent years, many more Nuclear Microprobe 
institutions started radiobiological programs  in Japan, in the USA and – above 
all – in Europe. Most of the European institutions collaborate within the Marie 
Curie Research and Training Network CELLION (6th framework program of 
the European Community) and thus guarantee the education and training of 
young researchers in this multidisciplinary field of research. Admittedly, most 
institutions / laboratories are not yet fully operational. Whereas large research 
institutions in general have resources to develop their infrastructure, Universities 
depend more heavily on funding via research projects which is particularly 
difficult in the start phase.
This article summarizes technical details of European Nuclear Microprobe 
facilities with radiobiological programs which are either operational or under 
construction. A short introduction to the principal components of these systems is 
given with an outlook of ongoing or planned applications. In some cases, reference 
is made to the installation at the Columbia University, USA. Instead of giving 
an extensive reference list with scattered pieces of information here and there 
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in a field which is rapidly changing, contact addresses and one reference per 
institution / laboratory are given in Table I for further enquiries.
2 The components of nuclear microprobes 
with “external beams”
2.1 Accelerators and ion sources
First, an accelerator is required which can deliver one or more different ions 
with a suitable energy. Judging from table I, the majority of the systems use 
tandem accelerators with a Van de Graaff high voltage generation. Exceptions 
are the SINGLETRONS (single-ended machine) with a Cockcroft-Walton power 
supply (Leipzig, Bordeaux in October 2005), the Van de Graaff CN (single-ended 
electrostatic accelerator; by HVEC) at the INFN-LNL, Legnaro, the cyclotron 
at Braunschweig, and the RF Linac at the GSI, Darmstadt. There is a general 
believe that a single-ended machine would be the best choice in order to achieve 
a maximum brightness (no losses due to the stripper in the Tandems) and, hence, 
the smallest possible beam diameter. However, for “external beams” other factors 
become important and it appears that all different machines are doing well for 
this purpose. In any case, a free choice of a dedicated accelerator is still considered 
luxury. Beam currents play no role for counted ion applications. The high voltage 
is usually in the range of 2 – 5 MV, as for ion beam analysis and modification. 
There is a variety of ion sources in use. Several institutions can provide proton 
and alpha beams (sometimes H2
+, 3He or d) ). Heavy ions are available only at 
the GSI (Darmstadt), Legnaro, München, and Uppsala. There is a need of higher 
ion energies to get ion ranges larger than 10 – 20 µm which are necessary to 
irradiate cells under living conditions. Uppsala is included in this compilation 
because of their nanotechnological contribution to CELLION but does not carry 
out direct radiobiological research. Thus the European facilities can provide ions 
with a wide range of linear energy transfer (LET) in biological samples ranging 
from about 5 to 104 keV/ µ.
Other important issues are anti-vibrational means and active compensation 
of stray magnetic fields. The need for such measures depends strongly on the 
location.
2.2 Horizontal versus vertical beamlines
For a cell biologist working with Petri dishes the only acceptable beamline would 
be a vertical beamline because otherwise the medium (and eventually the cells) 
would be spilled over the floor. However, the only two vertical beamlines are at 
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the GCI, London, and at the PTB, Braunschweig. The first one comes upwards 
from the cellar whereas the latter one is downwards (!). The majority of the 
institutions uses horizontal beamlines for a number of reasons: frequently one 
uses cells which adhere to the bottom of the Petri dish and a lack of adhesion is 
used as indicator for cell death; furthermore, often the medium is removed anyway 
in order to avoid irradiation and radiolysis in the medium and a minimum film 
covering the cells – eventually by exposing them to humidified air – is usually 
sufficient to keep them alive for a period of say 10 minutes or so. So, e.g. Legnaro, 
Leipzig and München do not use transmission detectors before the Petri dish 
but rather behind it and cannot tolerate thicker media layers. Interestingly 
enough, at the Columbia University a vertical beamline is used and the medium 
is removed nevertheless.
2.3 Beam formation
There are two possibilities for the production of beams with µm diameters: 
collimation and focussing. In the first case, the beam passes though a pinhole 
or a capillary which actually defines the beamsize (and eventually divergence). 
The target has to be scanned over the beam. In the latter case, the beam passes 
through object and aperture slits (defining beam diameter and divergence) and 
is subsequently demagnified by quadrupole lenses. In this way, minimum beam 
diameters of below 50 nm were achieved in vacuum. Usually, with focussed beams 
a scanning unit (magnetic or electrostatic) is used to allow for scanning the beam 
over the target. An advantage of beam scanning compared to mechanical sample 
scanning is speed. Scanning devices can be placed before or after the last lens. In 
the first case, the working distance can be rather small, the disadvantage being 
a greater influence of lens aberrations for non-paraxial rays.
Since the beam has to be extracted to the ambient, further factors like the 
ion exit window, (often used as transmission detector, see below), air gap between 
exit window and bottom of Petri dish, as well as Petri dish entrance window 
deteriorate the beam diameter and, hence, the hit accuracy. Reported accuracies 
in air are between 1 – 3 µm (collimated systems) and below 500 nm (Leipzig and 
München, focussed systems, relative accuracies). These are usually obtained by 
single (or few) ion(s)  bombardment of a radiation sensitive polymer like CR39 
with which single ion tracks can be visualized by etching.
Several groups are using various codes for ion beam optics. Bordeaux uses 
a “fully integrated” ray tracing approach which includes beamline, windows and 
cells /  media.
Another important component is a fast beam switch or beam blanker, 
usually electrostatic. After the detection of a single particle, the beam blanker 
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must be able to “shut” the beamgate fast enough that no further ion hits the 
sample at the very same position. Since usually 1000 – 3000 ions / s are used for 
single hit applications, this does not represent a real challenge with hardware 
pulses and high-voltage supplies with fast risetimes.
2.4 Exit windows
In principle pinholes and differential pumping is possible to extract the beam to 
the ambient. However, an air-jet enters the beamline with ultrasonic velocities 
and, hence, renders this method impractical for applications with Petri dishes as 
close as possible to the hole. Therefore, all institutions use vacuum-tight windows 
consisting of suitable polymers (e.g. mylar, kapton) or Si3N4. It is interesting to 
note that a 1mm × 1mm window of Si3N4 with a thickness of 100 nm only can 
withstand a pressure difference of 1 atmosphere. Unfortunately, with such an 
exit window the area of the Petri dish which can be irradiated without sample 
translation stage will be 1 mm x 1mm at best only. With polymer foils, larger 
exit windows are feasible. One should keep in mind that any window material 
bends towards the vacuum chamber leaving an air gap between ion exit window 
and entrance window of the Petri dish. An air gap of about 75 – 100 µm does 
deteriorate the beam quality. Therefore the München group works with an air 
gap <  25 µm.
A nearby fast automatic valve should be provided to prevent ventilation 
of the beamline (and the accelerator tube) in case of rupture of the ion exit 
window.
2.5 Ion detectors and on-line microscopy
With the exceptions of Legnaro, Leipzig, München and  the Columbia University 
all institutions install transmission detectors in front of the Petri dish, despite 
the deterioration of the beam quality. A common technique is the use of a 
plastic scintillator (in combination with a photomultiplier behind the cells. The 
München group uses a plastic scintillator after the Petri dish while the Legnaro 
group uses a silicon diode, an arrangement which requires higher ion energies 
in order not to suffer from the macroscopic amount of material (air, Petri dish 
exit window) between cells and detector. A disadvantage is that the on-line 
microscope (München) has to be retracted for particle detection. At the Columbia 
University, a gas proportional counter was built into the objective of the on-line 
microscope. A miniaturized low pressure gas proportional counters has been 
developed as transmission detector in Bordeaux and is used in routine conditions. 
The signal to background ratio is sufficient to allow 100% efficiency for MeV 
52
STUK-A234
protons and alphas with a very low level of “false positives”. The only drawback 
is a tail in the lateral distribution of the beam due to multiple scattering on gas 
molecules. Studies of semiconductor devices as transmission detectors are going 
on at  Lund, but are not yet satisfactory. Several groups are using Si3N4 exit 
windows which are coated with a thin layer of CsI and Au (to prevent charging 
up) and use secondary electrons and an upstream channeltron as transmission 
detectors. Doped diamond windows were tried as well. Such devices work very 
well for ions heavier than protons. A satisfactory transmission detector for 2 – 3 
MeV protons does not exist yet. By satisfactory we mean that every proton is 
detected with close to 100% efficiency and that no “false-positive” signals are 
produced in the absence of transmitted protons. A level below 1% false-positives 
is desirable. To place a downstream particle detector behind the cells with about 
100% efficiency requires the removal of media but poses no serious constraints 
to the distance between cells and detector because the lateral straggling in air is 
of minor importance after cell traversal. Here, a retractable on-line microscope is 
required, too; alternatively, cells could be observed on-line with a long-distance 
or retractable microscope through the ion exit window towards downstream, as 
done at Leipzig. Some institutions are equipped with on-line UV illumination 
for better recognition of stained cells (stains for the cell nucleus or the cytoplasm 
or other).
2.6 Petri dishes
There is a whole variety of Petri dish designs. Common to all is the requirement 
of a thin entrance window, usually a polymer foil. Leipzig uses a Si3N4 window. 
Cells are plated on the other side of the window. Thus the material must be 
biocompatible and cells must adhere, at least for the horizontal beamlines. 
Typical dimensions of the entrance window range from 2 mm × 2 mm to 30 
mm in diameter. In general, cells are plated all over the Petri dish bottom, not 
only over the entrance window. This raises questions about possible differences 
between cells residing on different materials. Some vertical Petri dishes are 
equipped with exit windows as well. Within the CELLION project “intelligent” 
Petri dishes using nanotechnology will be developed which could eventually 
result in cell arrays or even cells on electrodes.
2.7 Target translation stages
For collimated beams a target translation stage is indispensable. However, due 
to the small size of common exit windows, a target translation stage is also 
advisable for focussed beams. Computer controlled x-, y- (and -z) translation 
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stages with µm precision or better are commercially available or can be custom-
made. Precision is one issue, reproducibility another. Speed is also important for 
rapid scanning over thousands of cells. For this purpose voice-coil devices proved 
useful. Thus far, no sub-micrometer intracellular targets other than the nucleus 
were aimed at due to the limited hit accuracy. Hence, the existing translation 
stages are good enough at present.
2.8 Automatic cell recognition
The standard procedure is to use an off-line microscope to automatically register 
the cell nuclei positions of stained cells. The x- and y-coordinates are then used 
for automatic target translation movements or automatic beam scanning. Some 
institutions have such systems already installed. The need of stains always raises 
the question to what extent the stress which the cells suffer from the stain and 
the UV illumination might spoil the low dose results. The Legnaro group already 
developed a semi-automatic cell visualization, recognition and re-visiting system 
based on an inverted phase contrast optical microscope equipped with a CCD 
camera and on a dedicated software, without using any fluorescent staining or UV 
light. The Krakow group is working on an automatic cell recognition system which 
does not require stains and UV illumination. It uses three microscopy images, 
one in focus and two above / below focus and exploits the phase information. 
An obvious difficulty results from the requirement of absolute x- and 
y-coordinates. A reference or fiducial marker would be advantageous. However, 
tests with predetermined target positions in CR39 which are subsequently 
revisited with ions turned out useful for hit verification tests, too. Image overlay 
procedures for off- and on-line images would be useful and are under construction 
in several laboratories. For studies where a very high throughput of cells is 
required, an automatic cell recognition system is indispensable, contrary to the 
case where one or a few cells are targeted only.
3 Cell types and endpoints
Since this is a compilation of technical aspects, information on radiobiological 
programs will be kept rather short. A few comments, however, are appropriate to 
see where we are going. The GCI, London investigated by far the largest variety 
of cells. Thus far it is also the only institution which started studies of tissue. In 
most other laboratories which have started with single ion irradiation of living 
cells the choice of cells was dictated more by availability, ease of cell culturing, 
sometimes size of cells, adhesion properties and alike. As soon as routine work 
begins, a careful selection of cells is advisable. As far as possible endpoints are 
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concerned, cell survival experiments and bystander effect studies in order to 
catch up with existing literature (time consuming) are required. Apoptosis, DNA 
damage and repair mechanisms and dynamics, protein expression, stress markers 
are further possibilities, just to mention a few. An interesting “technical” aspect 
is the possibility to visualize tracks of individual ions using double-strand break 
markers (“foci”). Since the cells stay alive upon traversal of a single ion (or even 
more ions), any deviation from a straight trajectory in 3D-images taken with 
laser scanning confocal microscopes hours later is due to intranuclear dynamics, 
as shown by the München group. 
In order to discriminate true foci from spurious ones, several groups started 
to irradiate patterns, e.g. a cross consisting of 5 particles, or equidistant lines 
of points, which can be easily identified. The GSI, Darmstadt group did so with 
targeted irradiation whereas Leipzig and München “wrote” regular patterns all 
over a certain area of the Petri dish. It is astonishing how much new information 
can be extracted from such patterned irradiation. Thus far, 2.25 MeV protons 
did not lead to a clearly recognizable pattern of foci whereas alpha particles 
seem to work.
4 Outlook
Among radiation biologists a frequently encountered objection against the use 
of nuclear microprobes is the statement that such studies are carried out using 
molecular biology nowadays. This statement is misleading because molecular 
biology techniques are most useful and welcome, but do not eliminate the 
urgent need for targeted irradiation at the single particle level. In other words, 
very refined tools to introduce controlled damage with subcellular accuracy 
must be combined with state of the art detection schemes for the cellular 
response. The rapid grows of the European nuclear microprobe community with 
radiobiological programs is encouraging and parallels worldwide efforts. It is 
of utmost importance to understand the cellular response to ionising radiation 
in the low-dose regime, both for radiation protection issues as well as for the 
development of better radiation therapies.
55
STUK-A234
Ta
bl
e 
I.
In
st
itu
tio
n
St
at
us
A
cc
el
er
at
or
 (t
yp
e,
 M
V)
Io
n 
so
ur
ce
O
ri
en
ta
tio
n
Fo
rm
at
io
n
Io
n 
ex
it 
A
nt
i-
vi
br
at
io
na
l m
ea
ns
B
or
de
au
x
un
de
r
Va
n 
de
 G
ra
af
f K
N
40
00
 
RF
 p
, H
2+
, d
, 4
He
+  
ho
riz
on
ta
l
co
lli
m
at
io
n
Si
3N
4 w
in
do
w
 
gr
an
ite
 s
to
ne
co
ns
tru
ct
io
n
(u
p 
to
 J
ul
y 
20
05
)
15
0 
nm
 th
ic
kn
es
s
HV
EE
 3
.5
 M
V 
Si
ng
le
tro
n
1 
m
m
2
(fr
om
 O
ct
ob
er
 2
00
5)
B
ra
un
sc
hw
ei
g
op
er
at
io
na
l
Va
n 
de
 G
ra
af
f K
N
 3
75
0 
RF
, P
en
ni
ng
ve
rti
ca
l
fo
cu
si
ng
us
ua
lly
 5
 µ
 m
yl
ar
 
Cy
cl
ot
ro
n 
TC
C 
CV
-2
8
p,
 d
, 4
He
G
SI
 
op
er
at
io
na
l
RF
 li
na
c 
EC
R,
 P
IG
ho
riz
on
ta
l
fo
cu
si
ng
 
Si
3N
4 w
in
do
w
ai
r s
pr
in
g 
D
ar
m
st
ad
t
Ca
rb
on
 to
 U
ra
ni
um
20
0 
nm
 th
ic
kn
es
s
1 
m
m
2
20
 n
m
 G
ol
d
~ 
10
0 
nm
 C
sI
Kr
ak
ow
un
de
r
Va
n 
de
 G
ra
af
f, 
HV
EC
RF
 s
ou
rc
e,
 p
, 4
He
 
ho
riz
on
ta
l 
fo
cu
si
ng
Si
3N
4 w
in
do
w
co
nc
re
te
 b
lo
ck
 in
 s
an
d 
ba
th
co
ns
tru
ct
io
n
3M
V 
(2
.5
 M
V 
at
 p
re
se
nt
)
20
0 
nm
 th
ic
kn
es
s
op
tic
al
 b
an
k 
w
ith
 ru
bb
er
 
Cs
I (
10
0 
nm
)
ba
ck
in
g 
Au
 (2
0 
nm
) 
Le
gn
ar
o
op
er
at
io
na
l
CN
 7
 M
V 
p,
d,
 3 H
e,
 4 H
e,
 15
N
ho
riz
on
ta
l
co
lli
m
at
io
n
10
 µ
m
 a
-b
i-l
um
in
ize
d
va
n 
de
 G
ra
af
f
m
yl
ar
, 5
 m
m
 d
ia
.
Le
ip
zi
g
pa
tte
rn
ed
3.
5 
M
V 
SI
N
GL
ET
RO
N
RF
 p
, 4
He
+
ho
riz
on
ta
l
fo
cu
si
ng
Si
3N
4 w
in
do
w
se
pa
ra
te
 fo
un
da
tio
ns
LI
PS
IO
N
irr
ad
ia
tio
n
10
0 
nm
 th
ic
kn
es
s
1 
m
m
2
Lo
nd
on
fu
lly
4M
V 
Va
n 
de
 G
ra
af
f
p,
 3 H
e
ve
rti
ca
l 
co
lli
m
at
io
n
3 
µ 
m
yl
ar
flo
or
 is
 1
.5
m
 c
on
cr
et
e
(m
ov
e 
to
op
er
at
io
na
l
1µ
 b
y 
1 
m
m
 h
ol
e 
O
xf
or
d)
5M
V 
Ta
nd
em
 p
la
nn
ed
in
 a
 2
50
 m
m
 d
ia
.
bo
ro
si
lic
at
e 
gl
as
s
ca
pi
lla
ry
 
Lu
nd
un
de
r
si
ng
le
-e
nd
ed
 3
M
V
RF
 p
,d
,4 H
e
ho
riz
on
ta
l
fo
cu
si
ng
Si
3N
4 w
in
do
w
gr
an
ite
 b
lo
ck
 o
n 
pl
as
tic
 fo
am
co
ns
tru
ct
io
n
Pe
lle
tro
n
un
de
r d
ev
el
op
m
en
t
bl
oc
ks
, s
an
d-
da
m
pe
d 
co
nt
.
M
ün
ch
en
op
er
at
io
na
l
14
 M
V 
Ta
nd
em
Cs
-io
n 
sp
ut
te
r
ho
riz
on
ta
l 
fo
cu
si
ng
Ka
pt
on
 7
.5
 µ
m
 
gr
ou
nd
 fl
oo
r e
m
be
dd
ed
 in
 
SN
A
KE
 
pl
as
m
a 
so
ur
ce
s
M
yl
ar
 0
.9
 µ
m
 
pe
bb
le
s
p,
 d
, H
e,
 h
ea
vy
 io
ns
vi
br
at
io
n_
is
ol
at
ed
 m
ou
nt
in
g 
 
pl
at
e 
an
d 
sl
its
 
G
ui
ld
fo
rd
un
de
r
2 
M
V 
Ta
nd
em
p,
 H
e
ho
riz
on
ta
l
co
ns
tru
ct
io
n
ve
rti
ca
l
(p
la
nn
ed
)
U
pp
sa
la
na
no
te
ch
no
l.
5 
M
V 
15
SD
H-
2T
M
 
m
os
t i
on
s,
 e
xc
ep
t 
ho
riz
on
ta
l
fo
cu
si
ng
no
 d
ire
ct
 ra
d.
-
pe
lle
tro
n 
ta
nd
em
 N
EC
ra
di
oa
ct
iv
e 
io
ns
 a
nd
bi
ol
og
ic
al
 p
ro
gr
am
no
bl
e 
ga
se
s
56
STUK-A234
Ta
bl
e 
I (
co
nt
in
ue
d)
.
In
st
itu
tio
n
A
nt
i-
m
ag
ne
tic
 s
tr
ay
 fi
el
ds
 m
ea
ns
O
pt
ic
s 
co
de
Re
m
ar
ks
 a
cc
el
le
ra
to
r
Sc
an
ni
ng
Io
n 
tr
an
sm
is
si
on
 d
et
ec
to
r
B
or
de
au
x
Iro
n 
sh
ie
ld
in
g 
fo
r s
om
e 
pa
rts
 o
f
TR
AN
SP
OR
T, 
TR
AX
De
te
ct
or
 u
ps
tre
am
 th
at
 a
llo
w
s 
irr
ad
ia
tio
n 
w
ith
 c
el
ls
 im
m
er
se
d 
in
 m
ed
iu
m
 
ta
rg
et
 
pr
op
or
tio
na
l c
ou
nt
er
th
e 
be
am
lin
e
GE
AN
T 
IV
, Z
GO
UB
I
El
ec
tro
st
at
ic
 b
ea
m
 b
la
nk
in
g 
(p
er
fo
rm
an
ce
 w
ith
in
 5
00
 n
s)
is
ob
ut
en
e 
at
 lo
w
 p
re
ss
ur
e 
Lo
w
 m
ic
ro
be
am
 c
ur
re
nt
 (u
nc
on
tro
lle
d)
 (1
00
0 –
 30
00
 io
ns
 p
er
 s
ec
) 
B
ra
un
sc
hw
ei
g
TR
AN
SP
OR
T
fa
st
 e
le
ct
ro
st
at
ic
 b
ea
m
 d
ef
le
ct
io
n 
fo
r s
in
gl
e-
 o
r c
ou
nt
ed
-io
n 
irr
ad
ia
tio
n
ta
rg
et
sc
in
til
la
to
r
fa
st
 e
le
ct
ro
st
at
ic
 b
ea
m
 s
ca
nn
in
g 
up
 to
 5
00
00
 c
el
ls
 o
r p
os
ito
ns
 p
er
 h
ou
r 
G
SI
 
µ-
m
et
al
 s
hi
el
d 
al
on
g 
be
am
 tu
be
20
0 
ns
 b
ea
m
 s
w
itc
h 
us
in
g 
el
ec
tro
st
at
ic
 d
ef
le
ct
or
 a
t p
os
iti
on
 o
f o
bj
ec
t s
lit
be
am
se
co
nd
ar
y 
el
ec
tro
n 
D
ar
m
st
ad
t
 
em
is
si
on
 fr
om
 v
ac
uu
m
w
in
do
w
Kr
ak
ow
SI
M
IO
N
, P
RA
M
, 
Be
am
 b
la
nk
in
g 
pr
ov
id
ed
 b
y 
de
fle
ct
io
n 
el
ec
tro
de
s
ta
rg
et
Ch
an
ne
ltr
on
 a
s 
a 
se
co
n-
TR
AN
SP
OR
T
(+
 / -
22
0V
, 1
00
0V
 / µ
s 
sl
ew
 ra
te
); 
be
am
 b
la
nk
in
g 
tim
e 
13
 µ
s 
fro
m
 io
n 
 
da
ry
 e
le
ct
ro
n 
de
te
ct
or
 
pa
ss
ag
e 
re
gi
st
ra
tio
n 
to
 fu
ll 
vo
lta
ge
 o
n 
el
ec
tro
de
s.
 
(w
ill
 b
e 
re
de
si
gn
ed
)
Le
gn
ar
o
15
0 
ns
 b
ea
m
 
ta
rg
et
no
ne
, s
ili
co
n 
be
hi
nd
 c
el
ls
Le
ip
zi
g
ac
tiv
e 
co
m
pe
ns
at
io
n 
w
ith
 
fa
st
 e
le
ct
ro
st
at
ic
 b
ea
m
 d
ef
le
ct
io
n 
fo
r s
in
gl
e-
 o
r c
ou
nt
ed
-io
n 
irr
ad
ia
tio
n
be
am
no
ne
, d
et
ec
to
r b
eh
in
d
LI
PS
IO
N
He
lm
ho
ltz
-c
oi
ls
irr
ad
ia
tio
n 
tu
nn
el
 w
ith
 P
et
ri 
di
sh
 s
lid
e
Pe
tri
 d
is
h
35
0 
nm
 F
W
HM
 h
it 
ac
cu
ra
cy
 in
 a
ir
Lo
nd
on
no
ne
no
ne
be
tte
r t
ha
n 
99
%
 p
ar
tic
le
 d
et
ec
tio
n 
ef
fic
ie
nc
y
ta
rg
et
18
 m
ic
ro
n 
pl
as
tic
 B
C4
00
(m
ov
e 
to
Er
ro
rs
 a
re
 u
su
al
ly
 ‘f
al
se
-p
os
iti
ve
’ c
ou
nt
s
Ha
m
m
am
at
su
 p
ho
to
m
ul
tip
lie
r
O
xf
or
d)
tu
be
 a
bo
ve
 d
is
h 
Lu
nd
no
ne
PR
AM
, O
xt
ra
ce
be
am
 b
la
nk
er
: s
ee
 V
. A
uz
el
yt
e 
et
 a
l. 
N
IM
B 
21
9 –
 22
0 
(2
00
4)
 4
85
 –
 48
9
be
am
pa
rti
cl
e 
de
te
ct
or
 b
eh
in
d
ce
lls
 (u
nd
er
 d
ev
el
op
m
en
t)
M
ün
ch
en
so
ft 
iro
n 
be
am
 tu
be
 1
8 
m
 lo
ng
TR
AN
SP
OR
T
su
pe
rc
on
du
ct
in
g 
m
ul
tip
ol
e 
le
ns
 c
on
si
st
in
g 
of
 a
 th
re
e 
se
ct
io
n 
qu
ad
ru
po
le
  
be
am
 
sc
in
til
la
to
r b
eh
in
d 
Pe
tri
SN
A
KE
in
 fr
on
t o
f t
he
 s
up
er
co
nd
uc
tin
g
ho
m
e 
m
ad
e 
ra
y 
le
ns
 s
ph
er
ic
al
ly
 c
or
re
ct
ed
, 
di
sh
m
ul
tip
ol
e 
le
ns
 
tra
ci
g 
co
de
 
hi
t a
cc
ur
ac
y 
< 5
00
 n
m
 in
 x
- a
nd
 y
 (3
5 
M
eV
 L
i, 
55
 M
eV
 C
, 1
00
 M
eV
 O
) 
at
 1
00
0 
io
ns
 / s
. H
ig
h 
be
am
 c
ur
re
nt
s 
(1
 –
 10
0 
pA
) a
ls
o 
av
ai
la
bl
e 
G
ui
ld
fo
rd
1 
µm
 h
or
izo
nt
al
 b
ea
m
lin
e 
(u
nd
er
 c
on
st
ru
ct
io
n)
ve
rti
ca
l n
an
o-
be
am
lin
e 
(p
la
nn
ed
)
U
pp
sa
la
be
am
57
STUK-A234
Ta
bl
e 
I (
co
nt
in
ue
d)
.
In
st
itu
tio
n
Ta
rg
et
 tr
an
sl
at
io
n 
st
ag
e
Pe
tr
i d
is
h
M
ic
ro
sc
op
y
Im
ag
e 
ov
er
la
y
A
ut
om
at
ic
 c
el
l r
ec
og
ni
tio
n
B
or
de
au
x
M
ic
ro
co
nt
ro
l X
-Y
-Z
 M
FN
25
-C
C
po
ly
et
hy
le
ne
on
-li
ne
, e
pi
flu
or
es
ce
nc
e 
UV
/V
IS
un
de
r d
ev
el
op
m
en
t 
Im
ag
e 
pr
o 
pl
us
 (M
ed
ia
 C
yb
er
ne
tic
s)
re
pr
od
uc
ib
ili
ty
 <
 1 
µ,
 5
5 
nm
 re
so
lu
tio
n
4 
µ 
po
ly
pr
op
yl
en
e 
as
di
ffe
re
nt
 p
os
si
bl
e 
fil
te
rs
as
 p
ro
ce
ss
in
g 
pa
ck
ag
e
Co
nt
ro
le
r N
ew
po
rt 
ES
P3
00
en
tra
nc
e 
w
in
do
w
 / c
ul
tu
re
 s
up
po
rt
Ob
je
ct
iv
es
 x
10
 a
nd
 x
20
10
 m
m
 in
 d
ia
m
et
er
, 3
 m
m
 th
ic
kn
es
s
CC
D 
Ca
m
er
a 
Ko
da
k 
KA
I-2
09
2 
ch
ip
se
t
B
ra
un
sc
hw
ei
g
co
m
pu
te
r-c
on
tro
lle
d 
x-
y-
st
ag
e
cu
st
om
-m
ad
e 
st
ai
nl
es
s 
st
ee
l,
on
-li
ne
, o
ff-
lin
e
(Ip
p+
, m
ed
ia
-c
yb
er
ne
tic
s)
 w
ith
  
ab
ou
t 1
.5
 µ
m
 (F
W
HM
)
8 
an
d 
11
 m
m
 ID
, f
oi
l: 
5 –
 25
 µ
m
 
re
vi
si
tin
g 
ce
lls
 in
-s
itu
 a
nd
 e
x-
si
tu
fle
xi
bl
e 
cu
st
om
-m
ad
e 
ro
ut
in
es
G
SI
 
x-
y-
st
ag
e 
(in
tre
gr
al
 p
ar
t o
f v
ac
uu
m
 
20
 x
 2
0 
x 
3 
m
m
 s
ta
in
le
ss
 s
te
el
 w
ith
 c
en
tra
l
on
 li
ne
 2
0 
x 
m
ic
ro
sc
op
e
st
ai
ne
d 
ce
ll 
nu
cl
ei
D
ar
m
st
ad
t
ch
am
be
r’s
 e
nd
 fl
an
ge
)
ro
un
d 
pl
at
in
g 
ar
ea
 o
f 8
 m
m
 d
ia
m
et
er
le
ns
 p
ro
je
ct
in
g 
on
to
 C
CD
 c
am
er
a
(5
0 
nM
 o
f H
oe
ch
st
 s
ta
in
 a
nd
 le
ss
8.
5 
m
m
 tr
av
el
, 2
00
 n
m
 a
cc
ur
ac
y
4 
µm
 p
ol
yp
ro
py
le
ne
 o
r m
yl
ar
 fo
il 
50
 W
 H
g 
la
m
p;
 F
ilt
er
 w
he
el
 fo
r g
re
en
is
 p
os
si
bl
e)
 
lig
ht
; U
V 
fil
te
r f
or
 fl
uo
re
sc
en
ce
Re
vi
si
tin
g 
ce
lls
 o
ff-
lin
e
Kr
ak
ow
Ph
ys
ik
 In
st
ru
m
en
te
, V
oi
ce
 C
oi
l t
yp
e
un
de
r c
on
st
ru
ct
io
n
Of
f-l
in
e:
 Q
Pm
 s
ys
te
m
 
un
de
r d
ev
el
op
m
en
t 
Im
ag
e 
Pr
o 
Pl
us
 (M
ed
ia
 C
yb
er
ne
tic
s)
 
V-
10
6 
2S
, s
ub
-m
ic
ro
m
et
er
 re
so
lu
tio
n 
On
-li
ne
: l
on
g 
w
or
ki
ng
 d
is
ta
nc
e 
M
itu
to
yo
 o
bj
ec
tiv
e 
+ 
CC
D 
ca
m
er
a
Le
gn
ar
o
Ph
ys
ik
 In
st
ru
m
en
te
, a
cc
ur
ac
y 
0.
1 
µm
en
tra
nc
e:
 6
 µ
m
 m
yl
ar
  e
xi
t: 
6 
µm
 m
yl
ar
Ol
ym
pu
s 
in
ve
rte
d 
ph
as
e 
co
nt
ra
st
ce
ll 
ch
am
be
r t
hi
ck
ne
ss
 2
0 
µm
of
f-l
in
e;
 re
vi
si
tin
g 
ce
lls
Le
ip
zi
g
pl
an
ne
d
35
 m
m
 O
D 
w
ith
on
-li
ne
 V
IS
 
un
de
r d
ev
el
op
m
en
t
pl
an
ne
d
LI
PS
IO
N
2 
m
m
2  S
i 3N
4 2
00
 n
m
 th
ic
kn
es
s
of
f-l
in
e 
AX
IO
VE
RT
 x
40
 w
ith
 U
V 
la
m
p
as
 b
ot
to
m
 fo
r p
la
tin
g
Lo
nd
on
M
ar
zh
au
ze
r, 
ac
cu
ra
cy
 (r
ep
ro
du
ci
bi
lit
y)
3 
µ 
m
yl
ar
 m
ed
ic
al
-g
ra
de
 s
up
po
rte
d 
on
-li
ne
 O
ly
m
pu
s 
BX
2 
Vi
si
lo
g 
im
ag
in
g 
pr
oc
es
si
ng
 p
ac
ka
ge
(m
ov
e 
to
ab
ou
t 1
 m
ic
ro
n 
in
 s
ta
in
le
ss
 s
te
el
 d
is
h 
O
xf
or
d)
Lu
nd
x-
st
ag
e 
M
41
0 
re
s.
 0
.0
08
5 
µm
 / c
ou
nt
un
de
r d
ev
el
op
m
en
t
on
-li
ne
: O
ly
m
pu
s 
5x
, 2
0x
 +
 T
V-
ca
m
er
a
un
de
r d
ev
el
op
m
en
t
no
ne
y-
 a
nd
 z-
st
ag
e 
M
11
1 
re
s.
 0
.0
06
8 
µm
 / c
.
M
ün
ch
en
m
an
ua
l m
ic
ro
sc
op
e 
tra
ns
la
tio
n 
st
ag
e,
 
pl
at
e-
lik
e,
 s
ta
in
le
ss
 s
te
el
 c
on
ta
in
er
, 
on
-li
ne
: p
ha
se
 c
on
tra
st
 a
nd
 fl
uo
re
sc
en
ce
no
ne
 
no
ne
 
SN
A
KE
ac
cu
ra
cy
 1
 µ
m
 
ou
te
r d
im
en
si
on
s 
90
 m
m
 *
 9
0 
m
m
m
ic
ro
sc
op
e:
 Z
ei
ss
 A
xi
ov
er
t 2
5 
CF
L 
ce
ll 
fre
e 
sp
ac
e 
66
 m
m
 d
ia
m
et
er
, 
of
f-l
in
e:
 3
D 
flu
or
es
ce
nc
e 
m
ic
ro
sc
op
e 
3 
m
m
 in
 h
ei
gh
t
co
nf
oc
al
 la
se
r f
lu
or
es
ce
nc
e 
m
ic
ro
sc
op
e
G
ui
ld
fo
rd
U
pp
sa
la
58
STUK-A234
Ta
bl
e 
I (
co
nt
in
ue
d)
.
In
st
itu
tio
n
Ce
ll 
ty
pe
s
En
dp
oi
nt
s
Li
te
ra
tu
re
Co
nt
ac
t
B
or
de
au
x
Ha
Ca
t k
er
at
in
oc
yt
e 
ce
lls
 
Ap
op
to
si
s
Re
v. 
Sc
i. 
In
st
r. 
76
, 0
15
10
1,
 2
00
5
m
or
et
to
@
ce
nb
g.
in
2p
3.
fr 
DN
A 
da
m
ag
e
Si
gn
al
lin
g 
pa
th
w
ay
s
B
ra
un
sc
hw
ei
g
us
er
 s
pe
ci
fic
N
uc
l. 
In
st
r. 
an
d 
M
et
h.
 B
 2
17
 (2
00
4)
 5
05
 –
 51
2
ul
ric
h.
gi
es
en
@
pt
b.
de
 
G
SI
 
fib
ro
bl
as
ts
 
by
st
an
de
r, 
pr
ot
ei
n
B.
Fi
sc
he
r@
gs
i.d
e 
D
ar
m
st
ad
t
ex
pr
es
si
on
 a
nd
 D
N
A
 
da
m
ag
e 
an
d 
re
pa
ir
V7
9
su
rv
iv
al
CH
O
ov
er
ki
ll
Kr
ak
ow
Hu
m
an
 fi
br
ob
la
st
s 
by
st
an
de
r e
ffe
ct
Ja
nu
sz
.L
ek
ki
@
ifj
.e
du
.p
l 
(p
la
nn
ed
)
m
ut
at
io
ns
, D
N
A 
ab
er
ra
tio
ns
, r
ep
ai
r 
Le
gn
ar
o
ro
de
nt
 a
nd
 h
um
an
 c
el
ls
by
st
an
de
r, 
ad
ap
tiv
e
ro
be
rto
.c
he
ru
bi
ni
@
ln
l.i
nf
n.
it
re
sp
on
se
, h
yp
er
se
ns
.
Le
ip
zi
g
fib
ro
bl
as
ts
, H
eL
a
tra
ck
 v
is
ua
liz
at
io
n
N
uc
l. 
In
st
r. 
an
d 
M
et
h.
 B
 2
19
 –
 22
0 
(2
00
4)
 7
7
bu
tz
@
ph
ys
ik
.u
ni
-le
ip
zig
.d
e
LI
PS
IO
N
CH
O,
 H
UV
EC
us
in
g 
do
ub
le
-s
tra
nd
ep
ith
el
ia
l
br
ea
k 
m
ar
ke
rs
Lo
nd
on
m
an
y 
ce
ll 
ty
pe
s
by
st
an
de
r e
ffe
ct
s
fo
lk
ar
d@
gc
i.a
c.
uk
 
(m
ov
e 
to
ot
he
r n
on
-ta
rg
et
ed
 
O
xf
or
d)
ef
fe
ct
s
tis
su
es
 a
nd
 in
 v
iv
o 
Lu
nd
no
t d
ec
id
ed
ja
n.
pa
llo
n@
nu
cl
ea
r.l
u.
se
M
ün
ch
en
He
La
 
ce
ll 
su
rv
ei
lla
nc
e 
 
gu
en
th
er
.d
ol
lin
ge
r@
un
ib
w
-m
ue
nc
he
n.
de
 
SN
A
KE
st
ra
te
gi
es
; D
N
A-
re
pa
ir 
m
ec
ha
ni
sm
s 
 
an
d 
dy
na
m
ic
s
G
ui
ld
fo
rd
G.
Gr
im
e@
su
rre
y.a
c.
uk
U
pp
sa
la
kl
as
.h
jo
rt@
an
gs
tro
m
.u
u.
se
59
STUK-A234
Mathematical modelling of the radiation-
induced bystander effect and transmissible 
genomic instability applied to cancer
Mark P. Littlea,*, Kevin Priseb, Melvyn Folkardb and Oleg Belyakovc
a Department of Epidemiology and Public Health,  
Imperial College Faculty of Medicine, London W2 1PG, UK
b Gray Cancer Institute, P.O. Box 100, Mount Vernon Hospital,  
Northwood HA6 2JR, UK
c Radiation and Nuclear Safety Authority, Research and 
Environmental Surveillance, Radiation Biology Laboratory, 
P.O. Box 14, Laippatie 4, FI-00881 Helsinki, Finland
* To whom all correspondence should be addressed via:  
Tel. +44 (0)20 7594 3312 
Fax +44 (0)20 7402 2150 
Email: mark.little@imperial.ac.uk
Keywords: cancer, bystander effect, mechanistic carcinogenesis models, 
Armitage-Doll model, two-mutation model, dose response
Abstract
A variety of quasi-mechanistic models of carcinogenesis are reviewed, and in 
particular, the multi-stage model of Armitage and Doll and the two-mutation 
model of Moolgavkar, Venzon, and Knudson.  Both the latter models, and various 
generalizations of them also, are capable of describing at least qualitatively 
many of the observed patterns of excess cancer risk following ionizing radiation 
exposure. However, there are certain inconsistencies with the biological and 
epidemiological data both for the multi-stage model and the two-mutation 
model.  In particular, there are indications that the two-mutation model is not 
totally suitable for describing the pattern of excess risk for solid cancers that is 
often seen after exposure to radiation, although leukaemia may be better fitted 
by this type of model.  Generalizations of the model of Moolgavkar, Venzon, and 
Knudson which require three or more mutations, and models allowing for genomic 
instability, are easier to reconcile with the epidemiological and biological data 
relating to solid cancers.
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Bystander effects, whereby cells that are not directly exposed to ionizing 
radiation exhibit adverse biological effects, have been observed in a number of 
experimental systems. In contrast to the large amount of work on developing 
carcinogenesis models over the last 50 years, there has been comparatively 
little work on developing quasi-mechanistic models of the bystander effect, 
reflecting the comparatively recently available experimental data elucidating 
this phenomenon. The few quasi-mechanistic models of the bystander effect that 
have been developed are surveyed. In particular, a novel stochastic model of the 
radiation-induced bystander effect is considered that takes account of spatial 
location, cell killing and repopulation, features not explicitly taken into account 
in many previous models. The ionizing radiation dose- and time-responses of this 
model are explored, and it is shown to exhibit pronounced downward curvature 
in the high dose-rate region, similar to that observed in many experimental 
systems, reviewed in the paper. It is also shown to predict the augmentation 
of effect after fractionated delivery of dose that has been observed in certain 
experimental systems.
1 Mechanistic carcinogenesis models
1.1 Introduction
One of the principal uncertainties that surround the calculation of population cancer 
risks from epidemiological data results from the fact that few radiation-exposed 
cohorts have been followed up to extinction. For example, 50 years after the atomic 
bombings of Hiroshima and Nagasaki, about half of the survivors were still alive 
(Preston et al. 2003). In attempting to calculate lifetime population cancer risks 
it is therefore important to predict how risks might vary as a function of time 
after radiation exposure, in particular for that group for whom the uncertainties 
in projection of risk to the end of life are most uncertain, namely those who were 
exposed in childhood.
One way to model the variation in risk is to use empirical models 
incorporating adjustments for a number of variables (e.g. age at exposure, time 
since exposure, sex) and indeed this approach has been used in the Fifth Report 
of the Biological Effects of Ionizing Radiations (BEIR V) Committee (National 
Research Council 1990) in its analyses of data on the Japanese atomic bomb 
survivors and various other irradiated groups. Recent analyses of solid cancers for 
these groups have found that the radiation-induced excess risk can be described 
fairly well by a relative risk model (ICRP 1991). The time-constant relative risk 
model assumes that if a dose of radiation is administered to a population, then, 
after some latent period, there is an increase in the cancer rate, the excess rate 
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being proportional to the underlying cancer rate in an unirradiated population. 
For leukaemia, this model provides an unsatisfactory fit, consequently a number 
of other models have been used for this group of malignancies, including one in 
which the excess cancer rate resulting from exposure is assumed to be constant 
i.e. the time-constant additive risk model (UNSCEAR 1988).
It is well known that for all cancer subtypes (including leukaemia) 
the excess relative risk (ERR) diminishes with increasing age at exposure 
(UNSCEAR, 2000). For those irradiated in childhood there is evidence of a 
reduction in the ERR of solid cancer 25 or more years after exposure (Little et 
al. 1991, Little 1993, Thompson et al. 1994, Pierce et al. 1996, UNSCEAR 2000). 
For solid cancers in adulthood the ERR is more nearly constant, or perhaps even 
increasing over time (Little and Charles 1991, Little 1993, UNSCEAR 2000), 
although there are some indications to the contrary (Weiss et al. 1994). Clearly 
then, even in the case of solid cancers various factors have to be employed to 
modify the ERR.
Associated with the issue of projection of cancer risk over time is that 
of projection of cancer risk between two populations with differing underlying 
susceptibilities to cancer. Analogous to the relative risk time projection model 
one can employ a multiplicative transfer of risks, in which the ratio of the 
radiation-induced excess cancer rates to the underlying cancer rates in the two 
populations might be assumed to be identical. Similarly, akin to the additive 
risk time projection model one can use an additive transfer of risks, in which the 
radiation-induced excess cancer rates in the two populations might be assumed to 
be identical. The data that are available suggests that there is no simple solution 
to the problem (UNSCEAR 1994). For example, there are weak indications 
that the relative risks of stomach cancer following radiation exposure may be 
more comparable than the absolute excess risks in populations with different 
background stomach cancer rates (UNSCEAR 1994). Comparison of breast 
cancer risks observed in the Japanese atomic bomb survivor incidence data and 
those in various medically exposed populations, many from North America and 
Europe, where underlying breast cancer rates are higher than in Japan, suggests 
that ERRs are rather higher in the LSS than those in the medically irradiated 
groups, but (time- and age-adjusted) EARs are more similar (Little and Boice 
1999, Preston et al. 2002). The observation that gender differences in solid tumour 
ERR are generally offset by differences in gender-specific background cancer rates 
(UNSCEAR 1994) might suggest that EARs are more alike than ERRs. Taken 
together, these considerations suggest that in various circumstances relative or 
absolute transfers of risk between populations may be advocated or, indeed, the 
use of some sort of hybrid approach such as that employed by Muirhead and 
Darby (1987) and Little et al. (1999).
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The exposed populations that are often used for deriving cancer risks 
e.g. the Japanese atomic bomb survivors, were exposed to ionizing radiation at 
high doses and high dose rates. However, it is the possible risks arising from low 
dose and low dose-rate exposure to ionizing radiation which are central to the 
setting of standards for radiological protection. The International Commission 
on Radiological Protection (ICRP) (1991) recommended application of a dose and 
dose-rate effectiveness factor of 2 to scale cancer risks from high dose and high 
dose-rate exposure to low dose and low dose-rate exposure on the basis of animal 
data, the shape of the cancer dose-response in the bomb survivor data and other 
epidemiological data. Although the linear-quadratic dose-response model (with 
upward curvature) found for leukaemia is perhaps the most often employed 
departure from linearity in analyses of cancer in radiation-exposed groups (Pierce 
and Vaeth 1991, Pierce et al. 1996), other shapes are possible for the dose-response 
curve (UNSCEAR 1993). While for most tumour types in the Japanese data linear-
quadratic curvature adequately describes the shape of the dose-response curve, 
for non-melanoma skin cancer (NMSC) there is evidence for departures from 
linear-quadratic curvature. The NMSC dose-response in the Japanese cohort is 
consistent with a dose threshold of ≈ 1 Sv (Little and Muirhead 1996, Little and 
Charles 1997) or with an induction term proportional to the fourth power of dose, 
with in each case an exponential cell sterilization term to reduce NMSC risk at 
high doses (> 3 Sv).
Arguably, models which take account of the biological processes leading 
to the development of cancer can provide insight into these related issues 
of projection of cancer risk over time, transfer of risk across population and 
extrapolation of risks from high doses and dose-rates to low doses and dose-
rates. For example, Little and Charles (1991) have demonstrated that a variety 
of mechanistic models of carcinogenesis predict an ERR which reduces with 
increasing time after exposure for those exposed in childhood, while for those 
exposed in adulthood the ERR might be approximately constant over time. 
Mechanistic considerations also imply that the interactions between radiation 
and the various other factors that modulate the process of carcinogenesis may 
be complex (Leenhouts and Chadwick, 1994), so that in general one would not 
expect either relative or absolute risks to be invariant across populations.
1.2 Armitage-Doll multi-stage model
Mechanistic models of carcinogenesis were originally developed to explain 
phenomena other than the effects of ionizing radiation. One of the more commonly 
observed patterns in the age-incidence curves for epithelial cancers is that the 
cancer incidence rate varies approximately as ?]age[?C   for some constants C   
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Figure 1. Schematic diagram of the Armitage-Doll multi-stage model.
and ?  . At least for most epithelial cancers in adulthood, the exponent ?   of age 
seems to lie between 4 and 6 (Doll, 1971). The so-called multi-stage model of 
carcinogenesis of Armitage and Doll (1954) was developed in part as a way of 
accounting for this approximately log-log variation of cancer incidence with 
age. The model supposes that at age t  an individual has a population of X t( )   
completely normal (stem) cells and that these cells acquire one mutation at a rate 
M t( )( )0  . The cells with one mutation acquire a second mutation at a rate M t( )( )1  ,
and so on until at the ( )k ?1  th stage the cells with ( )k ?1   mutations proceed at a 
rate M k t( )( )?1   to become fully malignant. The model is illustrated schematically 
in Figure 1. It can be shown that when X t( )   and the M i t( )( )   are constant, a model 
with k  stages predicts a cancer incidence rate that is approximately given by the 
expression C k? ?[ ]age 1  with C M M M k k? ? ? ? ? ? ? ? ?( ) ( ) ... ( ) / ( ... ( ))0 1 1 1 2 1   (Armitage 
and Doll 1954, Moolgavkar 1978).
In developing their model Armitage and Doll (1954) were driven largely by 
epidemiological findings, and in particular by the age distribution of epithelial 
cancers. As can be seen from Figure 2, for many cancer endpoints, in particular, 
as shown here, for colon cancer, the age-incidence relationship is remarkably 
well described by a power of age, as predicted by this model. Departures from 
this form of relationship are only apparent at very young ages (< 10 years) 
(Figure 2). In the intervening thirty years, there has accumulated substantial 
biological evidence that cancer is a multi-step process involving the accumulation 
of a number of genetic and epigenetic changes in a clonal population of cells. 
This evidence is reviewed by the United Nations Scientific Committee on the 
Effects of Atomic Radiation (UNSCEAR) (1993, 2000). However, there are certain 
problems with the model proposed by Armitage and Doll (1954) associated 
with the fact that to account for the observed age incidence curve  ?]age[?C  
with ?   between 4 and 6, between 5 and 7 stages are needed. For colon cancer 
there is evidence that six stages might be required (Fearon and Vogelstein 
1990). However, for other cancers there is little evidence that there are as 
many rate-limiting stages as this. BEIR V (National Research Council 1990) 
surveyed evidence for all cancers and found that two or three stages might 
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Figure 2. SEER (2002) colon cancer data, and observed data (with 95% confidence 
intervals (CI), adjusted for overdispersion (McCullagh and Nelder 1989)) (taken from 
Little (2005)). The use of double logarithmic (log-log) axes shows that except for the 
youngest age group (< 10 years) the age-incidence relationship is well described by 
C·[age]k-1.
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be justifiable, but not a much larger number. To this extent the large number 
of stages predicted by the Armitage-Doll model appears to be verging on the 
biologically unlikely. Related to the large number of stages required by the 
Armitage-Doll multi-stage model is the high mutation rates predicted by the 
model. Moolgavkar and Luebeck (1992) fitted the Armitage-Doll multi-stage 
model to datasets describing the incidence of colon cancer in a general population 
and in patients with familial adenomatous polyposis. Moolgavkar and Luebeck 
(1992) found that Armitage-Doll models with five or six stages gave good fits to 
these datasets, but that both of these models implied mutation rates that were too 
high by at least two orders of magnitude. The discrepancy between the predicted 
and experimentally measured mutation rates might be eliminated, or at least 
significantly reduced, if account were to be taken of the fact that the experimental 
mutation rates are locus-specific. A “mutation” in the sense in which it is defined 
in this model might result from the “failure” of any one of a number of independent 
loci, so that the “mutation” rate would be the sum of the failure rates at each 
individual locus.
Notwithstanding these problems, much use has been made of the 
Armitage-Doll multi-stage model as a framework for understanding the time 
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course of carcinogenesis, particularly for the interaction of different carcinogens 
(Peto 1977). Day and Brown (1980) discuss in a qualitative way the pattern of 
variation of risk in a number of animal and human groups exposed to a variety 
of chemical carcinogens (as well as radiation). Freedman and Navidi (1989) 
also assess the fits of such models to various animal and human datasets, 
and as a result of fitting the model to three cohorts of smokers, in which they 
allow the mutation rates M i t( )( )   for early and late stages to be changed by the 
administration of tobacco smoke, conclude that none of the models adequately 
describes all the features of the data; this finding is to some extent contradicted 
by the fitting of similar models (allowing the first and penultimate mutation 
rates to be affected) to smoking data by Brown and Chu (1987). Brown and 
Chu (1983) also fitted the Armitage-Doll model to a dataset of copper smelter 
workers occupationally exposed to arsenic, as did Mazumdar et al. (1989); in both 
cases evidence was found that arsenic might act at both early and late mutation 
rates of such a multi-step process. Crump and Howe (1984) fitted the model to 
rats exposed to ethylene dibromide and found a satisfactory fit with a single 
affected stage (the first out of six stages). Thomas (1983) considered a cohort 
exposed to asbestos for which information on smoking was also available and 
found that the effects of both of these factors could each be modelled adequately 
by assuming that a single mutation rate was affected (stage four for asbestos 
and stage five for smoking in a model with a total of six stages). Thomas (1990) 
has fitted the Armitage-Doll model with one and two radiation-affected stages 
to the solid cancer data in the Japanese Life Span Study (LSS) 11 cohort of 
bomb survivors. Thomas (1990) found that a model with a total of five stages, of 
which either stages one and three or stages two and four were radiation-affected, 
fitted significantly better than models with a single radiation-affected stage. 
Little et al. (1992, 1994) also fitted the Armitage-Doll model with up to two 
radiation-affected stages to the Japanese LSS 11 dataset and also to data on 
various medically exposed groups, using a slightly different technique to that 
of Thomas (1990). Little et al. (1992, 1994) found that the optimal solid cancer 
model for the Japanese data had three stages, the first of which was radiation 
affected, while for the Japanese leukaemia data the best fitting model had three 
stages, the first and second of which were radiation affected. A version of the 
Armitage-Doll has also been fitted to the LSS solid tumour incidence data by 
Pierce and Mendelsohn (1999). Pierce and Mendelsohn (1999) found that a model 
with five or six stages gave the best fit to this data.
Both the paper of Thomas (1990) and those of Little et al. (1992, 1994) 
assumed the i  th and the j  th stages or mutation rates (M i M j( ), ( )? ?1 1  ) ( j i?  ) 
in a model with k  stages to be (linearly) affected by radiation and the transfer 
coefficients (other than M i( )?1   and M j( )?1  ) to be constant (as is the stem cell 
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population X t( )  ). In these circumstances it can be shown (Little et al. 1992) that 
if an instantaneously administered dose of radiation d   is given at age a  , then 
at age t a( )?   the cancer rate is approximately:
? ? ? ?? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?? ? ? ? ? ? ? ? ? ?t d a t a d a t a d a t ak i k i j k j i k j1 1 1 1 1 2 1 1[ ] [ ] [ ]
 
for some positive constants ?  ,?   and ?  , and where ?   is given by:
? ? ? ??
? ? ? ?
? ? ? ?
? ? ?
? ?
?
( ) ( )
( )
k i j
k
j i
j i
2
1
0 1
if
if
 
and ?(.)  is the gamma function (Abramowitz and Stegun 1964).
The first term (? ? ?t k 1 ) in expression corresponds to the cancer rate 
that would be observed in the absence of radiation, while the second term 
(? ? ? ? ?? ? ?d a t ai k i1 1[ ]  ) and the third term (? ? ? ? ?? ? ?d a t aj k j1 1[ ]  ) represent 
the separate effects of radiation on the i  th and j  th stages respectively. The 
fourth term (? ? ? ? ?? ? ?d a t ai k j2 1 1[ ]  ), which is quadratic in dose d  , represents 
the consequences of interaction between the effects of radiation on the i  th and 
the j  th stages and is only non-zero when the two radiation-affected stages are 
adjacent ( j i? ? 1 ). Thus if the two affected stages are adjacent, a quadratic 
(dose plus dose-squared) relationship will occur, whereas the relationship will be 
approximately linear if the two affected stages have at least one intervening stage. 
Another way of considering the joint effects of radiation on two stages is that 
for a brief exposure, unless the two radiation-affected stages are adjacent, there 
will be insignificant interaction between the cells affected by radiation in the 
earlier and later of the two radiation-affected cell compartments. This is simply 
because very few cells will move between the two compartments in the course 
of the radiation exposure. If the i  th and the j  th stages are radiation-affected 
the result of a brief dose of radiation will be to cause some of the cells which 
have already accumulated ( i ? 1 ) mutations to acquire an extra mutation and 
move from the ( i ? 1 ) th to the i  th compartment. Similarly, it will cause some 
of the cells which have already acquired ( j ?1 ) mutations to acquire an extra 
mutation and so move from the ( j ?1 ) th to the j  th compartment. It should be 
noted that the model does not require that the same cells be hit by the radiation 
at the i  th and j  th stages, and in practice for low total doses, or whenever the 
two radiation-affected stages are separated by an additional unaffected stage 
or stages, an insignificant proportion of the same cells will be hit (and mutated) 
by the radiation at both the i  th and the j  th stages. The result is that, unless 
the radiation-affected stages are adjacent, for a brief exposure the total effect on 
cancer rate is approximately the sum of the effects, assuming radiation were to 
act on each of the radiation-affected stages alone. One interesting implication of 
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models with two or more radiation-affected stages is that as a result of interaction 
between the effects of radiation at the various stages, protraction of dose in 
general results in an increase in cancer rate i.e. an inverse dose-rate effect (Little 
et al. 1992). However, it can be shown that in practice the resulting increase in 
cancer risk is likely to be small (Little et al. 1992).
The variant of the Armitage-Doll model fitted by Pierce and Mendelsohn 
(1999) is unusual in that it assumes that radiation equally affects all k  mutation 
rates in the model except the last. (In the last stage radiation is not assumed 
to have any effect.) This assumption distinguishes their use of this model from 
the approaches of Little et al. (1992) or Thomas (1990), both of whom assumed 
that radiation affected at most two of the mutation rates (and did not constrain 
the effects of radiation to be equal in these stages). There are some technical 
problems with the paper of Pierce and Mendelsohn (1999) arising from the 
authors failure to take account of interactions between the effects of radiation 
on the ( 2−k ) pairs of adjacent stages, and which contribute significantly, by 
adding a quadratic term in the dose-response. These cannot be ignored, even to 
a first order approximation. The fact that in general there is little evidence for 
upward curvature in the solid cancer dose-response in the LSS (Pierce and Vaeth 
1991, Little and Muirhead 1996, 1998, 2000) argues that if proper account were 
taken of these interaction terms the model of Pierce and Mendelsohn (1999) 
would not fit the data well. Moreover, one implication of the model of Pierce and 
Mendelsohn (1999) is that the ERR will be proportional to a/1  i.e. the inverse 
of attained age. However, this is known to provide a poor description of the ERR 
of solid cancer, even within the LSS cohort (Little et al. 1997a, Little et al. 1999). 
For these reasons, there are some grounds for regarding the model of Pierce and 
Mendelsohn (1999) as providing a poor description of the pattern of excess risk 
of solid tumours within the LSS cohort. Other problems with the model of Pierce 
and Mendelsohn (1999) are discussed by Heidenreich et al. (2002).
The optimal leukaemia model found by Little et al. (1992, 1994), having 
adjacent radiation-affected stages, predicts a linear-quadratic dose-response, in 
accordance with the significant upward curvature which has been observed in the 
Japanese dataset (Pierce and Vaeth 1991, Preston et al. 1994, Pierce et al. 1996). 
This leukaemia model, and also that for solid cancer, predicts the pronounced 
reduction of ERR with increasing age at exposure (see Figure 3) which has been 
seen in the Japanese atomic bomb survivors and other datasets (UNSCEAR 
2000). The optimal Armitage-Doll leukaemia model predicts a reduction of ERR 
with increasing time after exposure for leukaemia. At least for those exposed in 
childhood, the optimal Armitage-Doll solid cancer model also predicts a reduction 
in ERR with time for solid cancers. These observations are consistent with 
the observed pattern of risk in the Japanese and other datasets (Little 1993, 
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UNSCEAR 2000). Nevertheless, there are indications that the Armitage-Doll 
model may not provide an adequate fit to the Japanese data (Little et al. 1995). 
For this reason, and because of the other problems with the Armitage-Doll model 
discussed above, one needs to consider a slightly different class of models.
1.3 Two-mutation model
In order to reduce the biologically implausible number of stages required 
by their first model, Armitage and Doll (1957) developed a further model of 
carcinogenesis, which postulated a two-stage probabilistic process whereby a 
cell following an initial transformation into a pre-neoplastic state (initiation) 
was subject to a period of accelerated (exponential) growth. At some point in this 
exponential growth a cell from this expanding population might undergo a second 
transformation (promotion) leading quickly and directly to the development of 
a neoplasm. Like their previous model, it satisfactorily explained the incidence 
of cancer in adults, but was less successful in describing the pattern of certain 
childhood cancers.
The two-mutation model developed by Knudson (1971) to explain the 
incidence of retinoblastoma in children took account of the process of growth 
and differentiation in normal tissues. Subsequently, the stochastic two-mutation 
model of Moolgavkar and Venzon (1979) generalized Knudson’s model, by taking 
account of cell mortality at all stages as well as allowing for differential growth 
of intermediate cells. The two-stage model developed by Tucker (1967) is very 
similar to the model of Moolgavkar and Venzon but does not take account 
of the differential growth of intermediate cells. The two-mutation model of 
Moolgavkar, Venzon and Knudson (MVK) supposes that at age t   there are 
X t( )   susceptible stem cells, each subject to mutation to an intermediate type of 
cell at a rate M t( )( )0  . The intermediate cells divide at a rate G t( )( )1  ; at a rate 
D t( )( )1  they die or differentiate; at a rate M t( )( )1   they are transformed into 
malignant cells. The model is illustrated schematically in Figure 4. In contrast 
with the case of the (first) Armitage-Doll model, there is a considerable body of 
experimental biological data supporting this initiation-promotion type of model 
(see e.g. Moolgavkar and Knudson 1981, Tan 1991). The model has recently been 
developed to allow for time-varying parameters at the first stage of mutation 
(Moolgavkar et al. 1988). A further slight generalization of this model (to account 
for time varying parameters at the second stage of mutation) was presented by 
Little and Charles (1991), who also demonstrated that the ERR predicted by the 
model, when the first mutation rate was subject to instantaneous perturbation, 
decayed at least exponentially for a sufficiently long time after the perturbation. 
Moolgavkar et al. (1990), Luebeck et al. (1996), Heidenreich et al. (1999) and 
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Figure 3. Observed excess relative risk Sv-1 (+ 90% CI) for solid cancers and leukaemia 
and fitted excess relative risk (evaluated at 1 Sv) using optimal 2-mutation and 3-mutation 
generalized MVK models (Little, 1996).
Heidenreich et al. (2000) have used the two-mutation model to describe the 
incidence of lung cancer in rats exposed to radon, and in particular to model 
the inverse dose-rate effect that has been observed in this data. Moolgavkar et 
al. (1993), Luebeck et al. (1999), Leenhouts (1999), Hazelton et al. (2001) and 
Heidenreich et al. (2004) have applied the model to describe the interaction of 
radon, smoking and other agents causing lung cancer in various miner cohorts. 
The two-mutation model has also been utilised to model lung, stomach, and colon 
cancer in the Japanese atomic bomb survivor incidence data (Kai et al. 1997), 
and to model liver cancer in a cohort of Swedish Thorotrast-exposed patients 
(Heidenreich et al. 2003).
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Figure 4. Schematic diagram of the two-mutation (MVK) model.
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A curious finding in many analyses of lung cancer in relation to radon-
daughter exposure using the two-mutation model is that there is significant 
radon action on intermediate cell proliferation. This has been observed both 
in radon-exposed rats (Heidenreich et al. 1999, 2000), in the Colorado Plateau 
uranium miners (Luebeck et al. 1999, Little et al. 2002) and in the Chinese tin 
miners (Hazelton et al. 2001). This is very much an artifact of the two-mutation 
model. Analyses of rat data using a three-mutation generalized MVK model 
(see below) did not find any indications of an effect of radon daughter exposure 
on intermediate cell proliferation (Heidenreich et al. 2000). Likewise, analysis 
of the Colorado Plateau miners (the same dataset analysed by Luebeck et al. 
(1999)) using a three-mutation MVK generalized MVK model did not find any 
effect of radon daughter exposure on intermediate cell proliferation rates (Little 
et al. 2002).
Moolgavkar and Luebeck (1992) have used models with two or three 
mutations to describe the incidence of colon cancer in a general population 
and in patients with familial adenomatous polyposis. They found that both 
models gave good fits to both datasets, but that the model with two mutations 
implied biologically implausibly low mutation rates. The three-mutation model, 
which predicted mutation rates more in line with biological data, was therefore 
somewhat preferable. The problem of implausibly low mutation rates implied 
by the two-mutation model is not specific to the case of colon cancer, and is 
discussed at greater length by Den Otter et al. (1990) and Derkinderen et al. 
(1990), who argue that for most cancer sites a model with more than two stages 
is required.
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Figure 5. Schematic diagram of the generalized MVK model.
1.4 Generalized MVK and multi-stage models
A number of generalizations of the Armitage-Doll and two- and three-mutation 
models have been developed (Tan 1991, Little 1995, Little and Wright 2003). In 
particular two closely related models have been developed, whose properties have 
been described in the paper of Little (1995). The first model is a generalization 
of the two-mutation model of Moolgavkar, Venzon, and Knudson and so will 
be termed the generalized MVK model. The second model generalizes the 
multi-stage model of Armitage and Doll and will be referred to as the generalized 
multi-stage model. For the generalized MVK model it may be supposed that at 
age t   there are X t( )  susceptible stem cells, each subject to mutation to a type 
of cell carrying an irreversible mutation at a rate of M t( )( )0  . The cells with 
one mutation divide at a rate G t( )( )1  ; at a rate D t( )( )1   they die or differentiate. 
Each cell with one mutation can also divide into an equivalent daughter cell 
and another cell with a second irreversible mutation at a rate M t( )( )1  . For the 
cells with two mutations there are also assumed to be competing processes of 
cell growth, differentiation, and mutation taking place at rates G t( )2)(  , D t( )2)(  ,
and M t( )2)(  respectively, and so on until at the ( )k ?1  th stage the cells 
which have accumulated ( )k ?1   mutations proceed at a rate M k t( )( )?1  to 
acquire another mutation and become malignant. The model is illustrated 
schematically in Figure 5. The two-mutation model of Moolgavkar, Venzon, 
and Knudson corresponds to the case k ? 2  . The generalized multi-stage model 
differs from the generalized MVK model only in that the process whereby a 
cell is assumed to split into an identical daughter cell and a cell carrying an 
additional mutation is replaced by the process in which only the cell with an 
additional mutation results, i.e. an identical daughter cell is not produced. The 
classical Armitage-Doll multi-stage model corresponds to the case in which 
the intermediate cell proliferation rates G i t( )( )  and the cell differentiation 
rates D i t( )( )   are all zero.
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It can be shown (Little 1995) that the ERR for either model following a 
perturbation of the parameters will tend to zero as the attained age tends to 
infinity. One can also demonstrate that perturbation of the parameters M k( ? 2)  ,
M k( )?1  , G k( )?1  , and D k( )?1   will result in an almost instantaneous change 
in the cancer rate (Little 1995).
Generalized MVK models have been fitted to the Japanese atomic bomb 
survivor LSS 11 mortality data (Little 1996, 1997). Both for leukaemia and solid 
cancers the only models with a single radiation-affected parameter which give 
at all satisfactory fit are those in which radiation is assumed to affect M ( )0   
(Little 1996). Both for leukaemia and for solid cancer generalized two- and 
three-mutation MVK models fit equally well. For leukaemia, the three-mutation 
model provides at all satisfactory a fit only when M ( )0   and M ( )1   are assumed 
affected by radiation. For solid cancer and leukaemia there are indications of 
lack of fit to the youngest age at exposure group for the three-mutation model; 
there is also some lack of fit of the optimal solid cancer three-mutation model 
to this age at exposure group (Figure 3). Little et al. (1996) also showed that 
the age-incidence relationship for lymphocytic leukemia incidence in the UK 
population could be adequately described by models with either two or three 
stages. Little et al. (2002) modelled lung cancer mortality in the Colorado Plateau 
uranium miner cohort using generalizations of the MVK model, and demonstrated 
that models with three mutations provided a superior fit to models with 
two mutations.
For solid cancer only M ( )0   is (linearly) affected by radiation for two- or 
three-mutation generalized MVK models. In contrast to the solid cancer models, 
both leukaemia models assume a linear-quadratic dose-dependence of the M i( )  .
The non-linearity found in the leukaemia M i( )   dose-response reflects known 
curvature in the leukaemia dose-response in the Japanese (National Research 
Council 1990, Pierce and Vaeth 1991). There is some evidence e.g. for chromosome 
aberrations that the mutation induction curve is linear-quadratic at least for low 
LET radiation, although linearity is generally observed for high LET radiation 
(Lloyd and Edwards 1983).
Despite the indications of lack of fit discussed above, the variation of ERR 
with time since exposure and age at exposure predicted by the optimal two- and 
three-mutation models for solid cancer (Figure 3) is in qualitative agreement 
with the variation seen in the Japanese bomb survivors and in other irradiated 
groups (UNSCEAR 2000). In particular the optimal models demonstrate the 
progressive reduction in ERR with increasing age at exposure seen in many 
datasets (UNSCEAR 2000), together with the marked reduction in ERR with 
increasing time since exposure observed in various groups exposed in childhood 
(Little et al. 1991, Pierce et al. 1996, UNSCEAR 2000).
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Figure 3 reinforces the theoretical predictions of a previous paper (Little 
1995), and shows that immediately after perturbing M ( )0   in the two-mutation 
model the ERR for solid cancers and leukaemia quickly increases. However, 
there are no data in the first 5 years of follow-up in the Japanese cohort (Pierce 
et al. 1996), so that it is difficult to test the predictions made in a previous paper 
(Little 1995) concerning the variation in risk shortly after exposure using that 
dataset.
There is a suggestive increase in the ERR of cancers other than leukaemia 
and colon cancer in the UK ankylosing spondylitis patients < 5 years after 
first treatment (the first two datapoints in the top-left panel of Figure 6), but 
the authors caution against interpreting this as the effect of the X-irradiation 
(Darby et al. 1987). There are no strong indications of an elevation in risk in 
the first five years after radiotherapy for cancers other than leukaemia and of 
the reproductive organs in a study of women followed up for second cancer after 
radiotherapy for cervical cancer (Boice et al. 1985). This corresponds to the first 
two datapoints in the bottom panel of Figure 6. (Lung cancers are also excluded 
from the International Radiation Study of Cervical Cancer (IRSCC) data shown in 
the lower left panel of Figure 6 because of indications of above-average smoking 
rates in this cohort (Boice et al. 1985).) In general there are no strong indications 
of an elevation in solid cancer risk soon after irradiation in other exposed groups 
(UNSCEAR 2000). To this extent there are indications of inconsistency for solid 
cancers between the predictions of the two-mutation model and the observed 
variation in risks shortly after exposure.
Moolgavkar et al. (1993) partially overcome the problem posed by this 
instantaneous rise in the hazard after perturbation of the two-mutation model 
parameters in their analysis of the Colorado uranium miners data by assuming 
a fixed period (3.5 years) between the appearance of the first malignant cell 
and the clinical detection of malignancy. However, the use of such a fixed latent 
period only translates a few years into the future the sudden step-change in 
the hazard. To achieve the observed gradual increase in ERR shortly after 
exposure, a stochastic process must be used to model the transition from the 
first malignant cell to detectable cancer, such as is provided by the final stage(s) 
in the three- or four-mutation generalized MVK models used in the analysis of 
Little (1996). In particular, an exponentially growing population of malignant 
cells could be modelled by a penultimate stage with G k( )? ?1 0  and D k( )? ?1 0 ,
the probability of detection of the clone being determined by M k( )?1  . In their 
analysis of lung, stomach and colon cancer in the Japanese atomic bomb survivor 
incidence data Kai et al. (1997) did not assume any such period of latency, perhaps 
because of the long period after the bombings (12.4 years) before solid cancer 
incidence follow-up began in the LSS.
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Figure 6. Excess relative risk (+ 90% CI) for solid cancers (cancers other than leukaemia, 
colon in spondylitics; cancers other than leukaemia, lung, breast, ovary in the IRSCC) 
and leukaemia (= acute non-lymphocytic leukaemia in the IRSCC) in the UK ankylosing 
spondylitics (Darby et al. 1987) and in the IRSCC cervical cancer cohort (Boice et al.   1985).
The evidence with respect to the variation in ERR shortly after exposure for 
leukaemias is rather different from that for solid cancers. In the UK ankylosing 
spondylitis patients (Darby et al. 1987) there is significant excess risk even in 
the period < 2.5 years after first treatment (first datapoint in top-right panel of 
Figure 6). The IRSCC data (Boice et al. 1985) shows a significant excess risk for 
acute non-lymphocytic leukaemia in the period 1 – 4 years after first treatment (the 
second datapoint in the lower-right panel of Figure 6), and this pattern is observed 
in many other groups (UNSCEAR 2000). More detailed analysis of UK leukaemia 
incidence data indicate that the age-incidence curves for all subtypes of lymphocytic 
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leukaemia can be adequately modelled by two- and three-mutation generalized 
MVK models (Little et al. 1996, 1997b), although the two-mutation models for 
acute lymphocytic leukaemia (ALL) imply a very small number of stem cells (< 104 
cells) if the model is not to yield implausibly low mutation rates (Little et al. 1997b).
1.5 Multiple pathway models
Little et al. (1995) fitted a generalization of the Armitage-Doll model to the 
Japanese atomic bomb survivor and IRSCC leukaemia data which allowed for 
two cell populations at birth, one consisting of normal stem cells carrying no 
mutations, the second a population of cells each of which has been subject to a 
single mutation. The leukaemia risk predicted by such a model is equivalent to 
that resulting from a model with two pathways between the normal stem cell 
compartment and the final compartment of malignant cells, the second pathway 
having one fewer stage than the first. This model fitted the Japanese and IRSCC 
leukaemia datasets significantly better, albeit with biologically implausible 
parameters, than a model which assumed just a single pathway (Little et al. 
1995). A number of other such models are described by Tan (1991), who also 
discusses at some length the biological and epidemiological evidence for such 
models of carcinogenesis.
We now discuss what may appear to be a special case of these multiple 
pathway models, but which are of sufficient flexibility to embrace most categories 
of multiple pathway models. 
1.5.1 Multiple pathway models incorporating genomic instability
There is much biological data suggesting that the initiating lesion in the 
multistage process leading to cancer might be one involving a destabilization of 
the genome resulting in elevation of mutation rates. In particular, the findings of 
Kadhim et al. (1992, 1994), that exposure of mammalian haemopoietic stem cells 
to alpha particles could result in a general elevation of mutation rates to very 
much higher than normal levels, implies, if these findings are at all relevant to 
carcinogenesis, that there might be multiple pathways in the progression from 
normal stem cells to malignant cells. A carcinogenesis model based on genomic 
instability (GI) and clonal selection was proposed by Nowell (1976). More recently 
Loeb (1991, 2001) has presented evidence that an early step in carcinogenesis 
is mutation in a gene controlling genome stability. Stoler et al. (1999) showed 
that there are 11,000 mutations per carcinoma cell for a number of different 
cancer types, again implying that genomic destabilization is an early event in 
carcinogenesis. In particular, there is strong evidence of such an early genomic 
destabilization event for colon cancer (Loeb 1991, Stoler et al. 1999, Loeb 2001).
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There have been a few attempts to incorporate GI in mechanistic 
carcinogenesis models (Mao et al. 1998, Ohtaki and Niwa 2001), although in 
general these models have not been fitted to data in a statistically rigorous manner. 
Little and Wright (2003) developed a stochastic carcinogenesis model which 
allowed for genome destabilization, very close in spirit to the model of Mao et al. 
(1998), and generalizing the class of generalized MVK models developed by Little 
(1995, 1996, 1997), which in turn therefore generalize the two-mutation model 
of Moolgavkar, Venzon and Knudson (Knudson 1971, Moolgavkar and Venzon, 
1979). Little and Wright (2003) fitted the model to Surveillance, Epidemiology 
and End Results (SEER) population-based Caucasian colon cancer incidence 
data (SEER 2000). 
The model assumes that cells can acquire two sorts of mutation, those 
associated with progression to a malignant phenotype (‘cancer-stage’ mutations), 
and those associated with successive destabilization of the genome (‘destabilizing’ 
mutations). With acquisition of successively more destabilizing mutations the 
cancer-stage mutation rates are generally higher, corresponding to the genome 
destabilization that is characteristic of GI.
Specifically, the model supposes that at age t   there are X t( )   susceptible 
stem cells, each subject to mutation to a type of cell carrying an irreversible cancer-
stage mutation at a rate of ))(0,0( tM  . The cells in the stem cell compartment can 
also acquire a destabilizing mutation at a rate ))(0,0( tA  . Thereafter the cells in 
compartment ),( jiI  with i  cancer-stage mutation and j  destabilizing mutations 
divide into two such cells at a rate ))(,( tjiG  ; at a rate ))(,( tjiD  they die or 
differentiate. Each such cell can also divide into an equivalent daughter cell 
and another cell with an additional cancer-stage mutation at a rate ))(,( tjiM  .
In addition, each such cell can also divide into an equivalent daughter cell and 
another cell with an additional destabilizing mutation, at a rate ))(,( tjiA  . There 
are assumed to be a total of k  cancer-stage mutations required for a cell to 
become malignant. Likewise, there are assumed to be m  destabilizing mutations. 
Once a cell has acquired all m  such destabilizing mutations it is assumed to 
remain at the m th destabilizing mutation level. This model is illustrated 
schematically in Figure 7. The acquisition of carcinogenic (cancer-stage) mutations 
amounts to moving horizontally (left to right) in Figure 7, whereas acquisition 
of destabilizing mutations amounts to moving vertically (top to bottom) in this 
figure. The asymmetric cell divisions associated with most of the cancer-stage 
and destabilizing mutations (all except )0,0(),( =ji ), in which each cell produces 
a daughter cell identical to the parent and another carrying an additional 
mutation, should be contrasted with the symmetric cell divisions associated with 
the cell proliferation processes (with rates ),( jiG ), in which each cell produces 
two identical daughter cells. The two-mutation MVK model corresponds to the 
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Asymmetric cell division: one mutant daughter cell, one non-mutant daughter cell 
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Figure 7. Schematic diagram of the generalized MVK model with k  cancer-stage 
mutations and m  destabilizing mutations.
case k ? 2  , 0=m , while the generalized MVK model with K  stages developed by 
Little (1995, 1996, 1997) amounts to the case Kk = , 0=m . In fits to the SEER 
colon cancer data models with two cancer-stage mutations and one destabilizing 
mutation, with three cancer-stage mutations and one destabilizing mutation, 
and with five cancer-stage mutations and two destabilizing mutations all gave 
good fit (Little and Wright 2003, Little 2005).
Two other recent papers have appeared proposing formulations of 
stochastic carcinogenesis model that incorporate genomic instability (Luebeck 
and Moolgavkar 2002, Nowak et al. 2002), again both applied to colon cancer. 
These models are illustrated schematically in Figures 8 and 9. The model of Little 
and Wright (2003) includes as special cases the models proposed by Luebeck et 
al. (2002) and Nowak et al. (2002).
Little (2005) has compared the fits of all five of these models (Little 
and Wright two cancer-stage mutations + one destabilizing mutation, Little 
and Wright three cancer-stage mutations + one destabilizing mutation, Little 
and Wright five cancer-stage mutations + two destabilizing mutations three-
mutation, Luebeck and Moolgavkar, Nowak et al.) to the colon cancer data 
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Figure 9. Schematic diagram of the model of Luebeck and Moolgavkar (2002), similar 
to a generalized MVK model with four cancer-stage mutations and no destabilizing 
mutations.
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Figure 8. Schematic diagram of the model of Nowak et al. (2002), similar to a generalized 
MVK model with two cancer-stage mutations and one destabilizing mutation.
used by Little and Wright (2003). If the number of stem cells is fixed at a 
biologically plausible value, the best fitting model is that of Nowak et al. (2002), 
with the two-stage model of Little and Wright not markedly inferior, as shown 
in Figures 10 and 11. The fit of the three-stage model of Little and Wright 
(2003) is somewhat worse than these two, even more so that of Luebeck and 
Moolgavkar (2002) and the five stage model of Little and Wright (2003), as 
shown in Figures 10 and 11. Comparison of the predictions of the two-stage 
models of Little and Wright (2003) and Nowak et al. (2002), given in Figures 
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Figure 10. Cancer hazards predicted by models of Nowak et al. (2002) (with two cancer-
stage mutations and one destabilizing mutation), of Luebeck and Moolgavkar (2002) 
(with four cancer-stage mutations and no destabilizing mutations), and of Little and 
Wright (2003) (with two cancer-stage mutations and one destabilizing mutation, three 
cancer-stage mutations and one destabilizing mutation, five cancer-stage mutations 
and two destabilizing mutations), with stem cell population fixed to 108 cells, refitted to 
SEER (2002) colon cancer data, and observed data (with 95% confidence intervals (CI), 
adjusted for overdispersion (McCullagh and Nelder 1989)) (taken from Little (2005)).
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Figure 11. As for Figure 10, but showing cancer rates and model fits up to age 40 (taken 
from Little, 2005).
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Figure 12. Normalized excess relative hazard following perturbations of ),( jiG , ),( jiM  
and ),( jiA  in generalized MVK model with two cancer-stage mutations and one 
destabilizing mutation of Little and Wright (2003), with stem cell population fixed to 108 
cells, refitted to male SEER colon cancer incidence data (taken from Little (2005)). In the 
absence of perturbation the model is as described in Figures 7 and 10. The parameters 
),( jiG  are increased by 11 −y  at the age of 25,  for 1 year, the parameters ),( jiM  
and ),( jiA  are generally multiplied by 10 at the age of 25 ( )0,0(A  is augmented by 
310 y 1), for 1 year.
12 and 13, with patterns of excess risk in the Japanese atomic bomb survivor 
colon cancer incidence data, shown in Figure 14, indicate that radiation might 
act on cell proliferation rates in the model, and at least for the model of Little 
and Wright also on one of the parameters governing progression to genomic 
destabilization.
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Figure 13. Normalized excess relative hazard following perturbations of ),( jiG , ),( jiM  
and ),( jiA  in generalized MVK model with two cancer-stage mutations and one 
destabilizing mutation of Nowak et al. (2002), with stem cell population fixed to 108 
cells, fitted to male SEER colon cancer incidence data (taken from Little (2005)). In the 
absence of perturbation the model is as described in Figures 8 and 10. The parameters 
),( jiG  are increased by 11 −y  at the age of 25, for 1 year, the parameters ),( jiM  and 
),( jiA  are multiplied by 1000 at the age of 25, for 1 year. 
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Figure 14. Excess relative risk (per Sv) and 95% confidence intervals for male colon 
cancer incidence as a function of years since exposure in the Japanese atomic bomb 
survivor data of Thompson et al. (1994) (taken from Little and Wright (2003))
1.6 Other carcinogenesis models:  
breaking the assumption of conditional independence
A common assumption of most carcinogenesis models is that cells are statistically 
conditionally independent, so that the cell populations may be described by a 
branching process. This is assumed for analytic tractability, but it is difficult to 
test. To the extent that it is known that cells communicate with each other via 
cell surface markers and otherwise, it is unlikely to be precisely true. One tissue 
in which, because of its spatial structure, this assumption may break down is 
the colon. The colon and small intestine are structured into crypts, each crypt 
containing some thousands of cells, and organized so that the stem cells are at 
the bottom of the crypt (Potten and Loeffler 1987, Nowak et al. 2003). There is 
evidence that there may be more than one stem cell at the bottom of each crypt 
(Bach et al. 2000). The progeny of stem cells migrate up the crypt and continue 
to divide, becoming progressively more differentiated. The differentiated cells 
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eventually reach the top of the crypt where they are shed into the intestinal 
lumen. Potten and Loeffler (1987) and Nowak et al. (2003) have postulated similar 
models for cancers of the small intestine and colon taking account of the linear 
structure of the crypts, and in which necessarily the assumption of conditional 
independence breaks down. 
1.7 Mechanistic carcinogenesis modelling: conclusions
The classical multi-stage model of Armitage and Doll and the two-mutation model 
of Moolgavkar, Venzon, and Knudson, and various generalizations of them also, 
are capable of describing, at least qualitatively, many of the observed patterns 
of excess cancer risk following ionizing radiation exposure. However, there are 
certain inconsistencies with the biological and epidemiological data for both 
the multi-stage and two-mutation models. In particular, there are indications 
that the two-mutation model is not totally suitable for describing the pattern of 
excess risk for solid cancers that is often seen after exposure to ionizing radiation, 
although leukaemia may be better fitted by this type of model. Generalized MVK 
models which require three or more mutations, in particular ones with multiple 
pathways associated with genomic destabilization, are easier to reconcile with 
biological and epidemiological data relating to solid cancers.
2 Mechanistic bystander effect models
It has been generally accepted that most biological damage produced by ionizing 
radiation occurs when radiation interacts directly with DNA in the cell nucleus 
or indirectly through the action of free radicals (UNSCEAR 2000). However, 
in the last 10 or so years there have been a number of reports of cells exposed 
experimentally to α-particle radiation in which more cells showed damage than 
were traversed by α particles (Nagasawa and Little 1992, 1999, Azzam et al. 
1998, 2000, Belyakov et al. 2001, Huo et al. 2001, Sawant et al. 2001, Zhou et al. 
2001, Little et al. 2003) i.e. a bystander effect. This is observed for a number of 
end points, including cell killing, micronucleus induction, and mutation induction, 
as recently reviewed by Iyer and Lehnert (2000) and Morgan (2003a, 2003b). It 
is also clear, from the use of microbeam approaches, that direct DNA damage 
from energy deposition is not required to trigger the effect (Shao et al. 2004). 
The bystander effect implies that the dose response after broad-beam irradiation 
could be highly concave at low doses (i.e. with slope of the dose response generally 
decreasing with increasing dose), as shown in Figures 15 – 17. This sort of dose 
response occurs because of saturation of the bystander effect at high doses, and 
implies that predictions of low-dose effects obtained by linear extrapolation from 
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 Figure 16. Transformed C3H 10T½ colonies (and 95% CI) as a function of the exact 
number of α-particles received by each cell, and whether 10% or 100% of cells were 
irradiated, in the study of Sawant et al. (2001).
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 Figure 15. Percentage micronuclei (and 95% CI) as a function of the exact number of 
helium-3 ions received by each irradiated cell, and whether 1 or 4 cells were irradiated 
per dish, in the study of Belyakov et al. (2001).
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Figure 17. Chromosome aberrations per cell (and 95% CI) as a function of the α-particle 
dose received by each irradiated cell, and by knockout status, in the study of Little et 
al (2003).
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Figure 18. Percentage cell killing (and 95% CI) as a function of the dose received by 
each cell from which the conditioned medium was taken, and whether the dose was 
delivered in a single fraction or two equal fractions separated by 3 hours, in the study 
of Mothersill and Seymour (2002).
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data for high-dose exposures would be substantial underestimates. However, 
other forms of dose response are also possible, including ones exhibiting low-dose 
convexity, particularly if protective bystander processes occur. An interesting 
feature is that the bystander effect is augmented following fractionated delivery of 
dose, in a manner dependent on the total dose delivered (Mothersill and Seymour 
2002), and as illustrated in Figure 18.
Although the majority of work on the bystander effect has been with in 
vitro systems, bystander effects have also been observed in vivo, as reviewed 
by Mothersill and Seymour (2001) and Morgan (2003b). Two recent papers are 
particularly noteworthy in this respect. Camphausen et al. (2003) found that 
mice with wild-type p53 exhibit a reduction in growth of tumours associated 
with cells implanted distant from an irradiated leg, and that this occurs in 
a dose-dependent manner. However, p53 null mice or animals treated with a 
p53 blocker did not exhibit this effect, implicating p53 as a key mediator of the 
abscopal effect of radiation in these animals. Xue et al. (2002) injected nude mice 
with 125IUdR-labelled adenocarcinoma cells that accumulated lethal doses of 
radiation from the 125IUdR-label; they found that the mice exhibit a pronounced 
reduction in tumour growth associated with injected unlabelled adenocarcinoma 
cells, indicative of a bystander effect.
The form of dose response caused by the bystander effect is highlighted by a 
recent article by Brenner et al. (2001), who proposed a model for this phenomenon 
based on data for in vitro exposure of C3H 10T½ cells to α particles. The model 
proposed by Brenner et al. (2001), as extended by Little and Wakeford (2001), 
assumes that a certain fraction, ?  , of cells respond to a bystander signal and 
become oncogenically transformed. The model assumes also that a cell has a 
probability q  of surviving a single α-particle traversal of its nucleus, and the 
number of oncogenic transformations per surviving cell following N  α-particle 
traversals for the micro-beam data is ?? ??? NTF  . Following broad-beam 
irradiation with an average number, >< N , of α-particle traversals per cell 
nucleus, by elementary extensions of derivations of Brenner et al. (2001), Little 
and Wakeford (2001) showed that:
01]exp[ ???????????????? NNqNqTF ???  
Here 01 ???N  takes the value 0 for 0??? N  and is 1 otherwise. Brenner et al. 
(2001) discussed evidence from experimental systems that would be consistent 
with the linear extrapolation of high-dose effects to low doses underestimating 
oncogenic transformation rates by a factor of between 60 and 3000. However, 
Little and Wakeford (2001) analysed lung cancer risk in various human datasets 
and found little evidence of elevation of risk at low doses compared with linear 
extrapolations from the high-dose data. Fitting an extension of the model developed 
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by Brenner et al. (2001) discussed above, Little and Wakeford concluded that 
the bystander effect observed in the experimental C3H 10T½ system probably 
does not play a large part in the process of radon-induced lung carcinogenesis in 
humans. Recently, Brenner and Sachs (2002, 2003) proposed a slight extension 
of their earlier model for the bystander effect, which they fitted to a dataset of 
lung cancers in 11 cohorts of underground miners (Lubin et al. 1995). Like their 
earlier model the model assumes two cell populations, normal and hypersensitive; 
the hypersensitive cells are assumed to be respond to a bystander signal and to 
be sensitive also to killing by direct hits from α-particles. The model suggested 
that bystander effects might account for a fourfold elevation in risks at low 
doses (Brenner and Sachs 2002, 2003). However, the inverse dose-rate effect 
underlying the model of Brenner and Sachs (2002, 2003) is capable of alternative 
descriptions (Little 2004).
A defect of all the above recently proposed models (Brenner et al. 2001, 
Little and Wakeford 2001, Brenner and Sachs 2002, 2003) of the bystander 
effect, and various other models also (Dahle et al. 1997, Nikjoo and Khvostunov 
2003), is that they take no account of the spatial location of cells, which may 
well be important if the bystander signal is localized. Although all these models 
take account of cell killing, they take no account of cell repopulation. Little et 
al. (2005) have recently constructed a novel model of the bystander effect that 
takes account of spatial location, and also of cell killing and repopulation. The 
model assumes that each cell can either be: (i) alive (or undifferentiated) but 
unaffected; (ii) affected and signalling; (iii) affected and non-signalling; or (iv) 
dead (or differentiated). The affected (whether signalling or non-signalling) 
cells are assumed to have sustained the initiating transformation that may 
dispose them to further aberrant behaviour, possibly expressed as chromosome 
aberration, mutation or cancer; the affected signalling cells are the only one 
of the four cell populations capable of releasing the bystander signal. In these 
signalling cells the transformation is not complete and fixed, so that they are 
capable of re-conversion to unaffected cells, as well as to fully-affected cells (that 
do not produce a bystander signal).
As shown in Figure 19, for the illustrative parameters used by Little et al. 
(2005) the probability of being affected versus dose is an approximately linear 
function of the dose rate at low dose rates, although the dose response flattens 
out quite quickly for dose rates much above 1 Gy per hour. A particular feature 
of the model is the predicted augmentation of effect following fractionated 
delivery of dose, in a manner dependent on the total dose delivered, as shown 
in Figure 20.
There is evidence that the phenomena of the bystander effect and genomic 
destabilization may be linked. In particular, the work of Lorimore et al. (1998) 
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Figure 19. Average (cumulative) probability (average over all 25 cells) of a cell in 5 × 5 
rectangular lattice being affected and non-signalling, as a function of the radiation dose 
rate and time of follow-up, derived by 104 Monte Carlo simulations using the model of 
Little et al. (2005). 
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Figure 20. Average (cumulative) probability (average over all 25 cells) of a cell in 5 × 5 
rectangular lattice being affected and non-signalling, as a function of the radiation 
dose rate and time of follow-up, if the dose is administered over a single time period 
(0 – 2 hours) or split over 2 periods (0 – 2 hours, 5 – 7 hours), derived by 104 Monte Carlo 
simulations using the model of Little et al. (2005). 
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suggests that chromosomal instability may develop in unirradiated haemopoietic 
stem cells in proximity to similar cells that are irradiated with α particles. If 
this is confirmed in other systems, and in particular in vivo, it has important 
implications for future models of the bystander effect and carcinogenesis.
2.1 Mechanistic bystander effect modelling: conclusions
In contrast to the large amount of work on developing carcinogenesis models 
over the last 50 years, there has been comparatively little work on developing 
models of the bystander effect, reflecting the comparatively recently available 
experimental data elucidating this phenomenon. In particular, models accounting 
for the spatial location of cells, as well as cell killing and cell repopulation, all 
likely to be important in determining the magnitude of any bystander effect 
whether in vitro or in vivo, have only recently been developed.
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Abstract
Alpha-particle-emitting, bone-seeking radionuclides can induce leukaemia and/
or osteosarcoma in mice. Furthermore, plutonium-239, given to male mice 
before mating with normal females, while not directly leading to leukaemia 
in the progeny does lead to enhanced susceptibility to leukaemogenic agents. 
In the first case, the amounts of radionuclide are very small in experimental 
terms; and zero in the case of transgenerational activity. In both cases, the 
development of the disorders is remote in time and location relative to that of 
the contaminating radionuclide, making interpretation of the mechanisms and 
estimation of radiation risk problematic. It is necessary, then, to address questions 
involving the basis of haemopoiesis itself. Cellular kinetics of the development of 
blood from the pluripotent stem cells to the mature functional cells are outlined, 
describing compensatory proliferation mechanisms and extensive movement 
of cells throughout the marrow space. The locations of potential oncogenic 
target cells are identified and the nature of the stromal microenvironment that 
regulates haemopoiesis is defined. Plutonium-239, given to male mice, targets 
spermatogenesis at the stem cell level leaving unidentified damage that is 
inherited by his offspring. This leaves the offspring susceptible to a leukaemogenic 
agent encountered later in life. The characteristics of this, corroborated by 
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consideration of the cellular kinetics, are of an inherited genomic instability. Cells 
of the microenvronment, inheriting the same genetic damage, probably act in the 
role of an enhancing ‘bystander’. In adult mice, the mechanisms are different. 
Bone turnover results in radioactivity being gradually transported through the 
marrow by long-lived macrophages. A model based on temporal microdistributions 
of activity, defining specific target cell regions, is able to illustrate that considering 
bone marrow as a uniform mass of cells is inadequate to describe the observed 
patterns of development of leukaemia and osteosarcoma. 
1 Introduction
It is recognized that bone-seeking, α-particle-emitting radionuclides can result 
in the later development of osteosarcoma and myeloid leukaemia in mice [1 – 3]. 
These disorders arise late (months) and over an extended time scale. It has 
generally been assumed that the cause is the direct effect of α-particles on the 
appropriate target cells. Over a considerable period of time we have studied the 
effects of the radionuclides on the haemopoietic tissues with the aim of defining 
the cell populations involved. We have considered administration, mainly of 
plutonium 239, at several stages of murine development, namely, adult [5, 6] 
fetal and neonatal development [6, 7] and ultimately during preconception via 
contamination of the potential father [8].
This paper will consider the modes of action that may lead to the development 
of leukaemia and / or osteosarcoma. It will be seen that induction, in the case 
of adult contamination, is the direct result of indirect delivery of radiation to 
the appropriate target cells while, in the case of transgenerational induction, 
the probable mechanism is via transmitted genomic instability, enhanced by 
bystander support. In both cases it is necessary, first, to consider the basis of 
haemopoiesis because a few generalized concepts are pertinent to both situations.
2 Haemopoiesis
2.1 The cells of haemopoietic tissue
The structure of haemopoietic tissue has been described fully on many occasions 
[see 9, 10]. Briefly, blood cells develop through a three-tiered production system 
comprising a self-maintaining, pluripotential stem cell compartment, progenitor 
cells which are committed to specific lines of blood production and finally the 
maturation compartments which lead to fully functional blood cells. Most 
important is that there is fine structure in the stem cell compartment – the 
location of potential leukaemogenic target cells – in which the most primitive 
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stem cells have full or high self-renewal capacity, a property that diminishes 
as cells progress though mitotic divisions. Simultaneously, as self-renewal 
capacity falls, the probability of differentiation, induced by one or more of a 
large family of haemopoietic growth factors, into one of the recognized cell 
lineages, increases. 
The phases of development are closely integrated and interdependent, the 
results of which mean compensatory mechanisms would come into play if part 
of the process were to be damaged. For example, chronic irradiation results in 
a long-term depleted stem cell population [11] that is countered by extra cell 
division in the maturing cell compartments [12, 13], thus maintaining a normal 
output of cells.
2.2 The haemopoietic inductive microenvironment
Haemopoiesis is driven by the stromal microenvironment in which it exists. Cells 
of the microenvironment provide the appropriate growth factors that regulate 
the proliferative growth and development of the stem cell population, and, the 
differentiation of those stem cells into committed progenitor cells. Maturation 
rates are more probably regulated by feedback from the populations of mature, 
functional cells. 
2.3 Microarchitecture of the bone marrow
Bone marrow has commonly and traditionally been thought of as a loose mass 
of cells without any particular structure [14]. It seems, however, unreasonable 
to believe that such a complex, diverse tissue could function as efficiently as it 
does without showing as much formal structure as any other tissue in the body. 
Careful division of femoral marrow in mice allowed assays of all the different 
cell populations in different locations of the femur to be carried out. In this 
way it proved possible to define the distributions of those cells throughout 
the femur [15 – 19].
Multipotent stem cells were found in highest concentration close to bone 
surfaces – important, one might imagine, when dealing with bone-seeking 
radionuclides. The primitive stem cells, however, were found more specifically 
in regions distant from the bone.  These stem cells are very dormant [20] while 
those close to the bone proliferate rapidly. Differentiation appears to occur close 
to the bone and the subsequent developing cell populations then progress to 
the central venous sinus from which the functional cells enter the circulation. 
Furthermore, it appeared that these defined spatial distributions hold fast also 
for human marrow [18, 21].
101
STUK-A234
3 Practical implications
Thus, bone marrow cells are in a constant, but variable, state of flux, remaining 
static in neither development nor location. Potential target cells for oncogenic 
transformation may, in the case of contamination with α-emitters be remote from 
the primary source of radiation. These factors make it unlikely that bone marrow 
can be considered simply as a cylinder of tissue in which radiation doses can be 
directly computed. Neither can the ultimate result of radiation ever be derived 
from studying the effects on specific cell types in isolation. It is worthwhile, 
therefore, to consider a few experimental examples of radiation in bone marrow 
where interpretation might be compromised.
3.1 Growth of the stem cell population
During the course of studies on the effects of plutonium-239 administered to 
the developing embryo / fetus via its mother, the growth of the multipotent stem 
cell population (measured as spleen colony forming units or CFU-S, [22]) was 
monitored post-natally. 239Pu had been injected to the pregnant mother at either 
4 days or at 13 days of gestation. Following 4-day contamination, the infant was 
born with about half the normal number of CFU-S but these grew at a normal 
rate and stabilized, still at half population size by about 22 weeks [24]. By 
contrast, following 13-day contamination, the infant was born with a normal 
complement of CFU-S but these grew at a slow rate, ultimately achieving the 
same level as in the former group, and at about the same time. Measurements 
of the microenvironment 8 weeks after birth indicated damage in the case of 
13-day plutonium, but not following 4-day contamination. From injection at 13 
days, the CFU-S population was undamaged, but its microenvironment was 
and prevented its proper development. At 4 days, the microenvironment had 
not started to develop so the growth of the surviving, more sensitive early stem 
cells was not affected. There was the same long-term effect; but brought about 
by different mechanisms, thus illustrating the potential dangers of looking at 
effects on cell populations in isolation.
3.2 Dose weighting factors (effective RBE)
In an attempt to put radiation of differing qualities on a common footing, 
dose-weighting factors are employed. For α-particles relative to γ-rays 
this is usually taken as 20 as recommended by ICRP [24]. Is this realistic 
for haemopoietic stem cells? Direct α-radiation to, and assay of, CFU-S 
gave a value of 1 – 2 rather than 20 [25]. Jiang et al [26] took a different 
approach.
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It had been estimated that 30Bq 239Pu given to the pregnant female at 
13 days gestation delivered a dose of 10 – 14 mGy to the fetal liver, the major 
source of haemopoiesis, in the 6 days to birth [6]. As reported above, this was 
sufficient to result in a reduced CFU-S population in the adult offspring. Mason 
and his colleagues [7] also observed that the spatial distribution of CFU-S in the 
adult femur under these circumstances was disturbed as a long-term feature. 
However, they were unable to simulate the effect of plutonium by giving a total 
dose of 50 mGy per day γ-rays over the same period. Even 3 times this dose had 
relatively little effect. Jiang et al [26] did reproduce the alpha effect, however, 
by increasing the daily γ-ray dose to 600 mGy, a factor of ~ 250 over the α-dose. 
1, 20 or 250? The effective relative biological efficiencies of differing qualities of 
radiation clearly depend on the end-point chosen. 
Examples like these indicate a few generalizations that should always be 
borne in mind, both when interpreting experimentally observed phenomena, and 
in making theoretical interpretations as in model building. So,
(i) The distribution of potential target cells is not uniform as is often 
assumed.
(ii) One should not look at segments or cell compartments of the bone marrow 
in isolation.
(iii) Effects on, and of, the haemopoietic stromal microenvironment must always 
be taken into account.
(iv) The definition of end-points is important when making relative dose assess-
ments.
4 Transgenerational induction of leukaemia
4.1 The experiments
As part of our programme of studying the effects of α-emitters at various stages 
of development, and as a natural follow up to the Gardner Report [27], suggesting 
that childhood leukaemia clusters in Seascale (UK) could be related to a paternal 
history of contamination prior to conception, we looked for effects in the offspring 
of male mice that had been contaminated with plutonium-239 before mating 
with normal females.
The results of these experiments have been reported in full [28 – 30]. Briefly, 
two questions were addressed. One, were there defects arising in the development 
of haemopoiesis in the offspring? Secondly, did the earlier paternal exposure to 
plutonium leave the offspring more likely to develop leukaemia or, in any way 
sensitize them to the subsequent induction of leukaemia by other means? The 
experiments were conducted, in parallel, in two strains of mouse, neither of which 
103
STUK-A234
is susceptible to any significant level of spontaneous development of leukaemia. 
The potential fathers were injected with a single dose of plutonium-239, 12 
weeks before mating with normal females. The amount of plutonium used 
was up to the maximum that could be injected without measurable effect on 
spermatogenesis [31]. This was confirmed on observing normal litter sizes and 
male/female distributions at birth [28]. Given at 12 weeks before mating meant 
any potential, transmitted damage should originate from the spermatogenic stem 
cells, the normal spermatogenic cycle being ~ 56 days. 128 and 256 Bq.g-1 239Pu 
were calculated to give ~ 65 and 130 mGy radiation doses to the testes over the 
12 week period to mating (0.77 and 1.55 mGy.d-1) and no plutonium was carried 
over to the female partner or transmitted to their offspring. 
After birth, the male offspring were assessed for development of 
haemopoiesis over 18 weeks by measuring CFU-S (stem cells) and CFC-F 
(fibroblastoid colony-forming cells, a stromal cell measure). BDF1 (C57Bl x 
DBA2) female offspring were treated at 12 weeks of age with 50 mg.kg-1 of 
methyl nitroso urea (MNU): CBA-H (CBA-H × CBA-H) females with 3 Gy γ-rays. 
Both treatments are recognized as leukaemia inducing agents in mice [32, 33]. 
Accordingly, the offspring were monitored daily for up to 8 months. No cases of 
leukaemia developed in offspring not given MNU or radiation.
4.1.1 haemopoiesis
Assayed in groups in the normal way [34], there were no apparent changes in 
either CFU-S or CFC-F numbers. However, when assayed as individual mice 
it became clear that although the average numbers remained the same the 
distribution of numbers was, unusually, widely spread – more mice had high 
numbers, more mice had low numbers [28]. These changes did not directly 
affect the welfare of the mice; they grew as normal, with a normal blood picture, 
probably due the compensatory, adaptive proliferation discussed above, but 
they did indicate that preconception, paternal irradiation (PPI) might not be so 
innocent as originally assumed. As mentioned above, however, this did not lead 
directly to any overt signs of developing leukaemia.
4.1.2 leukaemia induction
50 mg.kg-1  MNU is known to induce initially, thymic lymphomas or, at a later 
stage myeloid leukaemia in a significant proportion of BDF1 mice. In the control 
mice the first disorders arose 3 months after injection of MNU and increased 
over the next 5 months to affect ~ 50% of the mice. Following paternal plutonium 
contamination, the first cases were seen after 2 months, and by 8 months these 
had risen to ~ 90% – a significant reduction in the latent period and increase in 
the rate of induction that was particularly evident in the myeloid leukaemias. 
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In CBA mice, similarly, 3 Gy irradiation is a classic method for inducing myeloid 
leukaemia that develops in about 30% of the treated mice. Again, there was a 
significant increase in the level of leukaemia following paternal irradiation. It 
should be noted that a similar result was obtained following a single preconception, 
paternal γ-ray treatment [35].
4.1.3 Mechanisms of leukaemia induction
MNU and radiation are well recognized leukaemogenic agents, and since 
preconception paternal irradiation alone resulted neither in direct induction of 
leukaemia, nor in transmission of radioactive elements that might subsequently 
induce leukaemia, but yet led to an increased level of the disease, it is clear that 
PPI had effected some change that increased the sensitivity of the offspring to 
the effects of a secondary exposure to a leukaemogen. This was probably manifest 
in the disturbance to the patterns of haemopoietic development. At the same 
time, there is no direct experimental evidence to indicate the nature of the basis 
to this disturbance. It is clear however, that the normal approach of radiation-
kill / radiation-survival measurements and radiation dosimetry will not help. 
Nevertheless, some pointers do exist.
The timing of the plutonium injection, and particularly of the PPI γ-rays – 
12 weeks before mating; longer than the duration of a single spermatogenic cycle 
– implicated damage at the stem cell level of spermatogenesis and, therefore, 
transmissible genetic damage. This was corroborated by the development of a 
significant increase in the overall level of chromosome aberrations in the offspring 
[28, 36]. Classical radiation-induced, point mutation genetics would indicate 
implausibly high mutation rates, specific to development of leukaemia, from 
the radiation doses (up to 130 mGy over 12 weeks PPI) to contemplate direct 
transmission, but Cox [37] suggested that under such circumstances the normal 
rules of genetics may be suspended, “…that non-Mendelian (epigenetic) processes 
operating during gamete formation can influence tumour susceptibility…”. Genomic 
instability as a result of PPI that is transmitted to the offspring therefore becomes 
a potentially major factor.  However, there are two complicating factors. First, 
PPI did not lead directly to leukaemia: any instability induced was not expressed 
spontaneously, either during development or over the longer term. It is expressed 
in the individual only during, or subsequent to, the recovery after a second 
leukaemogenic insult. Secondly, any inherited genetic defect should be expected 
to appear in all cells, but significantly increased chromosomal aberrations were 
seen only in bone marrow and not in splenic lymphocytes. Paradoxically, since the 
aberrations were clearly the result of inherited phenomena, intertissue variation in 
this expression may itself be interpreted as a manifestation of genomic instability. 
To appreciate this, knowledge of the kinetics of haemopoiesis is necessary.
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Since, by virtue of its definition, genomic instability is increasingly 
expressed over an extended phase of cell proliferation. Lymphoid and myeloid 
cells are both derived, separately, from the haemopoietic stem cell compartment. 
Lymphoid cells, however, arise from a more primitive cell than do myeloid 
cells. They have a shorter development phase, but the ‘end’ lymphocytes 
do retain the capacity for several additional divisions; when challenged by 
a mitogenic or antigenic stimulus. Taking account of the number of cells 
generated daily by the bone marrow and the life-spans of the mature cells, 
it can be shown that each primitive stem cell will generate about 220 (106) 
myeloid cells while resulting in only 210 (103) lymphoid cells [36]. Any inherited 
genomic instability expression rate might therefore be expected to result in 
~ 1000 times as many unstable aberrations in myeloid cells as in lymphoid 
cells. This is, therefore, compatible with experimental observations where 
significant aberrations were seen in marrow myeloid cells but not in splenic 
lymphocytes.
Thus, mice born following PPI appear to be born primed for a 
higher potential instability rate than normal. Subsequent treatment 
with a carcinogen, MNU or irradiation, then exposes this potential. These 
secondary cytotoxic agents kill a significant proportion of the stem cells 
inducing further regenerative proliferation, exposing any latent instability 
in the surviving stem cells and enhancing the mutagenic properties of 
the insult.
A further problem remains. Unstable aberrations in the inherited primitive 
stem cells should eventually build up to 100% aberration levels. This did not occur, 
in corroboration of an earlier observation of long-term instability in transplanted 
stem cells [38]. This means that the integrity of the genome is protected at the 
stem cell level, probably by its regulatory microenvironment, to ensure that any 
inherited genomic instability remains latent. This protection is probably the 
reason there was no detectable level of leukaemia in those PPI offspring that 
were not secondarily challenged. It will be recalled that large perturbations in 
the microenvironental CFC-F developed following PPI [28]. These cells may 
be considered as bystanders that, in this case, protect against development of 
instability. Other parts of the microenvironment, however, probably act as more 
conventional ‘bystander’ in enhancing the expression of instabilities. A function of 
the microenvironment is to generate the haemopoietic growth regulatory factors 
that promote myelopoiesis. A depleted stem cell population, associated with a 
possibly dysfunctional microenvironment – in the case of PPI also inherited since it 
itself is derived from the transgenerational stem cell –  requires compensensatory 
hyperproliferation of the maturing cells to maintain anything like a normal 
cell output. 
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5 Leukaemia and osteosarcoma following injection 
of 239Pu, 241Am and 233U in adult mice
The post-injection kinetics of bone-seeking radionuclides such as 239Pu, 241Am or 
233U, radionuclides that are known to induce leukaemia or osteosarcoma in mice 
[1 – 3] present a different set of complications in assessing radiation dosimetry 
and risk. The movement both of cells in the marrow and α-particle emissions 
in the bone and marrow make it essential to consider the locations of potential 
target cells in the marrow and to relate this to the changing microdistributions 
of α-particle activity over a period of time. 
5.1 Experimental analyses
From 1 to 448 days after injection of 40 Bq.g-1 of 239Pu, 241Am or 233U in 12-week-old 
mice α-activity in the femora was recorded [39] and parallel monitoring, primarily 
for onset of osteosarcoma and myeloid leukaemia, was conducted [40]. Using 
neutron-induced- and α-track autoradiography of those femora, we have 
systematically carried out computer-based image analyses of the distributions 
of α-activity and applied dosimetric methods to obtain radiation dose-rates to 
different regions of the marrow cavity. The methods and results have all been 
fully catalogued elsewhere [41 – 44]. Ultimately, a model was developed enabling 
dose-rates and accumulated dosages to be calculated and related to specific cell 
populations at any point in the bone marrow [45].
It is worth noting that measurements were made also on contaminated 
bones from baboons and from photographs of human bone autoradiographs, both 
kindly made available by Professor Nick Priest. It became clear that similar 
radionuclide kinetics held for other species and, with the inclusion of appropriate 
parameters defining these bones, the model was not limited to the murine studies.
5.2 Kinetics of radionuclides in bone and marrow
Briefly, plutonium, a bone-surface seeking radionuclide is initially deposited 
primarily on the endosteal bone surfaces. Over the next 7 days, activity moves 
below the surface but thereafter, due to bone surface turnover, the plutonium 
spills out into the marrow space. On breakdown of the surface bone tissue, 
plutonium is picked up first by the osteoclasts that cause the breakdown, and 
ultimately by macrophages that consequently accumulate large amounts of 
α-activity. These macrophages are long-lived and progress throughout the marrow 
in something of a random manner, resulting in high levels of activity in the centre 
of the marrow spaces by about 224 days. By 448 days, the cycle is complete with 
activity in the marrow dissipated, recycled and redeposited on the bones.
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Americium presents a broadly similar distribution. Initially more evenly 
distributed throughout the endosteal, periosteal and vascular canal surfaces, 
it moves more quickly than plutonium from the bone into the marrow, peaking 
there by 122 days and ending with a more general distribution by 244 days.
Uranium, a bone-volume seeker, is initially deposited on the endosteal 
bone surface but then is gradually absorbed deeper into the bone volume as it 
equilibrates with the bone tissue. Only traces of activity appear in the marrow 
throughout the observation period. 
A model, incorporating parameters of bone morphometry, the dynamic status 
of bone formation and turnover, surface affinities for the various radionuclides, 
recirculation parameters of the radionuclides and dynamic properties of 
osteoclasts and macrophages transporting the activity throughout the marrow, 
was constructed and validated using the data from the autoradiographic analyses 
of the mouse femur [45]. From the model it became possible it became possible to 
calculate radiation dose-rates and accumulated doses at any point in the marrow, 
at any time after incorporation of the radionuclide.
To understand the applications of this model and its implications for 
leukaemogenesis and osteosarcomagenesis it is necessary now to go, once again, 
back to the structure and micro-architecture of the bone marrow.
5.3 Application of the model to leukaemogenesis 
and osteosarcomagenesis
Myeloid leukaemia results from damage to the haemopoietic stem cell. It will be 
recalled that while the multipotent stem cells, the CFC-S, are more concentrated 
in the vicinity of bone surfaces, the more primitive, pluripotent stem cells, most 
likely to be the leukaemogenic target cells, are found more distant from those 
same surfaces. By contrast, osteogenic cells lie close to the bone surface and have 
generally been implicated in the onset of osteosarcoma. The target area for this 
has classically been taken as a ring of marrow up to 10 µm from the bone surface, 
well within the range of α-particle irradiation from radiaonuclides deposited in the 
bone. More recently there have been suggestions from histological observations 
that the target cells are somewhat more distant from the bone surface [46].
Use of the model to calculate doses to specific regions of the bone marrow 
volume has allowed us to compare dose with incidence of leukaemia and 
osteosarcoma in the original experiments [3, 44]. It was found that the ratios of 
leukaemia development due to 239Pu, 241Am and 233U were most closely matched 
by the cumulative doses, over 448 days, to the 5 – 10% of marrow closest to the 
centre of the marrow and corresponding to the highest incidence of primitive 
stem cells [44].
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Similarly, the incidence of osteosarcoma was most closely matched when 
calculating doses to a band of cells 20 – 40 µm from the bone surface [44], 
corroborating the histological suggestion that the appropriate target cells were 
not located within 10 µm of the surface [46].
Based on the results obtained from this model, the onset of leukaemia 
and osteosarcoma, although distant in time (and with much intervening cell 
proliferation history) and location with respect to the bone seeking nature of 
these radionuclides, is probably a direct effect of the α-radiation. In this case 
there appears to be little or no evidence of a genetic instability factor.
6 Conclusion
Leukaemia and osteosarcoma are distant developments of contamination with 
α-particle emitting, bone seeking radionuclides, distant both in time and location 
with respect to the origins of the activities. However, the manifestation of these 
abscopal effects is dependent on the conditions under which contamination occurs. 
Use of an appropriate model, describing the movement of radionuclides and 
calculating the resultant cumulative dose-patterns in the marrow suggest that 
in the case of injection to adult animals, the cause is probably a direct result of 
radiation, delivered by an indirect or intermediary means that is related to the 
biology of the tissue, to the appropriate target cells. By contrast, transgenerational 
leukaemogenesis, where no α-activity is transferred to the offspring, is indirect. 
Genetic radiation damage to spermatogenesis (possibly epigenetic damage) is 
transmitted at a survival level but is probably amplified as genetic instability, 
and further so by the haemopoietic microenvironment acting as a bystander 
effector. This damage is not, of itself, leukaemogenic but is complementary to 
subsequent exposure to a secondary leukaemogenic agent. Since inherited, 
potential genetic instabilities are necessarily present throughout the body, it 
is likely that exposure to other carcinogenic factors could enhance the tumour 
incidence in the relevant tissues, in a similar manner; for example lung tumours 
with urethane [47, 48]. 
In assessing the nature of radiation effects, it is necessary, always to take 
into account structure of the tissue and the kinetics of the cellular processes.
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Abstract
In recent years, radiation induced bystander effects have been reported in cells 
which were not themselves irradiated but were either in the vicinity of irradiated 
cells or exposed to medium from irradiated cells. The effects have been clearly 
shown to occur both in vivo and in vitro. This work has led to a paradigm shift 
in radiobiology over the last 5 – 10 years. The target theory of radiation induced 
effects is now being challenged because of an increasing number of studies which 
demonstrate non(DNA)-targeted effects. These effects appear to be particularly 
important at low doses.
Considerable evidence now exists relating to radiation-induced bystander 
effects but the mechanisms involved in the transduction of the signal are still 
unclear.  Cell – cell communication through gap junctions and / or secretion of a 
cytotoxic factor into the medium are thought to be involved in the transduction 
of the bystander signal.  Oxidative metabolism has been shown to be important 
in both mechanisms. 
Signalling pathways leading to apoptosis, such as calcium, MAP kinase, 
mitochondrial and reactive oxygen species (ROS) signalling are discussed. 
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The importance of oxidative metabolism and calcium signalling in bystander 
responses are demonstrated.
Further investigations of these signalling pathways may aid in the 
identification of novel therapeutic targets.
1 Radiation induced bystander effects
Radiation induced bystander effects occur when an irradiated cell communicates 
with non-irradiated cells via secreted factors and / or gap junctional intercellular 
communication and the non-irradiated cells exhibit responses that are normally 
characteristic of irradiated cells [see reviews; 1 – 4]. It has been suggested that 
bystander effects may be the predominant responses to low doses of low LET X or 
γ radiation [5] and to low doses of high LET α particle irradiation [6]. Bystander 
responses include sister chromatid exchanges [7 – 9], micronucleus formation 
[10 – 12], apoptosis [11, 13, 14], damage inducible stress responses [15 – 18], gene 
mutation [19 – 21], chromosomal instability [22] and transformation [23, 24]. 
While many of the studies have focussed on damage endpoints, other effects 
such as increased proliferation have been reported in bystander cells [25, 26]. A 
protective adaptive response has also been observed [27, 28] where bystander 
cells that are irradiated subsequently are more radioresistant than cells not 
exposed to bystander signals.
1.1 Nature of the bystander factor
Data are suggestive of a small peptide molecule but it is also possible that long 
lived radicals are produced [29]. These molecules could all be involved and interact 
to provide a progression from short lived radicals to more long lived molecular 
species. It has been shown that medium irradiated in the absence of cells show no 
bystander effects and the effects are dependent on the cell number at the time of 
irradiation, indicating a cell derived factor [30]. The inhibition of the bystander 
effect by heat treatment of the medium or by treatment of the irradiated cells with 
protein synthesis inhibitors suggests that the secreted factors could be proteins 
[8, 31]. Increases in IL-8 and transforming growth factor β1 have also been shown 
in bystander cell supernatants [25, 32]. In addition, a role for superoxide and 
hydrogen peroxide has been reported by many investigators [8, 13, 25, 29, 32 – 37].
1.2 Mechanisms of radiation induced bystander effects
Cell – cell communication through gap junctions and / or secretion of a cytotoxic 
factor into the medium are thought to be involved in the transduction of the 
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bystander signal. Oxidative metabolism has been shown to be important in both 
mechanisms. 
Gap junctions appear to play a vital role in the transduction of the bystander 
factor from irradiated cells to unirradiated cells when there is a high degree of 
cell to cell contact. This physical contact allows ions and low molecular weight 
molecules to pass between cells thorough gap junctions. However, when there 
is no cell to cell contact and cells are located distances apart, secretion of a 
factor in the medium is involved in the transduction of the signal. Incubation of 
unirradiated cells with irradiated cell conditioned medium (ICCM) also involves 
the transfer of a secreted factor.
2 Medium transfer experiments
Extracellular factors, including ROS, have been shown to lead to the induction 
of sister chromatid exchanges (SCEs) in unirradiated cells following transfer 
of conditioned medium from α particle irradiated cells [8, 33]. Mothersill and 
Seymour [30, 31] reported a reduced cloning efficiency associated with increased 
levels of apoptotic cell death in unirradiated cells following transfer of ICCM. This 
was further shown to be associated with early apoptotic events such as calcium 
fluxes, loss in mitochondrial membrane permeability and the induction of reactive 
oxygen species (ROS) [13]. Conditioned medium from α particle irradiated cells 
has also been reported to stimulate cell proliferation in unirradiated cells [27, 
38]. Suzuki et al [39] demonstrated that cells irradiated with α particles released 
medium borne factors which induced chromatin damage in bystander cells 
plated on the other side of a medium filled double mylar dish. Recently, a novel 
transwell insert culture dish method has been used to show medium mediated 
bystander effects following X-irradiation [40]. Increased micronuclei, induction 
of p21, γ-H2AX foci and ROS were observed.
3 Apoptotic bystander responses
Apoptosis has been reported to be a significant pathway to cell death induced 
by exposure to bystander factor(s) [10 – 14, 30].
3.1 Calcium signalling
Calcium is an important signalling molecule and changes in intracellular calcium 
[Ca2+]i modulate cell functions, such as secretion, enzyme activation, cell cycle 
regulation and can lead to apoptosis [41, 42]. Increased [Ca2+]i has been shown to 
cause mitochondrial ROS formation [43]. Calcium acts by activating downstream 
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Ca2+ dependent protein kinases and phosphates, such as MAP kinases, inositol 
trisphosphate (IP3), protein kinase C (PKC), calpain and endonuclease. Rapid 
transient calcium fluxes have been reported by our group in unirradiated cells 
exposed to ICCM [13]. Recent studies from our laboratory [44] have shown 
that chelation of extracellular calcium by EGTA or blockade of L-type calcium 
channels abolished the ICCM induced calcium fluxes, while depletion of 
intracellular calcium stores by thapsigargin attenuated but did not completely 
block the ICCM induced calcium fluxes. The data suggest that calcium release 
from the ER may be triggered by and dependent on ICCM induced calcium 
influx via L-type channels. In addition, when calcium influx was inhibited by 
either EGTA or verapamil, a calcium channel blocker, no bystander induced 
mitochondrial membrane potential depolarisation or apoptosis was observed. 
This indicates the importance of calcium signalling in the transduction of the 
bystander signal.
3.2 MAPK signalling
Multiple new signal transduction pathways have been discovered in the last 15 
years. Many belong to the MAPK (Mitogen Activated Protein Kinase) superfamily. 
The MAPK family is an important mediator of signal transduction prcesses in 
response to a variety of extracellular stimuli. Three major MAPK subfamilies 
have been described: the extracellular signal regulated kinases (ERK), cJun 
N-terminal kinases (JNK) and p38 kinases. Each MAPK is activated through 
a specific phosphorylation cascade [45]. The ERK pathway is involved in cell 
growth and the conferral of a survival advantage [46], whereas the JNK pathway 
is mainly involved in the induction of apoptosis [45]. ERK and JNK pathways 
appear to be in a dynamic balance with the pro-survival ERK pathway acting 
to inhibit the pro-apoptotic JNK pathway [47]. The p38 pathway has been 
shown to promote cell death and well as to enhance cell growth and survival 
[48, 49]. Exposure of cells to ionising radiation and other toxic stresses induces 
simultaneous compensatory activation of multiple MAPK pathways. These 
signals play critical roles in controlling cell survival following exposure [50]. 
Upregulation of proteins in the MAPK pathway has been shown to occur in 
bystander cells [29]. Activation of ERK, JNK and p38 in human fibroblasts was 
reported following exposure to low mean doses of α particles and this activation 
was attentuated by the antioxidants, SOD and catalase. Recent data from our 
laboratory has reported activation of ERK and JNK, but not p38, pathways in 
unirradiated cells exposed to ICCM [44]. Inhibition of the ERK pathway was 
shown to result in increased apoptosis while inhibition of the JNK pathway was 
shown to result in reduced apoptosis compared to exposure to ICCM alone in 
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the absence of inhibitors.  These results correlate well with the accepted roles 
of ERK and JNK in survival and apoptosis respectively.
3.3 Mitochondrial signalling
Mitochondria are pivotal organelles in the apoptotic cascade [51]. Mitochondria 
appear to be the primary target in the intrinsic apoptotic pathway and undergo a 
loss of mitochondrial membrane potential, ∆Ψmito, and release of apoptotic proteins 
including cytochrome c which activates the formation of the apoptosome (activated 
caspase 9 and Apaf-1) and is subject to regulation by Bcl-2 family members.  This 
pathway eventually converges on downstream effectors of cell death such as 
caspase 3. Proteins of the Bcl-2 family govern the commitment to and progression 
of apoptosis induced by a variety of stimuli. The pro-survival members of the 
Bcl-2 family inhibit the onset or progression of apoptosis by preventing release of 
apoptogenic molecules from mitochondria and / or sequestering the pro-apoptotic 
members of the family like Bid and Bax.
3.3.1 Mitochondrial membrane potential depolarisation
A reduction in ∆Ψmito releases the pro-apoptotic proteins located within the 
mitochondria. A reduction in mitochondrial membrane potential has been 
suggested to be induced by opening of a large conductance channel called the 
permeability transition pore (PT pore) [52]. Opening of the PT pore results 
in equilibrium of ions within the matrix and the intermembrane space which 
dissipates the H+ gradient across the inner membrane resulting in uncoupling 
of the respiratory chain. A volume dysregulation causes the inner matrix space 
to expand. As the inner membrane possesses a larger surface area due to its 
folded cristae, the matrix increases until finally the outer membrane is ruptured, 
releasing the pro- apoptotic proteases into the cytosol. Lyng et al [13] has shown 
mitochondrial membrane potential depolarisation 6 hours after ICCM exposure 
and this can be inhibited by blocking both calcium and ROS [44]. Recent studies 
have also shown that medium borne bystander factors resulting in mitochondrial 
membrane potential depolarisation were induced following microbeam irradiation 
[44].
3.3.2 cytochrome c release
Liu et al [53] reported that cytochrome c is an essential component of the complex 
that activates caspase 3, resulting in the apoptotic process. Cytochrome c is a 
highly conserved 12.5kDa nuclear DNA encoded protein, which is associated with 
the mitochondria. The release of cytochrome c from the mitochondria was believed 
to be the point of no return for the cell. This theory was based on caspase activation 
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upon release of cytochrome c which results in fast and ordered destruction of 
the cell. Experimental evidence has shown that release of cytochrome c from the 
mitochondria is not always a commitment to cell death. This suggests that the 
commitment to cell death lies downstream of cytochrome c release [54]. Recent 
studies by our laboratory have shown cytochrome c release 6 hours after ICCM 
exposure [55], coinciding with the depolarisation of the mitochondrial membrane 
potential. Cells receiving signals secreted into the medium from microbeam 
irradiated cells also showed elevated levels of cytochrome c in the cytosol [44].
3.3.3 caspase activation
Caspases are proteolytic enzymes, involved in signalling and execution of 
apoptosis. The caspase family was first discovered in 1993 by Yuan and co-workers 
[56]. Caspases are conserved across species from Caenorhabditis to Drosphila 
to mammals. Once activated, caspases induce a cascade of events that leads 
to cellular death. Active caspase function can be divided into three categories, 
initiators, inflammation inducers and effectors. Initiator caspases, such as caspase 
8, act to activate and process one or more downstream events. Inflammation 
caspases, such as caspase 12, induce an inflammation response. Effector caspases, 
such as caspase 3, act to carry out cellular death.  Recent data from our laboratory 
has shown activation of caspase 8 within 1 hour and caspase 3 within 6 hours 
at doses ≤ 0.5 Gy ICCM [55]. Inhibition of caspase 9 was also shown to block 
bystander responses at doses ≤ 0.5Gy ICCM. These results indicate that caspase 
independent pathways are activated at doses ≥ 0.5 Gy ICCM.
3.3.4 bcl-2 expression
The Bcl-2 family consists of evolutionarily conserved proteases with opposing 
pro and anti apoptotic properties. The Bcl-2 family can be divided into three 
different subdivisions, with all members sharing one of four characterised Bcl-2 
homology (BH) domains. Bcl-2 appears to localise to the outer mitochondrial 
membrane [57] and preserve the integrity of the mitochondrial membranes. Bcl-2 
acts directly or indirectly, preventing cytochrome c release from mitochondria. 
Recently, Maguire et al [58] reported increased Bcl-2 expression in HPV-G cells 
exposed to ICCM doses ≥ 0.5 Gy. ICCM doses ≤ 0.5 Gy resulted in no significant 
Bcl-2 expression. In addition, Lyng et al [44] showed increased Bcl-2 expression 
in HPV-G cells exposed to signals from microbeam irradiated cells.
3.4 ROS signalling
Lehnert and Goodwin [8] reported that the induction of sister chromatid exchanges 
in bystander cells was inhibited by the presence of a ROS inhibitor, superoxide 
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dismutase. Shao et al [26] demonstrated that dimethyl sulfoxide (DMSO), a 
known reactive oxygen species inhibitor, decreased the amount of micronuclei 
formation in bystander cells. Azzam et al [29] reported that the activation of stress 
inducible proteins in both p53 and mitogen-activated protein kinase pathways in 
bystander cells could be inhibited by superoxide dismutase and catalase. Recent 
studies from our laboratory [44, 55] have shown that antioxidants such as, SOD, 
catalase and N-acetylcysteine, can inhibit ICCM induced cell death.
Goldman et al [59] reported a correlation between elevation in 
intracellular calcium and formation of ROS in response to growth factors 
and hormones. The rise and decay of intracellular calcium levels have been 
found to be similar to those of ROS [59] indicating a close link between 
changes in [Ca2+]i and ROS production. Both calcium and ROS are secondary 
messengers. Both an increase in intracellular calcium levels [13, 14] and ROS 
[8, 26, 29, 44, 55] has been highlighted as important messengers in bystander 
induced effects.
4 Conclusions
Understanding the mechanisms and signalling pathways induced in bystander 
cells may lead to novel therapeutic approaches involving targeted radiotherapy 
regimens. For example, turning on cytotoxic bystander responses in tumour cells 
may improve the efficacy of targeted radiation approaches or combined gene 
therapy. It is also possible that normal tissues may be protected by turning off 
bystander responses.
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Abstract
Cancer gene therapy is a new, promising therapeutic agent. In the clinic, it should 
be used in combination with existing modalities, such as tumour irradiation. 
First, we summarise the most important fields of cancer gene therapy: gene 
directed enzyme pro-drug therapy; the activation of an anti-tumour immune 
attack; restoration of the wild type p53 status; the application of new, replication 
competent and oncolytic viral vectors; tumour specific, as well as radiation- and 
hypoxia-induced gene expression. Special emphasizes are put on the combined 
effect of these modalities with local tumour irradiation.
Using the available vector systems, only a small portion of the cancer cells 
will contain the therapeutic genes under therapeutic situations. Bystander cell 
killing might contribute to the success of various gene therapy protocols. We 
summarise the evidences that lethal bystander effects may occur during cancer 
gene therapy. Bystander effects are especially important in the gene directed 
enzyme pro-drug therapy. There, bystander cell killing might have different 
routes: cell communication through gap junction intercellular contacts; release 
of toxic metabolites into the neighbourhood or to larger distances; phagocytosis 
of apoptotic bodies; and the activation of the immune system. Bystander cell 
killing can be enhanced by the introduction of gap junction proteins into the cells, 
by further activating the immune system with immune-stimulatory molecules, 
or by introducing genes into the cells that help the transfer of cytotoxic genes 
and / or metabolites into the bystander cells.
In conclusion, there should be additional improvements in cancer gene 
therapy for the more efficient clinical application.
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1 Introduction
Gene therapy is a promising new therapeutic modality on the field of cancer 
treatment. There are many gene therapy approaches, which might be beneficial 
in the future when treating cancer patients. The potential modalities include 
the activation of the immune system against the tumour, the application of the 
gene directed enzyme pro-drug therapy (GDEPT) and oncolytic viruses. Despite 
of the success of numerous animal experiments, the clinical applications have 
not presented many promising data, so far. One of the possible explanations for 
the unpromising results is that mainly cancer patients in the final stage of their 
progressive diseases were included in the trials. Other possibility is that when the 
first generational vectors are used for the introduction of therapeutic genes into 
in vivo growing tumour cells, only a small portion of the cells will be transduced 
and it is not sufficient for tumour cure. Because of the low penetration ability of 
the available vector systems, the bystander effect is an absolute requirement to 
the success of cancer gene therapy. It was stated by Vile et al. [1] that “No single 
gene can be a serious contender, unless it has a demonstrable bystander effect”.
The new cancer therapy treatments should be used in conjunctions with 
existing modalities. Radiation therapy might be an excellent candidate to combine 
with gene therapy.
In this short review, first, we summarize the various gene therapy protocols 
that might have beneficial effects when combined with tumour irradiation and 
then will focus on the bystander effects of cancer gene therapy.
2 Basic gene therapy protocols,  
combination with radiation therapy
2.1 Gene directed enzyme pro-drug therapy
During cancer chemotherapy, a principle problem is the frequently observed 
acquired resistance, to the drugs [2]. Gene directed enzyme pro-drug therapy 
(GDEPT) with drug-sensitizing genes is a promising new tool to overcome 
resistance and decrease the unfavourable side effects of chemotherapy. In GDEPT, 
tumour cells are transduced with, so called suicide genes. The enzyme product 
of the suicide genes can convert potentially non- or mildly toxic drugs to highly 
toxic agents. After systemic drug administration, the suicide gene-modified 
tumour cells will metabolize the anti-tumour agent, and higher concentration 
of active metabolites is achieved within the tumour mass that leads to selective, 
increased cell killing. 
The most frequently used GDEPT protocol is the thymidine kinase /
ganciclovir system. The Herpes simplex derived thymidine kinase (HSVtk, 
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TK) converts ganciclovir (GC) to ganciclovir-monophosphate, which is further 
phosphorylated by cellular kinases to toxic ganciclovir-triphosphate. Ganciclovir-
triphosphate incorporates into the DNA and inhibits DNA synthesis [3 – 5]. 
Mammalian cells lack TK, thus GC causes toxic effects only after transfecting 
cells with TK.
One of the most widely applied cancer chemotherapy agents is 5-flurouracil 
(5-FU). In mammalian cells, 5-FU is metabolized first into nucleoside fluorouridine 
by uridine phosphorylase and then phosphorylated into 5-fluoro-2’-uridine-
5’-monophosphate (FUMP) by uridine kinase. FUMP incorporates into RNA 
through FUTP or further metabolized into FdUMP. FdUMP is a potent inhibitor 
of thymidylate synthase, a key enzyme in the synthesis of dTMP, which is a 
precursor of DNA replication [6]. Unfortunately, 5-FU resistance and toxic 
side effects are frequent in cancer patients. There might be two possibilities 
to overcome this problem. One of them is to produce 5-FU from the non-toxic 
5-fluorocytosine (5-FC) by bacterial or yeast cytosine deaminase enzymes (CD) 
through GDEPT [3, 4]. Another possibility is to introduce the E. coli uracil 
phosphoribosyltransferase (UPRT) gene into the tumour cells. UPRT converts 
5-FU directly and very efficiently into FUMP [2, 7].
Desaknai et al. [8] used a double-suicide GDEPT system against murine 
brain tumours. The applied adenoviral vector encoded both the TK and the UPRT 
genes. Intra-tumour injection of this vector and subsequent treatment with the 
corresponding agents substantially slowed down tumour progression. They have 
found that this protocol might be very efficiently combined with irradiation. Under 
in vitro circumstances, the combination of 5-FU and ganciclovir treatments with 
irradiation increased cytotoxicity by three orders of magnitude. In glioma-bearing 
mice, the combined treatment also improved survival compared to a single agent 
modality even when only 10% of the cells contained the suicide genes. 
2.2 Activation of anti-tumour immune attacks
There are several immune-therapy approaches, which might increase the 
immunogenicity of the tumours [9]. One possibility is the introduction of cytokine 
encoding genes into the tumour cells. This can be achieved either by direct intra-
tumour injection of viral vectors or by ex vivo modification of the malignant 
cells. The direct intra-tumour vector injection is much simpler than the ex vivo 
modification, but there are certain risks arising from the introduction of large 
number of viral particles into the human body. During the ex vivo approach 
most of the tumour is removed by surgery and first a primary cell culture is 
established from the malignant tissue. Then cytokine encoding vectors are 
introduced into the in vitro growing tumour cells and cell division is stopped by 
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high dose irradiation of the culture. Finally, the cytokine expressing irradiated 
tumour cells are used to vaccinate the same patient from whom the original 
tumour was removed. It is expected that the host immune system is activated 
by the vaccine, and it will attack both the residual tumour cells at the site of the 
surgery and the cells at distant metastases. The key requirement of this protocol 
is the presentation of tumour-associated antigens in the microenvironment of 
cytokine secretion [10, 11].
Li et al. [12] and Staba et al. [13] reported that the combination of radiation 
with intra-tumour administration of a cytokine (TNF-alpha) encoding vector 
substantially slowed down tumour progression. Lumniczky et al. [14] found 
that cytokine expressing vaccines might cure about 30 – 40% of brain tumour 
bearing mice. Local radiation therapy alone hardly increased life span; however, 
the combination of these two modalities improved survival rates up to 80 – 100%. 
One simple explanation for the synergistic effect of vaccination and radiation 
therapies is that there is a continuous competition between tumour growth 
and tumour eradication by the activated immune system. Local irradiation 
decreases the tumour burden, so the activated immune system could overcome the 
decreased tumour mass. Another possibility is that after irradiation the primary 
tumour cells die by necrosis. The necrotic death might lead to the liberation of 
immunogenic molecules that further enhances immune response. 
2.3 Restoration of wild type p53 status
It is well known that the p53 tumour suppressor gene is mutated in high 
percentage of human cancer. The p53 protein has basic roles in cell cycle regulation 
and in radiation response. The restoration of wild type p53 activity in tumour cells 
should have a strong impact on tumour treatment. In accordance, the enhanced 
radiosensitivity of glioma cells was detected after transduction with wild type 
p53 encoding vectors [15 – 17]. The radiosensitizing effect of p53 is probably 
established through its pro-apoptotic effect, but p53 might also suppress tumour 
vascularization. 
2.4 Replication competent and oncolytic viruses
The first generational viral vectors are not able to replicate in the transduced 
cells. After intra-tumour delivery of these vectors, the viral infection is limited 
to cells surrounding the needle track. This low infection rate probably highly 
contributed to the very limited success of the undergoing clinical trials. This 
problem might be overcome by the introduction of new generational viral vectors 
that are capable for propagation in tumour cells. 
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Some of the new replicative vectors might have oncolytic effects, as well. 
One of the first potentially replicative, oncolytic vectors was the ONYX adenovirus 
vector [18]. In the ONYX virus only the E1B region was removed from the wild 
type adenovirus. The E1B protein can bind to and inactivates the p53 tumour 
suppressor protein. The inactivation of the p53 protein will allow adenovirus 
replication in the infected cells. In the absence of the E1B region p53 should 
inhibit viral replication in normal cells. Because p53 is mutated in most of the 
cancer cells, the virus might replicate in and kill the p53 deficient tumour cells. 
The anticancer effect of ONYX virus is under evaluation in several clinical trials 
including head and neck [19] and metastatic lung tumours [20]. ONYX is much 
more effective when combined with radiation in colon carcinoma [21] and glioma 
[22] tumour models.
Some viruses, such as vaccinia, measles, herpes simplex, Newcastle 
disease virus might preferentially replicate in tumour cells and demonstrate 
oncolytic activities [23]. Ionizing radiation can augment the oncolytic effect of 
herpes simplex [24], vaccinia [25] and Newcastle disease (Safrany et al. MS in 
preparation) viruses.
2.5 Tumour specific and radiation driven therapeutic gene expression
In cancer gene therapy it would be highly preferable if the therapeutic genes 
were expressed and / or the vectors replicated only in the targeted tumour cells. 
To achieve this, gene expression and / or vector replication should be placed 
under the control of tumour specific promoters [26]. When cancer gene therapy 
is combined with radiation therapies, there might be two possibilities to achieve 
tumour specific expression: the application of radiation induced promoters and 
the introduction of hypoxia induced promoters into the vectors.
 Exposure of cells to ionizing radiation activates a number of genes 
including, early and late radiation response genes. The early response genes 
include c-jun, c-fos, EGR1, NFκB and p21WAF1 [26, 27]. Among these genes, 
the EGR1 promoter is extremely well characterized. It contains four copies 
of a CC(AT)6GG sequence, the so-called CArG element that is responsible for 
radiation induction. Gene expression from the EGR1 promoter will be induced 
about 3-fold by 2 Gy irradiation [28]. Synthetic promoters containing several 
CArG elements and a basal promoter might be created and linked to therapeutic 
genes. An adenoviral vector was constructed where the expression of TNFα 
was placed under the control of four CArG elements [29]. Using this vector and 
tumour irradiation, effective concentrations of TNFα might be achieved locally 
in the tumours without systemic toxic side effects. When breast cancer, lung, 
rectum, pancreas tumour and melanoma patients were treated with the vector 
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and tumour irradiation, very promising results were obtained [29]. The CArG 
element can be very efficiently used to drive gene expression from a TK construct 
after radiation [30], as well.
The p21WAF1 promoter, that is induced by radiation [26], also sensitive 
to hypoxia. The inducible nitric-oxide-synthase (iNOS) gene was placed under 
the control of the WAF1 promoter and used in a murine fibrosarcoma model in 
combination with tumour irradiation. Significant tumour growth delay and apoptosis 
induction in the tumour were observed [31]. It was also proved that inducible 
nitric-oxide-synthase (iNOS) gene therapy in combination with the inducible 
WAF1 promoter resulted in a significant tumour cell radiosensitisation [32].
2.6 Hypoxia-induced gene expression
It is well known that severe hypoxia might be present in various human tumours. 
Tumour hypoxia is usually associated with aggressive disease and poor prognosis. 
However, tumour hypoxia might be utilized in cancer gene therapy by putting 
the therapeutic genes under the control of hypoxia responsible elements (HREs). 
HREs are enhancers containing the (A /G)CGT(G /C)(G /C) sequence and are 
present in the promoter region of several hypoxia responsive genes, such as 
vascular endothelial growth factor (VEGF), erythropoietin and phosphoglycerate 
kinase [26]. Hypoxia sensitive promoters are regulated through the binding of 
HIF1 transcription factor to HREs. HIF1 is composed of two subunits (HIF1α 
and HIF1β) from which HIF1α is regulated by hypoxia on the post-translational 
level [33]. When five copies of HRE were linked to a minimal CMV promoter, 
hypoxia induced gene expression by 500-fold [34]. 
3 Bystander effects
It is well known that ionising radiation will induce bystander effects in directly not 
targeted cells. The bystander effect might contribute to the death of neighbouring 
cells, but it might induce genomic instability and mutations, as well. During 
cancer therapy and / or cancer gene therapy the beneficial effect is the death of the 
bystander cells. When cancer gene therapy is combined with radiation therapy, 
the radiation induced lethal bystander effects will obviously contribute to the 
death of malignant, as well as normal cells. Genetically modified cells during 
cancer gene therapy may also deliver various signals to the neighbouring cells. In 
the following chapters, we will focus on the death signals, which may contribute 
to a more efficient cancer cure.
As mentioned above the most frequently studied gene therapy system is 
the TK-GC model. Ganciclovir (GC) is not toxic for mammalian cells. After initial 
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phosphorylation by HSVtk, cellular kinases will generate the toxic triphosphate 
form of GC that kills TK containing cells. The question is whether TK-minus 
cells could be killed by bystander effects. This presumed bystander effect might 
present death signals or toxic pro-drug metabolites to the neighbouring cells 
and even to cells at distant metastases. The bystander effect might occur via 
intercellular communications, by phagocytosis of apoptotic bodies, through the 
activation of the immune system or by the release of cytotoxic metabolites. The 
lethal bystander effect of cancer gene therapy might be also augmented by 
different ways [36].
3.1 The mechanism of bystander effects
3.1.1 cell to cell contacts through gap junctions
The bystander effect, produced by ganciclovir-mediated killing of cells transduced 
with a herpes simplex virus thymidine kinase (HSVtk, TK) gene, defines the 
cooperative killing of non-HSVtk-transduced cells. In vitro, a major contributor 
to this phenomenon is metabolic cooperation involving the transfer of cytotoxic 
small molecules between cells mainly through cell-to-cell interactions. Several 
authors reported that when TK-positive cells were co-cultured with TK-negative 
cells at high densities, both TK-plus and -minus cells was killed by GC. However, 
when the cells were co-cultured at low cell densities, only the TK-positive cells 
were killed. This suggests that cell-to-cell contact is necessary for the bystander 
effect and cells might communicate through gap junctions. 
Gap junctions are important mediators of direct intercellular communication. 
Ions, small metabolite molecules, second messengers and certain dyes can pass 
through gap junctions. Gap junctions consist of two hexameric integral membrane 
protein hemi channels termed connexons, which interact across the narrow 
extracellular space to create a complete channel. The connexons are composed of 
six connexin protein subunits that surround the central pore. At least 14 different 
connexins have been identified in mammals. Gap junctions allow the passage of 
molecules less than 1 kDa in size, such as triphosphorylated GC. Intercellular 
communication via gap junctions is regulated at different levels. Connexin 
proteins are stored intracellularly, transported to cytoplasmic membrane, and 
assembled into gap junctions. Protein kinase A activated by cAMP mediated 
signals is the only well characterized signal transduction system that increases 
gap junctional intercellular communication (GJIC) in most cell types [35, 36]. 
The importance of gap junctions for bystander effects was proved both under 
in vitro and in vivo conditions. Transfection of connexin genes into connexin 
deficient cells will increase bystander effects (see later).
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The presence of gap junction in the target cells might be more important 
than in the effector cells. The bystander effect of TK-GC gene therapy was 
studied in different rat glioma cell lines (9L and C6 cells) under both in vitro 
and in vivo conditions. Mixed populations of wild-type cells (9Lwt and C6wt) 
and respective HSVtk gene-transduced cells (9Ltk and C6tk) were examined 
for their sensitivity to GC. A potent in vitro bystander effect was observed in 
9Lwt / 9Ltk and 9Lwt / C6tk combinations but not in C6wt / 9Ltk and C6wt / C6tk 
combinations. In vivo bystander effect studied in a subcutaneous tumour model in 
athymic nude mice was also potent in 9Lwt / 9Ltk and 9Lwt / C6tk combinations. 
Because the expression of connexin43, a major protein in the connexin family 
gene products, in 9L cells is much higher than in C6 cells, the results suggest 
that the amount of connexin in target (wild-type) cells but not in effector (HSVtk 
gene-bearing) cells is important for the generation of the bystander effect. This 
hypothesis was further confirmed by the observation that in vitro bystander 
effect in C6wt / C6tk combination was potentiated by transduction of the connexin 
43 gene to the target cells [37].
The intracellular TK level might also influence the bystander effects. Cells 
were transduced either with one or with two copies of TK. The efficiency of GC 
killing and the magnitude of the bystander effect were compared for the single- 
and double-copy TK-plus cell lines. Cells that expressed two copies of HSVtk 
metabolized GC more efficiently than single-copy HSVtk cells. They were also 
more sensitive to GC, and demonstrated improved bystander killing [38].
3.1.2 release of cytotoxic metabolites
Some of the published data suggest that the presence of gap junctions is not 
obligatory for the bystander effects. In a few instances bystander cell killing was 
reported when the TK-plus effector and the TK-minus target cells were not in 
contact or when they were separated physically by permeable membranes or even 
when the medium was transferred from one cell culture dish to the other. Princen 
et al. [39] analyzed the mechanisms of the bystander effect in two cell lines 
exhibiting different capacities of communication (DHD / K12 and 9L). The 9L cells 
exhibited a very good bystander effect, which was completely blocked by a long-
term inhibitor of GJIC, 18 alpha-glycyrrhetinic acid. DHD / K12 cells exhibited 
a moderate bystander effect that was not abolished by 18 alpha-glycyrrhetinic 
acid. They also observed a bystander effect in cultures where HSVtk-expressing 
DHD / K12 cells were physically separated from their untransfected counterparts 
but grown in the same medium. Moreover, the transfer of filtered conditioned 
medium from GC-treated HSVtk-expressing DHD / K12 cells to DHD / K12 
parental cells induced a decrease of survival in a concentration-dependent 
manner, suggesting that the bystander effect in this cell line was mediated by a 
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soluble factor. Beside this, the human colon carcinoma SW620 cells are able to 
form only a limited number of gap junctions and still they can present strong 
bystander signals to neighbouring cells. These cells can deliberate toxic GC 
metabolites into the medium [36, 40].
It seems that the contact independent bystander effect is cell type 
dependent. Several cell lines (DHD / K12, SW620 or A15A5 rat glioma) are 
capable for the release of cytotoxic metabolites (the phosphorylated forms of GC) 
into the medium, while others (9L rat glioma) are not.
3.1.3 Phagocytosis of apoptotic bodies
Some data suggest that the phagocytosis of apoptotic bodies might contribute to 
the bystander cell killing. After GC-treatment, TK-plus cells will dye mainly by 
apoptosis. During apoptotic cell death, apoptotic bodies are formed by the dying 
cells and these bodies might be phagocytized by other, TK-minus cells. By this 
manner, TK-minus cells can pick up death signals that lead to apoptotic death. 
It was demonstrated that some TK-positive cells exposed to GC were lethal to 
TK-negative cells, because of a bystander effect. The mechanism of this bystander 
effect on TK-negative cells appeared to be related to the process of apoptotic cell 
death. The data suggested that apoptotic vesicles generated from the dying gene-
modified cells were phagocytized by nearby, unmodified tumour cells. Prevention 
of apoptotic vesicle transfer eliminated the bystander effect [41]. However, 
according to other data it is also possible that toxic metabolites were already 
transformed to the TK-minus cells before the phagocytosis of the apoptotic bodies 
and this led to the cell death. Hamel et al. [42] detected apoptosis in bystander 
cells and found that bystander cell death could be inhibited by BCL2 expression. 
BCL2 is an anti-apoptotic factor. They determined that ganciclovir incubations 
for 10 h were sufficient to induce cell death in most bystander cells co-cultured 
with HSVtk-expressing cells. During this period, no phagocytosis was detected, 
although it was obvious at later stages.
3.1.4 the role of the immune response
The immune system might have substantial contribution to bystander cell 
killing under in vivo conditions. When animals with TK-plus tumours were 
treated with GC, the residual tumours were infiltrated by inflammatory cells. 
The inflammatory cells, consisted of CD4+ and CD8+ lymphocytes, NK cells, and 
macrophages. When surviving animals were re-injected with the tumour cells, 
it was rejected, demonstrating long-term immunity [43].
Bi et al. [44] assessed the bystander effect in vivo using cells of oral 
squamous cell carcinoma origin. Mixtures of HSVtk+ and HSVtk- tumour cells 
were implanted subcutaneously in the left flank of nude mice, and naive HSVtk- 
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cells were implanted subcutaneously in the right flank. The animals were 
treated with ganciclovir. The tumours in the left flank, which comprised of 
mixed cells were resolved, consistent with the predicted bystander effect. The 
naive tumours in the right flank either resolved or became static compared to 
controls. Concomitant treatment with dexamethasone impaired the anti-tumour 
effect on the contra-lateral side. Although nude mice are T cell deficient, but 
they have intact monocytes and macrophages and they are able to produce 
antibodies. When these experiments were performed in completely immune-
deficient SCID mice, there was a reduced anti-tumour effect on the ipsilateral 
flank and no anti-tumour response in the contralateral flank. The data clearly 
suggest an immune-related anti-tumour response that could account for the 
distant bystander effect.
3.2 Modulation of the bystander effects
3.2.1 improving gap junctions
As mentioned earlier the mechanism responsible for the bystander effect is 
highly dependent on the diffusion of toxic metabolites or apoptotic signals 
across gap junctions. The gap junction-dependent diffusion of phosphorylated 
ganciclovir metabolites from transfected cells to their neighbours proved to 
enhance the overall benefit of the TK-GC system. Unfortunately, tumour 
cells are often gap junction-deficient [36]. Retinoids have been reported to 
increase GJIC by inducing connexin expression. Addition of all-trans 
retinoic acid increased GJIC in tumour cell lines, augmented the expression 
of connexin 43, and was associated with more efficient GC-induced in vitro 
bystander killing. This augmentation of bystander effect could also be seen 
in vivo. HSVtk-transduced tumours in mice treated with the combination of 
GC and retinoids were significantly smaller than those treated with GC or 
retinoids alone [45].
Robe at al. [46] tried to restore GJIC pharmacologically to improve the 
efficacy of TK-GC treatment. They demonstrated that this approach was feasible 
in glioblastoma cells using dibutyryl adenosine 3’,5’-cyclic monophosphate (cAMP) 
as an inducer of gap junctions. In another system, HSVtk positive BeWo cells 
(human choriocarcinoma cell line) were sensitive to GC at the concentration of 
10 micrograms / ml in a time-dependent manner. The growth of HSVtk negative 
cells was inhibited when the population of cultured cells contained more than 
10% HSVtk positive cells and the addition of 8-bromo-cAMP further enhanced 
bystander effect. 8-bromo- cAMP increased connexin40 mRNA expression and 
gap junctional intercellular communication [47].
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GJIC can also be restored by co-transfection of the cells with connexin 
encoding genes. HeLa cells show very little, if any, ability to communicate 
through gap junctions. When HeLa cells were transfected with HSVtk gene 
and co-cultured with non-transfected cells, only HSVtk-transfected HeLa cells 
(tk+) were killed by ganciclovir. However, when HeLa cells transfected with a 
gene encoding for the gap junction protein connexin 43 (Cx43) were used, not 
only tk+ cells, but also tk- cells were killed, presumably due to the transfer – 
via Cx43-mediated GJIC – of toxic ganciclovir molecules. Such bystander effect 
was not observed when tk+ and tk- cells were co-cultured without direct cell-cell 
contact [48]. Duflot-Dancer et al. [49] injected different ratios of tk+ / tk- HeLa 
cells transfected with Cx43 into nude mice. When GC was administered before 
tumours were palpable, fewer animals developed tumours if the injected cells 
were mixtures of Cx43(+)-tk+ and Cx43(+)-tk-, while tumour growth was not 
prevented with mixtures of HeLa cells not expressing Cx43. When GC was given 
after the appearance of tumours, the size of the tumours from Cx43- cells was 
30% reduced for 3 weeks if 50% of the injected cells were tk+. However, for cells 
expressing Cx43, the tumour size was 66% reduced if 10% of the cells were tk+. 
This reduction demonstrated a long-term bystander effect which is dependent 
on Cx43 expression.
Connexin 43 is also the major component of astrocyte gap junctions. 
The susceptibility of two rat glioma cell lines (CNS1 and C6) to TK-GC was 
investigated before and after transfection with the Cx43 gene. A close correlation 
between the level of Cx43 expression, the extent of gap junctional communication 
and the amplitude of the bystander effect was reported. Transfection of C6 cells 
(which display a weak bystander effect and low levels of connexin) with a Cx43 
construct induced a strong bystander effect. Inhibition of gap junction activity 
by 18-alpha-glycyrrhetinic acid abolished the metabolic interaction between 
TK(+) and TK(-) cells. This metabolic interaction was also abolished if TK(+) 
and TK(-) cells were separated by a semi-permeable membrane. Surprisingly, 
transfection of only one of these two interacting cell types with the Cx43 gene 
was also sufficient to induce bystander effect, although it was weaker than that 
observed if both TK(+) and TK(-) cells expressed Cx43 [50].
3.2.2 immune-system activation
Increasing the anti-tumour immune response might enhance the bystander 
effect, as well. Walling et al. [51] used retroviral vectors to transfer the HSVtk 
and interleukin-2 genes to human osteosarcoma cells. Each gene was stably 
transduced and expressed; the HSVtk gene effectively conferred ganciclovir 
(GC) susceptibility to transduced cells. A strong bystander effect was observed 
in vitro, whereby non-transduced tumour cells in proximity to transduced cells 
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acquired susceptibility to GC killing. In athymic nude mice, subcutaneously 
implanted mixtures of human osteosarcoma cells and HSVtk vector producer 
cells developed into tumours that completely regressed upon administration of 
GC. Subcutaneously implanted mixtures of transduced and wild type cells showed 
a potent bystander effect upon administration of GC, with complete tumour 
ablation when as little as 10% of the cells were HSVtk+. A significant anti-tumour 
response was seen against primary tumours composed of unmodified cells when 
a secondary tumour of transduced cells was implanted at a distance, suggesting 
a diffusible bystander factor. The presence of interleukin-2-transduced cells (an 
immune stimulator) improved the efficacy of treatment.
3.2.3 other genes
It is possible to induce a gap junction independent bystander cytotoxic effect 
by linking the HSVtk gene to the gene of another herpes virus protein, VP22. 
The VP22 protein has been shown to pass freely between cells by an unknown 
mechanism. VP22, like a small number of the proteins such as interleukin 1-b, the 
HIV-1 tat protein, and the fibroblast growth factors, is exported from the producer 
cells, in spite of the lack of a signal sequence, by a Golgi-independent mechanism. 
VP22 is unique, however, in its ability to efficiently re-enter the surrounding cells. 
VP22 can spread to virtually every cell in a transfected monolayer from only a 
few producer cells. VP22 fusion proteins function as a potent protein delivery 
system. A VP22-HSVtk construct was tested in different tumour cells in vitro and 
in vivo to confer bystander effects. The VP22-tk chimeric proteins spread between 
cells in sufficient quantities to induce cell death in response to GC treatment, 
not only in the primary synthesizing cells but also in surrounding recipient cells, 
thus causing a bystander phenomenon even in cells devoid of gap junctions. 
This effect was observed upon GC treatment of transfected tissue culture cells 
and in vivo in GC treatment of mice injected with tumour cells transduced with 
VP22-tk fusion genes. However, the effect was observed only with relatively high 
numbers (50%) of VP22-tk-synthesizing cells present in the mixture [36, 52]. 
This offers a new strategy to enhance the effectiveness of suicide gene therapy 
for the treatment of cancers.
3.3 Apoptosis inducing therapeutic genes
The induction of apoptosis in cancer cells can be achieved by introduction of 
pro-apoptotic genes (p53, FasL, TRAIL) into cancer cells. The restoration of wild 
type p53 in tumours is a very promising gene therapy approach. Beside this, 
inducing Fas-mediated apoptosis is also promising. It was demonstrated that a 
Fas Ligand (FasL) expressing adenovirus (AdGFPFasL(TET)) was able to induce 
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Fas-mediated apoptosis in a panel of prostate cancer (PCa) cell lines regardless 
of their Fas-sensitivity. It was also reported that AdGFPFasL(TET)-infected 
cells produced apoptotic bodies and cellular debris that continued to elicit FasL-
mediated bystander killing in uninfected neighbouring cells. The infected cells 
released apoptotic bodies and cellular debris into the local environment and this 
material induced bystander killing in Jurkat, PPC-1, and PC-3 target cells, but 
not in DU145 and K-562 cells. Coincubation of PPC-1 target cells with apoptotic 
bodies and cellular debris (effector material) induced nearly complete target cell 
killing at 1 : 1 target to effector ratio [53].
Tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is 
a member of the TNF family and a potent inducer of apoptosis. TRAIL has been 
shown to effectively limit tumour growth in vivo without detectable cytotoxic 
side effects. An adenovirus expressing full-length TRAIL was constructed and 
its efficacy tested in several cancer cell lines. Ad-TRAIL-infected cancer cells 
localized full-length TRAIL protein to the cytoplasm and released same-sized 
TRAIL in the media. Ad-TRAIL was found to induce apoptotic cell death in 
several cancer cell lines resistant to soluble TRAIL (A549, SKOV3, HT-29 and 
LNCap) and in TRAIL-sensitive cell lines. Ad-TRAIL, but not soluble TRAIL, 
induced apoptotic cell death in TRAIL-resistant cell lines. Ad-TRAIL also induced 
a media-transferable bystander effect, but only in soluble TRAIL-sensitive cell 
lines [54].
Interferon (IFN)-gamma often modulates the anticancer activities of 
TNF family members including TRAIL. However, little is known about the 
mechanism. To explore the mechanism, A549, HeLa, LNCaP, Hep3B and HepG2 
cells were pre-treated with IFN-gamma, and then exposed to TRAIL. IFN-gamma 
pre-treatment augmented TRAIL-induced apoptosis in all these cell lines [55].
4 Conclusion
Animal experiments provided enormous data that cancer gene therapy was 
an efficient new therapeutic agent. Despite of this fact, the ongoing clinical 
trials proved only the safety of these treatment modalities, but they had not 
provided many promising outcomes. The development of new vector systems and 
improvements in modulating the bystander effects may provide new, additional 
opportunities to a more successful clinical approach. 
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Abstract
The dogma that genetic alterations are restricted to directly irradiated cells 
has been challenged by observations in which effects of ionizing radiation, 
characteristically associated with the consequences of energy deposition in 
the cell nucleus, arise in non-irradiated cells. These, so called, untargeted 
effects are demonstrated in cells that are the descendants of irradiated cells 
(radiation-induced genomic instability) or in cells that have communicated 
with neighbouring irradiated cells (radiation-induced bystander effects). There 
are also reports of long-range signals in vivo, known as clastogenic factors, 
with the capacity to induce damage in unirradiated cells. Clastogenic factors 
may be related to the inflammatory responses that have been implicated in 
some of the pathological consequences of radiation exposures. The phenotypic 
expression of untargeted effects reflects a balance between the type of signals 
produced and the responses of cell populations to such signals, both of which 
may be significantly influenced by cell type and genotype. There is accumulating 
evidence that untargeted effects in vitro involve inter-cellular signalling, 
production of cytokines and free radical generation. These are also features 
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of inflammatory responses in vivo that are known to have the potential for 
both bystander-mediated and persisting damage as well as for conferring a 
predisposition to malignancy. At present it is far from clear how untargeted 
effects contribute to overall cellular radiation responses and in vivo consequences 
but it is possible that the various untargeted effects may reflect inter-related 
aspects of a non-specific inflammatory-type response to radiation-induced stress 
and injury and be involved in a variety of the pathological consequences of 
radiation exposures.
1 DNA damage and repair
Genomic damage results from a wide variety of exogenous and endogenous 
sources. Important endogenous sources are the reactive oxygen species (ROS) 
that arise as an inevitable consequence of oxidative metabolism. Cells have been 
estimated to produce approximately 1010 ROS per day, resulting in about 20,000 
oxidatively damaged DNA bases [1]. Perhaps less well appreciated but equally 
important, spontaneous reaction of DNA with water causes depurination, and 
steady state levels of abasic sites range from 50,000 – 200,000 per cell [2]. Both 
types of endogenous damage are found at different levels in different tissues 
[2]. The production of cellular ROS rises with metabolic activity, increases with 
age and their deleterious effects can be alleviated by anti-oxidants in the diet 
[3, 4]. DNA replication itself can introduce errors into newly synthesized DNA, 
since no polymerase is ever 100% faithful. In addition to endogenous damage, 
we are all exposed to a variety of exogenous damaging agents, including ionizing 
and non-ionizing radiation, dietary chemicals and air-borne pollutants [5 – 9]. 
As maintaining the integrity of the genome is essential for normal function, 
cells have evolved highly sophisticated mechanisms for repair of a wide variety 
of lesions resulting from the range of different types of damage. These repair 
systems involve the activities of well over one hundred different gene products 
with distinct functions [10, 11]. Double-strand DNA breaks (DSBs) are regarded 
as being of of particular importance because their misrepair can result in 
chromosomal abnormalities and there is direct experimental evidence for DSBs 
as the source of chromosomal abnormalities seen in cancer [12, 13]. Recent 
measurements of endogenous DSBs in dividing human cells estimate that about 
50 DSBs are produced in every cell cycle (roughly equivalent to one break in 
each chromosome) [14]. In non-dividing cells, steady-state levels are about one 
DSB in every 20 cells [15]. 
The repair of DSBs in normal human cells involves one of two possible 
pathways (Figure 1); non-homologous end-joining (NHEJ) or homologous 
recombination (HR) [16, 17]. NHEJ is a simpler method for repairing DSBs and 
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Figure 1. A schematic representation of the major steps in DNA repair by homologoius 
recombination and non-homologous end joining.
involves binding of the Ku dimer (comprised of Ku70 and Ku80) to a DSB in a 
non-sequence-dependent manner. The Ku complex acts to target the catalytic 
subunit of DNA-dependent protein kinase (DNA-PKcs) and the tertiary complex 
forms the DNA-PK enzyme, which is activated by interaction with a single 
stranded region within a DSB. The majority of DNA DSBs contain modified bases 
at their end and require processing to remove these lesions before repair. In both 
HR and NHEJ, this process utilizes the exonuclease and endonuclease activities 
of the Mre11 / Rad50 / NBS1 complex. Immunocytochemical demonstration of 
this complex [18, 19] provides a potential marker for DSBs in normal and 
pathological tissues. After processing, ends are directly ligated by Ligase IV in 
combination with Xrcc4, and loading of the ligation complex is mediated through 
Ku. HR is considered to be a more faithful repair, since it uses the undamaged 
sister chromosome as a template for re-synthesis of the damaged chromosome. A 
complex containing Nbs1, Mre11 and Rad50 resects the broken ends. The complex 
of Rad51 with proteins including replication protein A, Rad52, and Rad54 initiates 
binding to DNA ends by a process that requires Rad52. The Rad51 complex then 
interacts with Rad55 and undamaged DNA and catalyses strand-exchange at a 
homologous site, where the damaged DNA sequence invades the intact molecule. 
After synthesis using the intact molecule as the template, which requires Rad54, 
the ends are ligated by DNA ligase 1 and the crossovers are resolved by cleavage 
and ligation. Whilst HR should by its mechanism allow for faithful repair, it can 
nonetheless give rise to mutated DNA, for instance when repeat sequences lie 
adjacent to the DSB. 
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In normal cells, it seems that both HR and NHEJ are employed for repair of 
endogenous and exogenously produced lesions [20]. Although NHEJ is a simpler 
process, it is rarely error-free due to base removal prior to ligation giving rise 
to small deletions. Moreover, if more than one DSB exists, NHEJ can produce 
inversions or translocations. Therefore, it is expected that differences in the 
reliance of cells on these two distinct forms of DSB repair in different cell types 
would significantly affect damage responses outcome. Furthermore, analysis 
of damage sensitivity in transgenic mice suggests specialized roles for HR and 
NHEJ following exposure to different genotoxic agents and changes in the relative 
contributions of these repair mechanisms during development [21].
2 Signalling from DNA strand breaks
DNA damage triggers cellular processes of growth arrest or apoptosis to ensure 
that damaged DNA is not transmitted to daughter cells. Most damage is repaired 
very quickly and checkpoint pathways are only activated in the presence of 
damage that is difficult to repair, or when damage levels are much higher 
than normal. One initial sensor of damage is the Ku complex, which binds and 
activates DNA-PK and initiates NHEJ [17]. Recent work has demonstrated 
that another major sensor of a DSB is the ATM kinase, which is activated at 
the site of a DNA break by auto-phosphorylation, probably as consequence of 
local changes in chromatin structure [22]. Another feature of the initial events 
in DSB recognition is phosphorylation of a specific histone protein, H2AX, to 
produce γ-H2AX. This phosphorylation event is rapid and extensive, with half-
maximal levels seen within 1 minute [23, 24]. Phosphorylation of H2AX can 
be mediated by either DNA-PK or ATM (25) and γ-H2AX appears to provide a 
structural framework for the subsequent recruitment of DNA repair proteins 
[26, 27]. Because each DSB is associated with a visible γ-H2AX focus [24, 28], 
the immunocytochemical demonstration of γ-H2AX foci acts as a specific and 
sensitive marker of DSBs.
3 Activation of the p53 pathway
The p53 tumour suppressor gene (see Figure 2) is a key regulator of cell cycle 
checkpoints and apoptosis after DNA damage [29 – 32]. In addition, p53 can 
influence DNA repair through transcriptional mechanisms and direct interaction 
with repair proteins, correlating with the localization of p53 at sites of damage 
[33 – 35]. In normal cells, p53 is constantly produced and  levels are controlled 
by Mdm-2-mediated ubiquitination and proteosomal degredation.  This process 
in turn appears to depend on the related protein, Mdmx, which acts to stabilise 
147
STUK-A234
Figure 2. A schematic representation of the p53 signalling pathway in genomic damage 
responses.
Mdm2 [36]. In damaged human cells p53 is phosphorylated at serine 15 by 
DNA-PK, ATM (or the ATM-related kinase ATR) thersby inhibiting Mdm-2 binding 
[37 – 39]. ATM also phosphorylates Mdm-2, further preventing it from degrading 
p53, and Mdm-2 phosphorylation appears to precede p53 phosphorylation [40, 
41]. ATM and / or ATR also phosphorylate a variety of other proteins involved in 
repair and checkpoint control, such as Chk1 and Chk2 and, in turn, activated 
Chk1 and Chk2 phosphorylate p53 at serine20, further affecting the stability 
and activity of p53 [42, 43].
The primary role of activated p53 is to act as a transcription factor to induce 
the expression of proteins involved in cell cycle arrest, or apoptosis [29 – 31]. 
However, p53 may exert pro-apoptotic effects through transcription-independent 
mechanisms, including its translocation to mitochondria and interaction with 
members of the Bcl-2 family (44 – 46). 
Activated p53 is required for the transcriptional activation of the cyclin-
dependent kinase inhibitor CDKN1A (p21waf1 / cip1) to bring about growth arrest in a 
damaged cell. For apoptosis, early studies using p53- / - transgenic mice indicated 
that apoptosis of thymic and gut epithelium after DNA damage requires p53, 
whereas levels of spontaneous apoptosis or apoptosis induced by non-genotoxic 
agents occurs independently of p53 [47 – 49]. A wide variety of gene products 
have now been implicated in inducing p53-dependent apoptosis, including 
pro-apoptotic members of the Bcl-2 family such as Bax, BID, Noxa and PUMA 
and the pro-apoptotic receptors Fas and Killer / DR5 [29 – 31]. However, none of 
these proteins have been shown to be essential for p53-mediated apoptosis after 
genotoxic stress. In addition, p53 stabilization is a tissue- and cell-type-specific 
response after genotoxic insult and the relationship between p53 and apoptosis 
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depends on cell type [50 – 52]. The p53-dependent induction of pro-apoptotic genes 
after whole-body γ-irradiation also varies in different cells and different tissues 
[53 – 56] and different p53-induced proteins have different effects in different cell 
types. For example, p53-mediated induction of p21 has an inhibitory effect on 
p53-dependent apoptosis in the spleen, but does not provide the same survival 
advantage in the small intestine [57]. In contrast, p53-mediated induction of Bax 
influences stress-induced apoptosis of lymphocytes in the splenic white pulp, 
whereas apoptosis in the intestine is not affected by Bax, but instead depends 
on Bcl-2 and Bcl-w [53, 55, 58, 59].
Given that p53 can induce either apoptosis or growth arrest, and that these 
two outcomes will have a profound influence on consequences of cellular responses, 
regulators of the decision between p53-mediated growth arrest and apoptosis in 
individual cells will be key determinants of outcome after both endogenous and 
exogenous damage. High levels of p53 are required for apoptosis while low p53 
levels protect from apoptosis in vitro [60, 61] and  cells from p53+ / - transgenic 
mice show intermediate levels of apoptosis after genotoxic insult [47, 48, 62]. In 
vivo, the level of p53 induced in different individual cells in skin or intestinal 
epithelial cells also correlates with apoptosis [63, 64]. A related determinant is 
the amount of damage incurred by cells influencing differential activation of 
signalling kinases [65] and yet another factor would be differences in the mode 
of activation of p53. Disruption of DNA-PK activity (specific for NHEJ repair of 
breaks) inhibits p53-mediated apoptosis but not growth arrest, whilst disruption 
of ATM signalling has the opposite effect of abolishing growth arrest without 
affecting apoptosis and these effects correspond with differential activation of 
p21 and Bax [66, 67]. Similarly, Chk2 activity is not required for p53-mediated 
growth arrest but is essential for a full apoptotic response [68]. Thus, the decision 
between growth arrest or apoptosis may reflect different phosphorylation patterns 
induced after DNA damage. Direct tests of this hypothesis using transgenic mice 
with mutation of the p53 serine-15 or serine-20 targets have indicated that lack 
of phosphorylation of these residues does not affect growth arrest after DNA 
damage but reduces the apoptotic response [69, 70], although other similar 
studies have suggested that serine-20 phosphorylation affects neither process 
[71]. A further potential mechanism for determining apoptosis versus growth 
arrest is the co-expression of proteins that act as co-factors for p53-mediated 
transcriptional activation. Examples of this mechanism include activities of the 
ASPP proteins, which increase the activation of pro-apototic p53 target genes 
but do not affect p21 activation [72]; the Brn-3a transcription factor enhances 
p53 for activation of p21 but simultaneously blocks Bax induction [73]; the 
transcriptional repressor hDaxx reduces p21 induction but not Bax [74]; p300 
deficiency causes a failure of p21 transactivation and a preferential activation 
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of pro-apoptotic PUMA [75]; and HMBG1/2 selectively inhibit p53-mediated 
Bax expression, in a cell-type specific manner [76].Whilst p53 is undoubtedly 
a central integrator of damage response pathways, not all genotoxic mediated 
apoptosis is p53-dependent [62, 63, 77 – 81]. Given the complexity of the cell 
type- and genotype-dependence of damage responses, it is not surprising that 
experimental studies of damage responses using different systems produce 
different results.
4 Indirect untargeted effects of radiation 
Recently, the view that radiation-induced deposition of energy in the nucleus of an 
irradiated cell leads to all the adverse consequences of radiation exposure has been 
challenged by observations in which effects of ionizing radiation are demonstrated 
in cells that are not themselves irradiated but are the descendants of irradiated 
cells (radiation-induced genomic instability) or cells that have communicated with 
irradiated cells (radiation-induced bystander effects). Radiation-induced genomic 
instability is characterized by the appearance of a number of delayed non-clonal 
effects in the clonal progeny of irradiated cells, including delayed chromosomal 
aberrations and gene mutations, reduced plating efficiency and delayed cell 
death. Radiation-induced bystander effects are generally demonstrated very 
rapidly after irradiation but are characterized by appearing in non-irradiated 
cells that are in close proximity to irradiated cells. Reported bystander effects 
include a variety of both potentially detrimental and protective responses and 
seem to reflect the complexity of damage responses and the mechanisms that 
modulate such responses outlined above. Both classes of untargeted effect do 
not demonstrate a linear relationship to dose but are maximally induced by the 
lowest doses investigated, including a single alpha-particle traversal and have 
recently been very extensively reviewed [82 – 90].
4.1 Radiation-induced genomic instability
Many laboratory studies have demonstrated non-clonal chromosome aberrations 
[91 – 99] and mutations [100 – 104] in the clonal progeny of irradiated cells and 
progeny of irradiated cells have been shown to exhibit an enhanced death rate 
and loss of reproductive potential [102, 105 – 110]. All these various dysgenetic 
effects have been interpreted as manifestations of a radiation-induced genomic 
instability,  a genome-wide process [91, 111 – 113] with a cellular phenotype 
similar to that of the inherited chromosome instability syndromes [114 – 116]. 
Despite the apparent similarities, radiation-induced genomic instability seems to 
reflect epigenetic processes rather than mutation of genome maintenance genes 
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[117 – 120]. However, the radiation-induced chromosomal instability phenotype 
in both haemopoietic tissue [121] and mammary epithelium [122] is strongly 
influenced by genetic factors with some genotypes being susceptible and others 
relatively resistant. 
Although the studies are limited,  there is evidence for radiation-induced 
genomic instability in vivo a [98, 99, 123 – 125] although the consequences of the 
expression of instability are far from clear. In whole body irrradiation studies 
of the haemopoietic system, there was significant inter-individual variation in 
the expression of the chromosomal instability phenotype despite the fact that 
the mice used were inbred, irradiated at the same time and had concurrent 
age-matched controls. The, inter-individual variation in the expression of 
chromosomal aberrations must reflect the biological variation that might be 
expected of complex responses in vivo. Furthermore, when compared to in vitro 
studies of haemopoietic cells, the in vivo data showed less damage per cell and 
fewer cells demonstrating chromosomal instability. This difference also can 
probably be attributed to the cellular mechanisms that have evolved to recognize 
and respond to damage and remove abnormal cells.
At present, the mechanism of induction of instability by ionizing radiation 
is not fully understood nor is it clear whether all endpoints reflect a common 
mechanism. In all the various studies, the frequency of induced instability is 
orders of magnitude greater than that of conventional gene mutation frequencies 
and consistent with epigenetic. processes. In addition, the characteristics of 
delayed mutations more resemble the mutation spectra of spontaneously arising 
mutations than conventional radiation-induced mutations [103] and many of 
the cytogenetic aberrations associated with radiation-induced chromosomal 
instability in primary cells are similar to those arising spontaneously [96, 98, 
99, 126]. Unstable aberrations characteristic of radiation-induced chromosomal 
instability may commonly result in apoptosis and this may account for a 
component of the delayed reproductive death / lethal mutation phenotype in 
some cell systems [105, 118]. Overall, the data are consistent with the induced 
instability phenotype reflecting a process or processes that increase the incidence 
of “spontaneous” genetic lesions.
It is well established that cultured cells acquire spontaneous mutational 
changes as a consequence of free-radical toxicity, attributable largely to the 
generation of hydrogen peroxide from polyamine substrates [127] and in vivo, 
major causes of spontaneous DNA damage are oxidative damage associated with 
normal metabolism [128], ROS produced by phagocytic cells [129, 130] and from 
lipid peroxidation [131]. Thus, the association of radiation-induced chromosomal 
instability with increased intracellular ROS, oxidative DNA base damage and 
vulnerability to free-radical mediated membrane damage in haemopoietic cells 
151
STUK-A234
[117] and an association of increased ROS with radiation-induced delayed death 
in CHO cells [118, 132] provided a potential epigenetic mechanism for radiation-
induced genomic instability. The induction of instability by agents other than 
ionizing radiation is also consistent with free radical-mediated / oxidative stress 
mechanisms [118, 133 – 137]. 
4.2 Radiation-induced bystander effects
The paradigm of genetic alterations being restricted to direct DNA damage 
has also been challenged by a variety of effects, normally detected in irradiated 
cells, being  demonstrated in cells that are not themselves irradiated but in the 
neighbourhood of irradiated cells or exposed to factors produced by irradiated 
cells. Such effects are collectively regarded as radiation-induced bystander effects 
[87 – 89, 119, 138].
Bystander responses include damage-inducible stress responses [139 – 142], 
sister chromatid exchanges [143 – 145], micronucleus formation [146, 147], 
apoptosis [146], gene mutation [148 – 150], and transformation of rodent cells 
in vitro [151, 152]. Whilst many of the studies have concentrated on genome 
damage endpoints, there have also been reports of other effects being induced 
in bystander cells including increased cell proliferation [153] and increased 
cell proliferation associated with decreases in levels of damage signalling 
molecules [154]. A protective adapative response has also been reported, where 
bystander cells that are subsequently irradiated are more radioresistant than 
cells not exposed to bystander signals [155, 156]. Bystander induction of terminal 
differentiation with loss of proliferative potential [157] may also be regarded as a 
protective response. This confusing array of responses is probably explaianed by 
the variety of cell systems used reflecting the complexity of the various responses 
discussed above.
The induction bystander effects may be mediated by at least two separate 
mechanisms for the transfer of a damaging signal from irradiated cells although 
the differences between these two mechanisms may be related not only to cell 
type but also to cell density and other cell context aspects of the in vitro systems 
used in the various studies. One mechanism seems dependent on gap junction 
intercellular communication stimulating a damage-signalling pathway mediated 
by the tumour suppressor gene product p53 [140, 141]. Other studies implicate a 
second mechanism in which irradiated cells secrete cytokines such as TGF-β or 
IL-8 or other factors that act to increase intracellular levels of ROS in unirradiated 
cells [143, 154, 158, 159] and there is evidence linking the NADPH oxidase / NFκB 
pathway to this bystander effect [154]. It has been shown that alpha-particle-
induced reactive oxygen species lead to activation of stress-inducible proteins in 
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both the p53 (e.g. p21, MDM2, p34cdc2) and mitogen-activated protein kinase (e.g. 
ERK12, JNK, p38, Raf1) pathways in bystander cells [142]. Superoxide dismutase 
and catalase were capable of suppressing these effects and also inhibited the 
activation in bystander cells of redox-sensitive transcription factors (NF-κB, 
AP-1 and ATF2). Nitric oxide has also been implicated as a signaling molecule 
in bystander effects [153].
5 Clastogenic factors: long-range acting 
non-targeted mechanisms
Prior to the recent studies of bystander effects, there are numerous reports 
that irradiated cells may produce factors in vivo that can affect the survival 
and function of unirradiated cells [160 – 165]. The effect is attributed to stable 
clastogenic activity in plasma that has also been obtained from atomic bomb 
survivors [166] and Chernobyl liquidators [167, 168].These clastogenic factors 
are also produced by other cellular stresses and in patients with a variety of 
chromosome instability syndromes and inflammatory disorders [169, 170]. 
The factors, a mixture of oxidation products and cytokines, are produced by 
superoxide-mediated mechanisms and they also induce the production of 
superoxide; this may be the explanation of their persistence over many years. 
The vicious circle of clastogenic factor formation and action shifts the pro-oxidant / 
anti-oxidant balance in cells towards the pro-oxidant state and clastogenic 
factors can be regarded as markers of oxidative stress. In general, free radical-
mediated processes and oxidative stress are implicated in a wide variety of 
responses to stress and injury as well as the targeted and untargeted responses of 
ionizing radiation.
6 Radiation-induced bystander effects and 
genomic instability are interrelated 
In addition to the similarity of underlying mechanisms, a link between radiation-
induced genomic instability and bystander effects was indicated by the persistent 
reduction in cloning efficiency of non-irradiated normal and malignant epithelial 
cell lines exposed to medium from irradiated cultures [171]. This effect is 
associated with rapid calcium fluxes, subsequent loss of mitochondrial membrane 
potential and increases in reactive oxygen species in the non-irradiated cells 
[172, 173]. An additional connection was provided by investigations of instability 
in the Chinese hamster-human hybrid GM10115 cell line [97, 118] where 
radiation induces conditions and / or factors that stimulate the production of 
ROS. The reactive species  contribute to a chronic pro-oxidant environment 
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promoting chromosomal recombination and other phenotypes associated with 
genomic instability [174] mediated, at least in part, by a soluble cytotoxic 
factor [120, 175].
The possibility that an instability phenotype might be directly induced 
by a bystander mechanism was raised by the observation that more clonogenic 
haemopoietic stem cells than were traversed by an alpha-particle expressed an 
instability phenotype in vitro [95, 176] and the phenotype was transmissible 
in vivo by bone marrow transplantation [123]. However, the transplantation 
studies were complicated by non-irradiated cells inevitably and unavoidably 
being transferred with irradiated survivors (because of the Poisson distribution 
of α-particles) and it was unclear whether any, or all, chromosomal instability in 
vivo might be attributed to a bystander mechanism. Accordingly, to investigate 
the potential for such a mechanism, mice were transplanted with mixtures of 
non-irradiated cells and cells exposed to neutrons (a densely ionizing radiation 
like α−particles) to model the mixture of irradiated and non-irradiated cells 
in the α-irradiation experiments, The transplantation protocol incorporated 
a congenic, sex-mismatch three-way marker system that distinguished not 
only host-derived cells from donor-derived cells but also cells derived from the 
irradiated or non-irradiated donor stem cells. Using this system, chromosomal 
instability was demonstrated in the progeny of both irradiated and non-irradiated 
stem cells for up to 24 months post-transplantation [124]. A transmissible 
instability could explain the delayed cytogenetic aberrations in the descendants 
of irradiated stem cells but not those in cells descended from non-irradiated stem 
cells. Moreover, the design of the experiment was such that direct interactions 
between irradiated and unirradiated cells were unlikely to be responsible for 
the chromosomal instability phenotype. Rather, the data are consistent with 
descendants of irradiated cells, rather than irradiated cells themselves, providing 
(or inducing) the bystander signal(s). Evidence that these rather complex cell 
interactions are not restricted to experimental models is provided by report of 
a 35-year-old man accidentally exposed to acute high-dose total body neutron 
radiation who received a stem cell transplant from his HLA- identical sister. In 
monitoring this patient, chromosomal instability in donor female cells [177].The 
experimental and clinical data point to the importance of cellular interactions 
in the expression of untargeted effects in vivo.
7 Microenvironmental factors and indirect DNA damage
In an intact organism, all cells are subject to complex regulatory mechanisms 
that depend on their interactions with the cells and cellular products comprising 
their microenvironment. Therefore, cells cannot be considered in isolation, but 
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rather the whole tissue has a role in determining the response of any individual 
cell to any regulatory or damaging signals [178]. In addition, alterations to the 
microenvironment may cause release of DNA damaging agents and the best known 
examples are for inflammation where the production of reactive oxygen species 
and / or reactive nitrogen species by tissue macrophages or neutrophils causes 
collateral damage in neighbouring cells, including gene mutations [179], DNA 
base modifications [180], DNA strand breaks [181, 182] and cytogenetic damage 
[183]. Macrophage derived NO in ulcerative colitis leads to p53 stabilization and 
phosphorylation in colonic epithelium [184] and ROS can also lead to changes 
in DNA methylation, a process that leads to epigenetic alterations in gene 
expression [185].
Recent studies have revealed genotype-dependent, indirect mechanisms 
of tissue responses that result in increased numbers of macrophages exhibiting 
the phenotype of activated phagocytes after whole body irradiation [186]. Nitric 
oxide synthase expression, lysosomal enzyme activity and the capacity to produce 
superoxide were increased in these cells and time course investigations correlated 
enzyme induction with phagocytosis of apoptotic cells. That the macrophage 
activation was associated with the phagocytic clearance of radiation-induced 
apoptotic cells, rather than activation being a direct effect of radiation, was 
confirmed by a number of investigations using p53- / - mice that lack p53-dependent 
radiation-induced apoptosis. Further investigations of the haemopoietic tissues 
revealed an unexpected accumulation of neutrophils at the margins of the 
splenic blood vessels and in splenic tissue. These are classical signs of an 
acute inflammatory response and the timing coincided with the increased 
macrophage activity. Whilst it would be expected that the cell death resulting 
from irradiation requires rapid phagocytic clearance, the increase in enzyme 
activity after phagocytosis, the length of time that activated macrophages persist 
and the inflammatory nature of the process would not be expected as apoptosis is 
generally regarded as a non-inflammatory process and many in vitro studies have 
suggested it to be actively anti-inflammatory [187 – 189]. However, the findings 
are remarkably similar to the neutrophil infiltration observed in the thymus 
after irradiation [190] and a variety of studies now indicate that apoptotic cell 
removal can indeed produce inflammatory-type processes and altered release of 
regulatory cytokines as well as DNA-damaging free-radicals [189]. In vitro studies 
have shown that phagocytosis of apoptotic cells may results in the production of 
both pro- and anti-inflammatory cytokines [191, 192]. Additionally, nitric oxide 
can be either pro- or anti-apoptotic, can either downregulate or upregulate p53 
activity [193, 194] and may be pro- or anti-inflammatory [195] depending on 
context. These findings further highlight the potential for context-dependent 
outcome in damage responses.
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8 Inflammation and pathological 
consequences of genome damage
Inflammation-associated increased free radical production has the potential to 
lead to increased mutation whilst the simultaneous altered secretion of cytokines 
by macrophages will compromise normal immunohaemopoietic regulatory 
circuits. There is direct evidence for such changes and for persistence of these 
changes as the Japanese A-bomb survivors show sub-clinical inflammation even 
50 years after their exposure [196, 197]. Taken together, the experimental and 
clinical  findings provide a plausible mechanistic framework for understanding 
in vivo radiation-induced bystander effects [83 – 85, 87, 88, 138] and for the 
observations of clastogenic factors that are characteristic of ongoing oxidative 
processes [168 – 170, 198].
In addition to the specific examples of tumours associated with 
inflammation, there is a substantial body of evidence for altered stromal function 
associated with inflammatory processes contributing to the development of 
malignancy. A particularly relevant example is radiation leukaemogenesis 
where, in mouse models, acute myeloid leukaemia is reproducibly induced by 
irradiation but not when the mice are re-derived and irradiated under sterile 
conditions. Transferring the mice to conventional housing restores the leukaemia 
inducibility [199]. In an unrelated study, the induction of inflammation did not 
affect the incidence of myeloid leukemia in unirradiated mice but significantly 
increased the incidence of leukaemia in irradiated mice [200]. These studies 
clearly implicate inflammation as microenvironmental component of radiation 
leukaemogenesis.
A role for microenvironmental factors is also supported by studies in which 
bone marrow stromal cells have been shown to aid the survival of irradiated stem 
cells and contribute to the selection and proliferation of a malignant clone [201, 
202]. This is particularly well demonstrated by the frequency of transformation 
of unirradiated growth factor-dependent cells being significantly increased 
by co-culture with irradiated bone marrow stromal cell lines [203 – 205] or by 
transplantation into irradiated syngeneic mice [206, 207]. These effects appear to 
be due to activation of signalling pathways responsible for changes in adhesion 
and growth factor production [208] and for the release of cytokines, such as 
TGF-beta [201] and / or nitric oxide [209] by the irradiated stroma resulting 
in the co-cultured haemopoietic cells expressing high levels of reactive oxygen 
species [201]. Relevant to consideration of stromal influences is the uncommon 
but well-validated occurrence of leukaemia in donor cells following allogeneic 
marrow transplantation for leukaemia or aplastic anaemia [210 – 215] and 
many human and animal studies of leukaemia and myelodysplasia have shown 
functional abnormalities in stromal cells [201, 208, 216 – 220].
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Figure 3. A schematic representation of how targeted and untargeted responses may 
act homeostatically or have the potential for patholo.
Given that inflammation contributes to ageing and a variety of pathological 
conditions [221 – 224], it would be expected that any pathological consequences 
of untargeted inflammatory-like radiation  responses would not be confined to 
malignancy. The increases in cardiovascular, digestive and respiratory system 
diseases in the Japanese A-bomb survivors [225, 226] and the associated 
inflammatory activity that is demonstrable in the blood of these individuals [196, 
197] lends support to the proposal that untargeted consequences of radiation 
injury that have these persisting  inflammatory characteristics may predispose 
to a wide range of health consequences.
9 Conclusions 
The long-standing dogma that energy from ionizing radiation must be deposited in 
the cell nucleus to elicit a biological effect is challenged by, so called, non-targeted 
effects in which responses characteristically associated with directly irradiated 
cells are exhibited by non-irradiated cells. These effects include radiation-induced 
genomic instability and radiation-induced bystander effects. Their expression is 
clearly influenced by cell-type and genetic factors and it is likely that either effect 
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may be a cause or a consequence of the other. At present it is not known to what 
extent these untargeted effects contribute to overall cellular radiation responses, 
especially in vivo, but clearly they may be of particular significance at low doses 
of radiation and may increase or decrease risk of pathological consequences 
depending on the nature of the response. The underlying mechanisms share 
features with inflammatory responses that are characterized by inter-cellular 
signalling, production of cytokines and reactive oxygen / nitrogen species and such 
responses may be protective or damaging depending on context. Whether or not 
all untargeted effects reflect a common mechanism remains to be determined. 
Their manifestations and consequences appear to represent a balance between 
the production of genotoxic / clastogenic factors and the response of the cell to 
such damaging agents and both signal production and signal response may be 
significantly influenced by genetic and cell-type specific factors. It is probable 
that, in addition to targeted effects of damage induced directly in cells by 
irradiation, a variety of untargeted effects may also make important contributions 
to determining overall outcome after radiation exposures (see Figure 3).
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